age	death	sex	hospdead	slos	d.time	dzgroup	dzclass	num.co	edu	income	scoma	charges	totcst	totmcst	avtisst	race	meanbp	wblc	hrt	resp	temp	pafi	alb	bili	crea	sod	ph	glucose	bun	urine	adlp	adls	sfdm2	adlsc
85.6559448242	1	male	0	12	63	Lung Cancer	Cancer	2	12		26				8.5	black	97	9.69921875	56	20	36.59375	357.125		0.3999633789	1	143	7.44921875					7		7
42.258972168	1	female	0	8	370	Colon Cancer	Cancer	0	11	$25-$50k	0	9914			8	hispanic	84	11.298828125	94	20	38.1953125		4.69921875	0.1999816895	0.7999267578	139					0			0.4947998524
43.5399780273	0	female	0	115	2022	ARF/MOSF w/Sepsis	ARF/MOSF	1			26	706577	390460.5		38.25	white	67	24.59765625	172	20	38.796875	113.328125			0.5999755859	134	7.3994140625						SIP>=30	2.7641601563
45.4179992676	1	male	0	7	827	Lung Cancer	Cancer	2			0	8400			7	white	97	10.798828125	100	24	37.296875	585.125		0.299987793	1.0998535156	137	7.4892578125							3.3515625
63.6629943848	1	female	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	0	22	$25-$50k	26	283303	156674.125		40	white	69	30.09765625	108	22	36.6953125	155.53125	2.8999023438	14	2.8999023438	130	7.44921875					0	<2 mo. follow-up	0
41.5219726563	1	male	1	21	21	MOSF w/Malig	ARF/MOSF	2	18	>$50k	26	320843	165178.875		32.6666564941	white	66	0.1999816895	130	18	37.5	315	1.8999023438	3.7998046875	7.2998046875	134	7.359375					0	<2 mo. follow-up	0
60.100982666	1	male	0	15	195	Cirrhosis	COPD/CHF/Cirrhosis	1			0	63466	32079.953125		27.6666564941	white	110	6.2998046875	125	10	38.09375	208	2.7998046875	3.3999023438	1	142	7.439453125							2.3813476563
41.9599914551	1	male	0	4	503	Lung Cancer	Cancer	1	16	>$50k	0	4173	2648.09765625		3	white	97	10.798828125	88	20	36.3984375	380.9375	3.7998046875	0.5	1.0998535156	133	7.4794921875						no(M2 and SIP pres)	2.1796875
31.7019958496	0	female	0	49	1973	Cirrhosis	COPD/CHF/Cirrhosis	0	14		0	231119	101867.9375		15.5	black	77	7.69921875	80	20	37.1953125	490.4375	2.1997070313	2.6997070313	1.3999023438	127	7.4892578125				6	1	SIP>=30	1
72.1719970703	1	male	1	12	12	Lung Cancer	Cancer	1			0	62158	31507.8125		25	white	63	5.099609375	140	36	36.5	176.65625	2.6997070313		1.0998535156	135	7.5595703125					0	<2 mo. follow-up	0
89.5879516602	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	2			100	19238	9710.90625		34	white	33	13.69921875	0	0	38.5	122	2.2998046875	0.5	1	130	7.2890625						<2 mo. follow-up	5.568359375
67.4909667969	0	male	0	24	1951	ARF/MOSF w/Sepsis	ARF/MOSF	1			26	172597	87621.75		24.6666564941	white	100	18.296875	102	20	37.3984375	156	4.7998046875	1.3999023438	5.7998046875	141	7.4697265625							2.7509765625
52.0899963379	1	male	0	11	35	Cirrhosis	COPD/CHF/Cirrhosis	3	8	$11-$25k	0	13414	8930.671875		7.5	white	89	6.3994140625	92	20	37.3984375	442.8125	2.1997070313	10.8984375	1.1999511719	133	7.4296875				5	1	<2 mo. follow-up	1
59.4059753418	1	male	0	9	96	CHF	COPD/CHF/Cirrhosis	2	12	>$50k	0	19852	11541.8046875		17.5	white	57	7.599609375	114	28	36.5		4	1.0998535156	2.7998046875	135					0	0	adl>=4 (>=5 if sur)	0
72.8379516602	1	male	1	109	109	ARF/MOSF w/Sepsis	ARF/MOSF	1			26	740010	357918.75		47.5	white	67	11.599609375	95	18	38.796875	140	2.6997070313		3.5	134	7.4697265625						Coma or Intub	2.8237304688
71.9039916992	1	male	0	9	385	Colon Cancer	Cancer	1	10		0	24612	14901.6640625		7.5	hispanic	106	13.8984375	88	20	36		3.8999023438	0.5999755859	1.2998046875	136					1	0	no(M2 and SIP pres)	0
65.3089599609	1	female	0	25	866	COPD	COPD/CHF/Cirrhosis	1	12	under $11k	26	84901	40449.3125		16	white	99	14.599609375	150	16	37.3984375	348.5625			0.6999511719	136	7.4697265625						SIP>=30	3.0009765625
56.3499755859	1	female	0	15	74	Lung Cancer	Cancer	2			0	26731	13389.5703125		14.3333282471	white	67	7.599609375	140	36	39	216.65625			0.7999267578	135	7.4599609375							3.6875
75.367980957	1	male	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	1			26	125256	64887.8125		35	white	63	12.8984375	60	4	37.796875	166		1.0998535156	8.599609375	132	7.4697265625						<2 mo. follow-up	2.9306640625
53.866973877	0	male	0	4	1909	CHF	COPD/CHF/Cirrhosis	2	18		0	20923	12116.03125		6	white	63	6.5	68	26	36	400	3.8999023438	0.0999908447	1.2998046875	139	7.4599609375				0		no(M2 and SIP pres)	0.4947998524
37.7189941406	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	0	13		26	268805	132976.5		48	white	61	0.0999908447	140	45	39.09375	238		0.7999267578	2.7998046875	148	7.4296875					1	<2 mo. follow-up	1
77.1309814453	1	male	0	5	465	Lung Cancer	Cancer	3			0	29403	5321.59375		17	white	62	5.599609375	82	12	36.3984375	276.1875			1.1999511719	135	7.4296875							2.9814453125
58.9599914551	0	female	0	26	1882	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	$25-$50k	9	207902	121042.4375		23	white	115	6.19921875	132	20	39.796875	326.625			0.5999755859	136	7.5					0	adl>=4 (>=5 if sur)	0
77.0949707031	1	male	0	9	248	CHF	COPD/CHF/Cirrhosis	2	16	>$50k	9	23862	13112.53125		17.5	white	93	11.599609375	86	22	36.59375				3.3999023438	137					3	0		0
83.6409912109	0	male	0	12	1862	CHF	COPD/CHF/Cirrhosis	1	10		9	25653	14852.3984375		14.5	white	63	10.69921875	62	28	39.3984375	214.28125		1	2.5	131	7.439453125				1	1		1
61.4539794922	1	male	0	16	523	Colon Cancer	Cancer	1	30	>$50k	0	60175	33484.4375		17.6666564941	white	102	12.8984375	90	20	37		3.599609375	0.5	1.5	137							no(M2 and SIP pres)	2.0556640625
77.7469482422	1	male	0	6	422	Lung Cancer	Cancer	1			0	16325	7677.796875		11	other	89	19.296875	80	18	36.8984375			0.5	1.2998046875	133						0	no(M2 and SIP pres)	0
71.5459594727	1	male	0	7	77	Lung Cancer	Cancer	1	20	>$50k	0	23304	12482.875		12	white	120	3.5	89	26	36.8984375	257.125		0.5999755859	1.1999511719	137	7.509765625				1	0	no(M2 and SIP pres)	0
52.6789855957	0	male	0	5	1853	CHF	COPD/CHF/Cirrhosis	2	16		0	17110	10086.71875		21	asian	60	3.599609375	150	16	36.796875		4.099609375	0.6999511719	1.0998535156	137					0		no(M2 and SIP pres)	0.4947998524
25.4869995117	1	male	1	19	19	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	126732	61916.21875		19.6666564941	white	123	1.6999511719	100	48	38.5	191.8125	3.099609375	9	2.2998046875	143	7.4091796875						<2 mo. follow-up	2.3955078125
88.6949462891	1	male	1	9	9	Coma	Coma	2		>$50k	89	24242	14263.6171875		16	white	102	11.599609375	123	14	38.3984375	397.125	3.099609375	0.6999511719	5.69921875	135	7.4091796875					0	<2 mo. follow-up	0
71.8629760742	1	male	0	3	12	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	3869	2602.37109375		6	white	87	8.099609375	80	20	36.09375	342.8125			1.5	138	7.439453125						<2 mo. follow-up	2.2963867188
56.6649780273	1	male	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	0			0	206651	102511.375		47.6666564941	white	63	18.59765625	125	30	38.5	148		16.796875	4.099609375	147	7.189453125						<2 mo. follow-up	2.3227539063
52.4489746094	1	male	0	6	1079	Lung Cancer	Cancer	2			0	10469	6520.19921875		10	white	84	11.5	80	20	36.1953125		4.5	0.299987793	1	136						0		0
50.5299987793	1	male	0	6	1349	CHF	COPD/CHF/Cirrhosis	2	13		0	18574	11205.3984375		16		66	4.8994140625	80	24	36.6953125				1.3999023438	134								2.0595703125
52.3719787598	1	male	0	5	644	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	6622	3758.236328125		11	black	102	15.5	80	18	37	300			1	140	7.4296875				1		no(M2 and SIP pres)	1.1668996811
38.8829956055	0	male	0	15	1807	ARF/MOSF w/Sepsis	ARF/MOSF	0	16		37	34680	18825.921875		18.6666564941	hispanic	83	7	110	30	38.6953125	257.125	3.599609375	0.0999908447	0.6999511719	133	7.44921875					6	adl>=4 (>=5 if sur)	6
60.8569946289	1	female	0	9	309	Lung Cancer	Cancer	0			0	22052	13990.0859375		11	white	98	3.7998046875	110	20	37.5	196	4.19921875	0.0999908447	1.0998535156	136	7.4091796875							2.55078125
66.5459594727	1	male	1	45	45	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	>$50k	0	348628	177669.875		37.75	white	67	19.69921875	150	20	39.3984375	182.5	3.7998046875	1.6999511719	1.5	127	7.4697265625						<2 mo. follow-up	2.9897460938
20.31199646	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	0	13		0	99728	51038.15625		45.5	white	117	6.2998046875	160	26	40.09375	130	2.8999023438	2.5	3	141	7.439453125					3	<2 mo. follow-up	3
80.1939697266	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	0			61	29857	15619.8046875		17	white	98	11.099609375	90	32	38.5	355.5			1.1999511719	141	7.439453125						<2 mo. follow-up	2.9487304688
23.816986084	1	male	0	73	144	MOSF w/Malig	ARF/MOSF	1	13	$25-$50k	0	245347	129712.875		15	black	127	17	140	28	37.8984375	53.328125			1.3999023438	135	7.4296875				0	2	adl>=4 (>=5 if sur)	2
81.4539794922	1	male	0	30	163	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	92518	46889.40625		21.75	white	60	8.3984375	75	40	38.8984375	391	3		1.0998535156	132	7.529296875							2.4912109375
38.4969787598	0	male	0	62	1766	ARF/MOSF w/Sepsis	ARF/MOSF	1	17	>$50k	26	463001	269057		26.5	white	73	10.099609375	130	18	38.59375	237.5	3.099609375	13.798828125	1.0998535156	145	7.529296875					0	no(M2 and SIP pres)	0
57.0179748535	1	female	0	5	1462	CHF	COPD/CHF/Cirrhosis	2			0	12504	7491.3046875		9	white	93	12.19921875	88	18	37.1953125	423.75	4.69921875	0.5999755859	0.8999023438	133	7.419921875							2.4633789063
67.410949707	1	male	1	4	4	Coma	Coma	1			100	19247	10152.1171875		32	white	35	13	140	10	41	171.40625			4.2998046875	151	7.509765625						<2 mo. follow-up	2.9233398438
34.4609985352	1	female	1	3	3	MOSF w/Malig	ARF/MOSF	1			0	193371	93435.3125		33	white	33	1.0998535156	130	35	35.8984375	80	2.5	0.8999023438	1.2998046875	141	7.369140625						<2 mo. follow-up	1.951171875
49.2899780273	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	0	73143	38012.75		60	white	47	2.3999023438	160	40	34	85			3	139	7.0693359375						<2 mo. follow-up	2.1860351563
52.6899719238	1	male	0	8	353	MOSF w/Malig	ARF/MOSF	1			26	50315	27577.90625		13	white	125	15.599609375	118	36	37	310			0.8999023438	141	7.4697265625							3.7290039063
73.6649780273	1	male	0	7	31	Colon Cancer	Cancer	1	12	under $11k	0	9640	6026.8203125		7	white	93	3.5	84	20	36.3984375				1.5	133						3	<2 mo. follow-up	3
46.5789794922	1	male	0	7	316	CHF	COPD/CHF/Cirrhosis	1	22	under $11k	0	17254	10264.8203125		12	black	72	6.2998046875	100	20	36.1953125				1.5998535156	136					0			0.4947998524
70.6389770508	1	male	0	32	376	ARF/MOSF w/Sepsis	ARF/MOSF	1	18		0	104045	60743.46875		14.5	white	80	11.298828125	95	18	37	148.3125	4.19921875	0.6999511719	5.7998046875	139	7.2294921875				0			0.4947998524
35.25	1	female	0	38	1607	MOSF w/Malig	ARF/MOSF	1			0	271731	130874.125		26.75	white	60	6.7998046875	135	33	39	128.875	3	0.1999816895	5.5	133	7.51953125							2.2861328125
61.7879943848	0	female	0	3	1690	Lung Cancer	Cancer	1	12		0	4226			12	black	93	8.099609375	106	24	37			0.299987793	1.5998535156	129							no(M2 and SIP pres)	2.50390625
79.1649780273	0	female	0	3	1655	CHF	COPD/CHF/Cirrhosis	2		under $11k	0	3974	2517.951171875		8	white	139	6.19921875	76	24	36.3984375	466.625			1	141	7.4599609375							2.2495117188
81.6649780273	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	0	17	$11-$25k	41	31827	16880.546875		22	white	97	22.09765625	100	24	38.3984375	225.6875			1	135	7.44921875						<2 mo. follow-up	3.646484375
50.7539978027	1	male	1	18	18	ARF/MOSF w/Sepsis	ARF/MOSF	1			100	448431	236295.25		33	white	42	10.69921875	118	12	38.8984375	270	3.599609375	13.69921875	1.6999511719	131	7.509765625						<2 mo. follow-up	3.8657226563
54.4909973145	0	male	0	6	1638	Cirrhosis	COPD/CHF/Cirrhosis	2			0	9974	5706.22265625		10	white	95	6.8994140625	78	18	36.3984375		2.3999023438	5.599609375	0.8999023438	125								3.3310546875
42.2939758301	1	male	1	5	5	Cirrhosis	COPD/CHF/Cirrhosis	4			44	49389	24999.875		37	white	67	23.59765625	130	32	36.5	167.5	3.1997070313	8	2.599609375	134	7.529296875						<2 mo. follow-up	3.955078125
24.4929962158	0	male	0	37	1619	ARF/MOSF w/Sepsis	ARF/MOSF	0	12		0	149776	73399.875		28	white	108	29.796875	140	10	38.6953125	394.25	2.2998046875	7.599609375	0.7999267578	132	7.44921875					0	SIP>=30	0
67.583984375	1	male	0	4	482	Lung Cancer	Cancer	3	12	$11-$25k	0	10819	5204.73046875		17	black	97	12	80	20	35.796875				1.1999511719	135							no(M2 and SIP pres)	2.7944335938
66.0009765625	0	male	0	7	1608	CHF	COPD/CHF/Cirrhosis	2	12	$25-$50k	0	31463	15501.328125		9	white	57	8.69921875	115	22	36.5		4.7998046875	0.3999633789	1.5998535156	135					1	0	no(M2 and SIP pres)	0
51.6219787598	1	male	1	4	4	MOSF w/Malig	ARF/MOSF	1	10		44	85043	42495		47	black	57	0.0499954224	145	40	40	178		2.1997070313	7.7998046875	133	7.2890625						<2 mo. follow-up	2.771484375
26.0229949951	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	under $11k	44	166772	82111.625		47	hispanic	40	3.2998046875	125	32	36	158			2.8999023438	130	7.3193359375					1	<2 mo. follow-up	1
60.5449829102	1	male	1	16	16	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$25-$50k	26	283844	136717.875		41	hispanic	107	10.599609375	125	35	38.5	202	1.6999511719	9.298828125	1.1999511719	143	7.3896484375						<2 mo. follow-up	2.7592773438
76.6349487305	1	male	0	25	59	CHF	COPD/CHF/Cirrhosis	2	11	$11-$25k	0	63938			14.25	white	47	14.3984375	95	30	37.5	184			1.5998535156	134	7.4599609375				0	1	<2 mo. follow-up	1
24.566986084	0	female	0	66	1571	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	392270			29.75	hispanic	65	10.19921875	130	32	38.5	166.65625		0.7999267578	8.798828125	137	7.369140625					0	adl>=4 (>=5 if sur)	0
21.0919952393	1	male	1	6	6	Coma	Coma	0	12	>$50k	89	91295	43409.40625		36	white	57	26.69921875	130	14	38.8984375	463.3125		12.5	1.0998535156	150	7.4296875						<2 mo. follow-up	2.5375976563
66.1409912109	1	male	1	8	8	COPD	COPD/CHF/Cirrhosis	3	16	>$50k	0	21075	9588.359375		11	white	108	14.099609375	132	32	36.59375	247.8125			1	137	7.2890625						<2 mo. follow-up	4.0595703125
79.9779663086	1	female	1	37	37	ARF/MOSF w/Sepsis	ARF/MOSF	1	15		26	214894	94687		34.75	white	64	25.5	111	40	36.5	105		0.7999267578	2.3999023438	129	7.369140625					0	<2 mo. follow-up	0
72.7149658203	0	female	0	17	1490	CHF	COPD/CHF/Cirrhosis	1	14	$11-$25k	0	76132	37674.5625		10.6666641235	black	105	7.5	110	26	36.5				1	138					0	0	adl>=4 (>=5 if sur)	0
65.5389404297	0	female	0	6	1490	Lung Cancer	Cancer	2	14	$25-$50k	0	7769	3896.740234375		10	white	125	9.599609375	88	22	36.3984375				0.7999267578	139					0	0	no(M2 and SIP pres)	0
81.6759643555	1	female	1	16	16	ARF/MOSF w/Sepsis	ARF/MOSF	2			41	125968	60127.875		39.3333129883	white	58	16	60	10	37.1953125	74.4375			0.8999023438	135	7.4296875						<2 mo. follow-up	3.7275390625
59.1019897461	1	male	0	8	25	CHF	COPD/CHF/Cirrhosis	3	7	$25-$50k	0	34775	17118.25		18.5	hispanic	55	8.099609375	85	28	36.296875		3.1997070313	3	1.2998046875	134					2	2	<2 mo. follow-up	2
60.7939758301	1	female	0	20	136	ARF/MOSF w/Sepsis	ARF/MOSF	2	10		26	141714	67726.3125		31.3333282471	white	59	12.8984375	155	28	38.59375	119.984375		1.1999511719	0.8999023438	137	7.5					0	no(M2 and SIP pres)	0
42.0369873047	1	male	1	28	28	Cirrhosis	COPD/CHF/Cirrhosis	1	20	>$50k	0	100295	48086.9375		16.25	white	77	6.7998046875	82	20	36.3984375		1.3999023438	17.296875	2	128						0	<2 mo. follow-up	0
59.8059997559	0	female	0	21	1437	COPD	COPD/CHF/Cirrhosis	2	14	$25-$50k	26	75895	34792.25		15.3333282471	asian	128	13.69921875	145	26	37	222.84375			0.6999511719	143	7.349609375					0		0
47.9319763184	1	female	1	5	5	MOSF w/Malig	ARF/MOSF	3			0	92238	45525.53125		45	white	60	0.0499954224	150	40	36.296875	167.34375	2.599609375	2.1997070313	2.8999023438	129	7.3994140625						<2 mo. follow-up	3.251953125
48.1479797363	0	male	0	4	1432	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	23166	11004.8984375		11	white	78	14.099609375	82	18	36.796875	86		0.6999511719	1	138	7.4091796875							2.1948242188
77.8589477539	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1			26	89858	41205.5625		39	white	58	8.69921875	165	16	38.796875	91.109375	1.6999511719	0.8999023438	1.5	143	7.4091796875						<2 mo. follow-up	3.6572265625
72.3229980469	1	male	0	18	66	Colon Cancer	Cancer	2			0	36244	20509.875		11.3333282471	white	81	16.296875	112	20	39.1953125		3.099609375		0.7999267578	128								3.3491210938
34.3219909668	1	female	0	40	150	ARF/MOSF w/Sepsis	ARF/MOSF	3	10	$11-$25k	55	271769	136256.625		26.5	hispanic	115	13.19921875	110	16	39.5	166.65625		0.6999511719	7.3994140625	136	7.359375					6	adl>=4 (>=5 if sur)	6
65.7109985352	1	female	0	44	394	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	>$50k	0	497053	228884.625		38.75	white	50	13.69921875	95	12	38.5	106.65625	3.599609375	2.3999023438	5	144	7.5					0		0
66.0919799805	1	male	0	4	54	Lung Cancer	Cancer	1	18	>$50k	0	8272	3430.810546875		11	asian	83	6.2998046875	90	20	36.59375				0.7999267578	132					0		<2 mo. follow-up	0.4947998524
67.9259643555	1	female	0	11	1000	Colon Cancer	Cancer	1	12		0	30406	15743.890625		19	white	108	28.19921875	108	20	36.59375		3.2998046875	2.099609375	0.6999511719	137								2.3935546875
78.0509643555	0	male	0	26	1328	ARF/MOSF w/Sepsis	ARF/MOSF	1	16		26	167412	81337.0625		28	white	52	8.3984375	110	10	38.5	98.75			1.3999023438	141	7.529296875					0	no(M2 and SIP pres)	0
49.6099853516	0	female	0	4	1084	Cirrhosis	COPD/CHF/Cirrhosis	1	14	>$50k	0	5215	3137.345703125	3357.189453125	8	white	71	4.8994140625	64	22	36.3984375		2.2998046875	1.5	1.0998535156	139		104	19	360	1	1	no(M2 and SIP pres)	1
44.900970459	1	female	1	25	25	MOSF w/Malig	ARF/MOSF	4	14	>$50k	0	307552	119536.1875	134474.75	36.25	other	62	16.8984375	95	26	36.296875	125	3.3999023438	2.5	2.8999023438	144	7.4794921875	433	40	1240		0	<2 mo. follow-up	0
70.9079589844	1	male	1	18	18	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	9	390845	51077.6875	54144.125	36.6666564941	white	50	26.19921875	120	28	38.6953125	392.5625		5.5	2.1997070313	133	7.509765625	213	65	5880			<2 mo. follow-up	3.4643554688
61.3939819336	1	male	0	11	20	CHF	COPD/CHF/Cirrhosis	3	14	$11-$25k	0	54893	23850.453125	28051.6875	31.5	white	75	9.798828125	65	20	36			1.5998535156	1.7998046875	129		80	63	2375		2	<2 mo. follow-up	2
62.5	1	female	0	4	229	Lung Cancer	Cancer	1	9	under $11k	0	10163	4479.34765625	4604.37890625	16	white	113	6.5	80	20	36		3.7998046875		0.8999023438	138		194	9	5700	5		no(M2 and SIP pres)	3.8549804688
79.7039794922	1	female	1	11	11	MOSF w/Malig	ARF/MOSF	5	16	$11-$25k	0	56752	24689.453125	31170.0625	33.5	white	60	22	110	36	36.09375	108	2.599609375		0.5	135	7.4599609375		16	1870			<2 mo. follow-up	3.6772460938
67.7149658203	0	female	0	7	1036	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	>$50k	0	46447	10272.25	12649.1328125	14.5	white	72	8.798828125	72	22	36.5	83.328125	2.3999023438	0.6999511719	0.8999023438	133	7.5390625	95	11	2050	2		no(M2 and SIP pres)	1.8388671875
48.7359924316	1	female	0	26	314	Lung Cancer	Cancer	1			0	117616	50040.34375	57753.0625	12	white	73	5	96	24	37.5			0.1999816895	0.8999023438	135		88	9	4735				3.0268554688
44.0249938965	1	male	0	6	8	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	55	35099	14571.921875	56632.71875	38	white	75	11.19921875	100	10	37.5	328.5625	2	35	1.1999511719	136	7.4296875	106	19	3520		6	<2 mo. follow-up	6
47.9509887695	1	male	0	10	77	MOSF w/Malig	ARF/MOSF	3	18	$11-$25k	0	53439	16939.046875	18911.234375	23.5	hispanic	98	12.5	110	36	39.3984375	419	1.7998046875		1.5998535156	134	7.369140625	157	25	1450		0	adl>=4 (>=5 if sur)	0
75.876953125	0	male	0	9	969	ARF/MOSF w/Sepsis	ARF/MOSF	1	19	>$50k	0	39709	17396.390625	20330.390625	32	white	68	7.3994140625	95	8	37.6953125	243.3125			1.2998046875	133	7.5498046875		25	4468			no(M2 and SIP pres)	2.2265625
38.9429931641	1	female	1	16	16	Cirrhosis	COPD/CHF/Cirrhosis	5	12	under $11k	94	283724	59525.15625	61740.71875	39	asian	118		115	34	36.5	178		50.09375	3.1997070313	151	7.5791015625	261	65	1200		0	<2 mo. follow-up	0
48.4709777832	1	female	0	15	22	Lung Cancer	Cancer	1	17	under $11k	0	41422	21064.265625	117872.1875	15.3333282471	white	69	12.798828125	112	24	36.1953125	366.625	3.3999023438	0.1999816895	0.6999511719	136	7.4697265625	184	9	2800	1	0	<2 mo. follow-up	0
62.3459777832	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$25-$50k	26	54050	23091.921875	26999.375	53	white	45	24.3984375	75	27	39.796875	115	2	1.7998046875	1.1999511719	146	7.5595703125	145	56	2540		0	<2 mo. follow-up	0
19.7649993896	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	0			0		21340.4375	97894.9375	49	hispanic	45	18.796875	145	40	38.3984375	402.8125			1.6999511719	135	7.369140625	302	71	1707			<2 mo. follow-up	2.1357421875
69.125	0	female	0	8	942	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	64500	9428.2890625	25010.859375	17	white	105	10.69921875	120	28	36	134.6875		0.1999816895	0.7999267578	140	7.4091796875			540	0	2	no(M2 and SIP pres)	2
72.3389892578	0	female	0	23	923	ARF/MOSF w/Sepsis	ARF/MOSF	0			37	146792	47670.3125	73489.0625	24.3333282471	white	132	19.296875	75	16	37.6953125	293.875			0.5999755859	135	7.3896484375	149	18	1615		1		1
70.6229858398	1	male	0	15	44	Lung Cancer	Cancer	1	12	$25-$50k	0	48292	20661.46875	23549.265625	15.3333282471	white	93	25.09765625	104	20	36.59375		3.2998046875	0.299987793	1.2998046875	129		148	19	3250	0	0	<2 mo. follow-up	0
55.583984375	1	female	0	110	208	MOSF w/Malig	ARF/MOSF	1	11	$11-$25k	0				50.5	white	130	19.5	125	24	37.59375	81.109375	1.6999511719	7.7998046875	0.6999511719	126	7.349609375	188	22	6865			SIP>=30	2.9018554688
82.9899902344	1	male	0	12	220	CHF	COPD/CHF/Cirrhosis	2	8	$11-$25k	0	51711	26562	33344.65625	22	white	73	9.5	60	28	36.1953125		3.8999023438	1	1.8999023438	139		113	32	4750	0	0	no(M2 and SIP pres)	0
38.0779724121	0	female	0	4	911	MOSF w/Malig	ARF/MOSF	1	16	$11-$25k	0	51241	13257.8125	8457.6953125	18	white	67	9.3984375	108	24	35.796875	410	2.1997070313	0.5999755859	1.3999023438	131	7.3994140625	104	37	2850				2.4296875
27.2909851074	0	female	0	11	910	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	50203	21781.484375	21434.46875	13	white	107	16.796875	125	35	39.3984375	96	3.599609375	0.299987793	2.3999023438	144	7.4296875	128	28	1741				3.1616210938
65.7469482422	1	female	0	21	186	ARF/MOSF w/Sepsis	ARF/MOSF	1			44	130357	47683.0625	58079.34375	29.6666564941	white	67	13.599609375	55	8	38	105.09375		20.09765625	1.2998046875	135	7.5			4017				3.0336914063
23.2469940186	1	male	1	23	23	MOSF w/Malig	ARF/MOSF	1	12	>$50k	0	419195	115365.25	102054.6875	36.3333129883	white	67	0.0499954224	145	42	38.3984375	144.875		8.69921875	1.6999511719	145	7.2890625	598	69	3920		0	<2 mo. follow-up	0
45.3109741211	1	male	0	11	93	Colon Cancer	Cancer	2	12	$11-$25k	0	32838	14494.5859375	16710.171875	14.5	white	125	7.8994140625	74	22	38.5			2.3999023438	0.6999511719	140		111	10	1800	0	1		1
65.9989624023	1	male	0	5	62	Colon Cancer	Cancer	1	18	$25-$50k	0	3792	2358.478515625	2450.26953125	9	black	77	6.2998046875	64	24	36.3984375		3.7998046875	1.3999023438	1.2998046875	124		121	15	1935	0			0.4947509766
54.8529968262	1	male	0	37	174	ARF/MOSF w/Sepsis	ARF/MOSF	4			26	272366	77111.5625	117935.1875	37.25	white	72	8.5	125	26	39.3984375	174		3	1.6999511719	142	7.4892578125	122	32	3411				3.4838867188
64.883972168	1	male	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	4	14	$25-$50k	0	221993	45616.8125	47116.8125	30.5	white	48	15.69921875	95	22	36.796875				3.099609375	127			60	100		5	<2 mo. follow-up	5
88.9119873047	0	female	0	11	841	Coma	Coma	2	17	$25-$50k	41	43891	17630.46875	18825.796875	17	black	131	15.099609375	150	8	38	371.375			0.8999023438	134	7.3994140625		12	1830		5	adl>=4 (>=5 if sur)	5
63.3699951172	0	male	0	19	825	ARF/MOSF w/Sepsis	ARF/MOSF	0			0	140411	28087.625	41106.78125	19	hispanic	72	8.69921875	60	34	37.8984375				0.7999267578	126			28	1585		0	Coma or Intub	0
91.6189575195	1	male	0	5	172	Coma	Coma	2	12		55	10709	5111.09375	6091.73828125	12	white	69	10.3984375	80	24	38				1	140			10	1125		7	adl>=4 (>=5 if sur)	7
58.6059875488	1	female	0	25	103	ARF/MOSF w/Sepsis	ARF/MOSF	3	15	>$50k	26	538323	52945.78125	48681.09375	36.5	asian	57	10	115	34	37.796875	323.3125	4.099609375	1.5	2	128	7.5	156	58	2708		0	no(M2 and SIP pres)	0
40.7799987793	0	male	0	19	814	ARF/MOSF w/Sepsis	ARF/MOSF	2	18	$11-$25k	0	105330	47823.34375	61883.25	32	white	58	5	115	10	38.8984375	234		1.5998535156	1.0998535156	132	7.4599609375	76	12	3055		0	no(M2 and SIP pres)	0
77.2899780273	0	male	0	4	809	CHF	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	4408	2348.4765625	2657.638671875	8	white	65	5.7998046875	68	16	36				1.3999023438	130			26	3220	0		no(M2 and SIP pres)	0.4947509766
58.1439819336	1	male	0	10	540	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	32904	18238.03125	17585.109375	20	hispanic	57	9.099609375	70	24	36.5		3.6997070313	0.5999755859	1.7998046875	136		102	25	4050	0		no(M2 and SIP pres)	0.4947509766
58.0939941406	1	male	0	13	47	MOSF w/Malig	ARF/MOSF	1	14		44	75939	27794.015625	30730.8125	35	white	62	13.3984375	120	20	36.3984375			0.8999023438	2.1997070313	134		72	54	1207		0	<2 mo. follow-up	0
35.5019836426	0	female	0	14	796	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	under $11k	26	86275	36490.5	38960.21875	25.6666564941	black	68	2.6997070313	115	26	39.5	118.515625	3.3999023438	2.1997070313	1.1999511719	136	7.5390625	174	24	3550			no(M2 and SIP pres)	3.861328125
65.0289916992	0	female	0	7	795	Coma	Coma	1	12		37	64130	33178.59375	32269.296875	19	white	98	12.798828125	55	28	37.8984375	300			0.5999755859	138	7.5	263	14	5420		0	adl>=4 (>=5 if sur)	0
34.4719848633	0	male	0	4	790	ARF/MOSF w/Sepsis	ARF/MOSF	0			26	19858	8356.9140625	9044.4453125	24	white	83	8.69921875	105	32	36.59375	247.59375			0.8999023438	135	7.5	149	16	1000				2.8930664063
41.4869995117	0	male	0	11	777	Colon Cancer	Cancer	1			0	37940	15992.109375	14087.5546875	19	black	108	3.5	135	24	37.8984375		4.5		1.2998046875	139		90	12	3021				2.162109375
78.9049682617	1	male	0	6	255	CHF	COPD/CHF/Cirrhosis	2	10		0	19787	8015.1484375	9785.4765625	17	white	62	6.5	115	24	36.1953125				1.0998535156	138			12	1125	0	0		0
54.616973877	1	male	0	8	300	Lung Cancer	Cancer	1	14	$25-$50k	0	20575	10134.015625	10377.90625	14.5	white	79	0.299987793	60	22	38				0.6999511719	126			11	3250		2	no(M2 and SIP pres)	2
39.5239868164	0	male	0	4	723	CHF	COPD/CHF/Cirrhosis	2	11		0	8793	4615.76953125	4074.408203125	13	black	72	4.3994140625	115	20	36.09375				1.3999023438	132		82	22	5620				2.2358398438
54.616973877	1	female	0	28	312	ARF/MOSF w/Sepsis	ARF/MOSF	5	12		26	144291	53110.90625	56445.84375	22.75	white	57	19.8984375	110	6	39.09375	222.84375			6.19921875	142	7.4296875	96	36	5	5			3.8549804688
61.491973877	0	female	0	39	715	ARF/MOSF w/Sepsis	ARF/MOSF	0			0	270064	81985.25	78320.625	26.25	black	72	19.3984375	115	34	38.5	292.5			1.6999511719	148	7.5595703125	110	71	1118				2.1645507813
51.4609985352	1	female	1	9	9	Lung Cancer	Cancer	3			9	38782	15543.375	15952.21875	10.5	white	59	10	112	36	36.59375				1	141		112	14	350			<2 mo. follow-up	3.2802734375
69.1329956055	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	$25-$50k	44	57562	18690.71875	23200.703125	51	asian	68	5.3994140625	135	28	38.1953125	80		0.5999755859	1.1999511719	133	7.4599609375	140	15	3010		3	<2 mo. follow-up	3
68.0879516602	0	male	0	69	692	ARF/MOSF w/Sepsis	ARF/MOSF	1	18		0	543761			45.25	white	67	18.09765625	75	12	36.59375	186.65625		2.3999023438	5	129	7.4892578125	221	63	20		0	adl>=4 (>=5 if sur)	0
27.3019866943	0	female	0	16	691	ARF/MOSF w/Sepsis	ARF/MOSF	2			26	147320	44378.1875	43762.8125	26.3333282471	hispanic	98	15.599609375	105	48	36.796875	197.9375		0.6999511719	1.1999511719	135	7.419921875	177	22	3405				3.5473632813
64.6629638672	0	female	0	25	690	CHF	COPD/CHF/Cirrhosis	2	15	$11-$25k	0	82891	35861.9375	35270.21875	20.75	white	58	12.19921875	145	26	36.1953125		2.8999023438	0.6999511719	1	129		92	13	1265	0			0.4947509766
37.2569885254	1	male	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	6	10	under $11k	0	188152	63810.84375	66264.5	59	hispanic	65	9.8984375	100	42	34.8984375	87.5		31.5	4.19921875	146	7.4296875	152	75	847		0	<2 mo. follow-up	0
57.9139709473	1	female	0	34	95	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	0	376476	77035.1875	83668.4375	37.75	white	120	23	125	12	37.59375	130			1.1999511719	136	7.44921875	294	40	2770		2	adl>=4 (>=5 if sur)	2
43.1289978027	1	female	0	9	380	Lung Cancer	Cancer	1			0	32776	15275.6171875	15465.8125	12.5	white	73		80	16	38.1953125				0.6999511719	140		87	10	2375				2.9306640625
75.4609985352	1	female	0	5	451	CHF	COPD/CHF/Cirrhosis	3			0	22979	9299.4453125	9028.5234375	31	black	114	7.099609375	70	30	36.59375	211.09375			0.8999023438	145	7.33984375	102	18	5650				3.3642578125
82.0259399414	1	male	0	26	311	ARF/MOSF w/Sepsis	ARF/MOSF	3			0	122708	45664.90625	48383.53125	23.75	white	55	18.09765625	175	31	36	260			1.7998046875	137	7.4697265625	179	50	1337			Coma or Intub	3.47265625
84.467956543	1	female	1	3	3	Coma	Coma	2	10	under $11k	100	9740	4209.60546875	4440.21875	17	black	110	15.099609375	155	44	36.59375	680	2.599609375	0.8999023438	1.5998535156	131	7.4599609375	114	47	15			<2 mo. follow-up	5.763671875
63.8819885254	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	2			41	178201	23809.09375	25333.078125	47	white	113	12.599609375	135	49	39.5	130			1.3999023438	143	7.4794921875	148	24	1710			<2 mo. follow-up	3.2309570313
50.5109863281	0	female	0	25	636	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	$25-$50k	9	131648	43402.21875	27873.109375	23.5	white	99	40.796875	120	24	37.8984375	254.65625		4.099609375	0.7999267578	139	7.529296875	107	8	3320	0			0.4947509766
42.4499816895	1	female	0	3	38	Lung Cancer	Cancer	1	17	>$50k	0	10409	4667.83984375	5180.37890625	12	white	115	11.69921875	112	24	36.796875				0.6999511719	138			7	570			<2 mo. follow-up	2.4477539063
29.2699890137	1	male	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	2			41	272792	110223.4375	120070.4375	45	hispanic	105	6.19921875	115	10	38	228	3	8.798828125	1.5998535156	155	7.5	259	99	6920			<2 mo. follow-up	3.0727539063
71.1289672852	1	female	0	8	116	COPD	COPD/CHF/Cirrhosis	1	13	$11-$25k	37	57493	14015.828125	13624.9296875	16	white	98	17.09765625	135	39	36.5	225.6875			1	130	7.3896484375	224	23	2487			Coma or Intub	3.3452148438
69.1939697266	0	male	0	8	586	CHF	COPD/CHF/Cirrhosis	3	12		0	23046	12267.5390625	10595.765625	16	white	51		95	20	35.8984375				1.6999511719	128			27	2750	0	4		4
68.6869506836	1	male	0	5	257	CHF	COPD/CHF/Cirrhosis	2	12	>$50k	0	7975	4697.3515625	4011.48828125	12	white	72		75	16	36.5				1.5	142			26	3855	0		no(M2 and SIP pres)	0.4947509766
62.3439941406	0	male	0	17	577	CHF	COPD/CHF/Cirrhosis	3	14	$25-$50k	0	145561	81578.1875	66213.625	24.6666564941	white	68	35.8984375	120	28	36				1.1999511719	136			21	2790	0	0	no(M2 and SIP pres)	0
67.8929443359	1	female	0	20	279	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$25-$50k	44	269491	54600.34375	57670.75	42.6666564941	white	65	6.599609375	75	8	38		3.2998046875	3	3.5	135		106	101	3360		0	no(M2 and SIP pres)	0
53.491973877	1	female	0	13	15	ARF/MOSF w/Sepsis	ARF/MOSF	3	4	under $11k	41	199060	58617.875	60350.5625	42.5	hispanic	70	26.09765625	110	28	35.5	302.5		22.59765625	2.1997070313	133	7.349609375	223	77	1885		5	<2 mo. follow-up	5
80.3229980469	1	female	0	12	49	ARF/MOSF w/Sepsis	ARF/MOSF	4			26	51079	21268.84375	20973.21875	32.5	white	57	44	125	35	36	233.3125			1	136	7.44921875	415	34	1870			<2 mo. follow-up	6.4658203125
48.7689819336	0	male	0	27	534	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	>$50k	44	318152	72123.125	67590.3125	31.25	white	70	14.69921875	75	10	38.1953125	212		1.5998535156	3.099609375	152	7.51953125	492	111	2264		0	no(M2 and SIP pres)	0
52.3199768066	0	male	0	4	531	CHF	COPD/CHF/Cirrhosis	3	16	>$50k	0	14200	8216.984375	8403.46875	17	white	62	9.69921875	65	20	36.1953125		3.8999023438	0.5999755859	0.8999023438	139		124	18	1660			no(M2 and SIP pres)	2.1513671875
60.3999938965	1	male	0	7	499	MOSF w/Malig	ARF/MOSF	1	10		0	81201	10525.8984375	11691.65625	15	white	110	4.599609375	62	24	36.796875				1.2998046875	138		366	33	4400		0	adl>=4 (>=5 if sur)	0
83.4959716797	0	male	0	21	491	ARF/MOSF w/Sepsis	ARF/MOSF	2	9		26	174489	53113.59375	54059.21875	30	white	62	12.5	65	29	37.8984375	66.25			1.2998046875	142	7.4892578125	126	31	2175				4.51171875
77.5549926758	1	female	0	25	33	Coma	Coma	2			44	168806	38366.5625	34710.125	24.75	white	72	19.59765625	115	32	37.5	197.9375			1.6999511719	155	7.5390625	468	69	2455		3	<2 mo. follow-up	3
60.2049865723	0	female	0	17	472	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	>$50k	26	189109	46810.65625	36146.28125	25	asian	143	0.0499954224	135	36	35.5	540	3		1.5	135	7.5595703125		29	2480		0	no(M2 and SIP pres)	0
60.6599731445	1	female	0	16	51	Coma	Coma	1			9	59110	27980.5625	30758.34375	12	hispanic	103	20.19921875	105	20	36.796875				0.6999511719	141		172	9	1750			<2 mo. follow-up	2.8994140625
72.2029418945	1	male	0	9	146	Lung Cancer	Cancer	1	18	$11-$25k	0	38812	18041.359375	19459.875	9.5	white	75	10.599609375	60	14	36				0.6999511719	133		202	22				no(M2 and SIP pres)	3.4951171875
31.8409881592	0	female	0	9	441	Colon Cancer	Cancer	1	12		0	34588	15645.4296875	19370.5	12	white	71	4.19921875	120	24	38.3984375		3.6997070313	2.3999023438	0.5999755859	139		138	6	3350	0			0.4947509766
59.3539733887	1	female	0	9	218	Colon Cancer	Cancer	1	18		0	30984	14547.359375	16878.578125	14	white	69	7.5	74	16	36.3984375			0.5999755859	1.0998535156	135		78	12	1525	0	0	no(M2 and SIP pres)	0
20.2959899902	1	female	1	40	40	MOSF w/Malig	ARF/MOSF	2	12		0	355578			35.25	hispanic	32	0.0499954224	155	22	39			1.1999511719	1.0998535156	133			10	7750		1	<2 mo. follow-up	1
60.2979736328	0	female	0	11	415	ARF/MOSF w/Sepsis	ARF/MOSF	0			0	51183	23294.484375	26903.875	22	white	72	6.599609375	115	12	38.296875	547.5			4.099609375	143	7.119140625	395	50	2535				2.7836914063
40.7469787598	0	male	0	64	408	ARF/MOSF w/Sepsis	ARF/MOSF	3	16		26	310749	128527.625	111230.5625	31	white	35	13	120	26	38.5	128	3.8999023438	2.099609375	7.8994140625	138	7.4296875	119	88	0		0	adl>=4 (>=5 if sur)	0
68.0739746094	1	male	0	9	43	COPD	COPD/CHF/Cirrhosis	1	8	$11-$25k	0	66904	19334.0625	17372.359375	27	white	102	17.296875	95	20	36	116.3125	3.1997070313	1.3999023438	1.5	136	7.419921875	180	39	2295	5	6	<2 mo. follow-up	6
60.5449829102	1	male	1	31	31	MOSF w/Malig	ARF/MOSF	1	16	>$50k	26	239928	76509.625	71946	26.5	white	65	15	125	40	38.8984375	262.8125			0.7999267578	152	7.51953125	244	30	2795		4	<2 mo. follow-up	4
81.5739746094	1	male	0	9	64	CHF	COPD/CHF/Cirrhosis	2	16	$25-$50k	0	19878	11246.796875	9558.0859375	12.5	white	83	6.2998046875	100	22	38				1.5	138			22	2850	2		adl>=4 (>=5 if sur)	1.8388671875
66.1519775391	0	male	0	22	384	CHF	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	80163	36860.3125	31019.375	22	black	78	10.8984375	125	22	38.1953125	122.4375		0.299987793	4.8994140625	133	7.3193359375	373	117	1475	5	4	adl>=4 (>=5 if sur)	4
85.4509887695	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	1	20		94	65216			33.5	white	60	19.296875	135	20	37	70	2.599609375		2.5	131	7.2392578125	92	80	1109			<2 mo. follow-up	4.56640625
80.5039672852	1	male	1	4	4	Coma	Coma	2			55	23637	9525.28125	10073.8671875	23	white	83	17.8984375	95	24	38.296875	150		0.6999511719	1.2998046875	149	7.5	431	37	3850			<2 mo. follow-up	4.599609375
65.8099975586	0	male	0	8	2029	CHF	COPD/CHF/Cirrhosis	1	15		0	7104	5181.796875		9.5	black	113	5.3994140625	100	20	37.59375	380.9375	4.5		1.7998046875	143	7.4794921875				0	0	no(M2 and SIP pres)	0
34.1439819336	1	female	1	16	16	ARF/MOSF w/Sepsis	ARF/MOSF	4			100	44464	19419.25		43.3333129883	white	45	17.09765625	158	40	37.5	121.65625	2.7998046875	3.5	1.3999023438	145	7.5390625						<2 mo. follow-up	4.13671875
62.8449707031	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	2			0	79451	59804.65625		51	white	40	18.09765625	158	28	37.59375	240			4.5	135	7.439453125						<2 mo. follow-up	2.3706054688
54.6369934082	0	male	0	12	2024	CHF	COPD/CHF/Cirrhosis	1			0	10749	8246.9921875		12	white	79	10.099609375	124	42	40.09375	227.5	4.099609375	1	1.1999511719	132	7.4892578125							2.4262695313
53.6729736328	1	male	1	3	3	Coma	Coma	0	17	$11-$25k	100	6521	2071.109375		22	black	33	5.099609375	0	0	35.1953125	211.65625	3.1997070313	0.5	2.3999023438	145	7.3798828125						<2 mo. follow-up	2.2983398438
79.676940918	1	female	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	under $11k	0	27784	20989		38	white	73	12.298828125	77	22	36.296875	296.625		0.299987793	2.3999023438	137	7.44921875				6	5	<2 mo. follow-up	5
51.4609985352	0	female	0	27	1989	Cirrhosis	COPD/CHF/Cirrhosis	2	8	under $11k	37	30321	23567.21875		9.75	white	73	8.578125	140	22	38.59375	384	2.1997070313	17.69921875	1.5998535156	135	7.3798828125						SIP>=30	3.533203125
77.7599487305	1	male	1	37	37	CHF	COPD/CHF/Cirrhosis	2	12		0	35881	29816.265625		12.5	white	44	7.8994140625	76	24	35.796875	376.1875			1.5998535156	136	7.5				1	3	<2 mo. follow-up	3
52.4959716797	0	male	0	10	1971	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	>$50k	0	12827	10778.3125		25.5	white	116	5	51	24	36.59375	148.96875	2.1997070313	1.2998046875	2.1997070313	138	7.349609375				0	0	no(M2 and SIP pres)	0
45.0699768066	1	female	0	11	256	Lung Cancer	Cancer	1	16	$25-$50k	0	11897	8689.203125		13.5	white	81	9.3984375	80	20	37.796875		2.599609375		0.8999023438	136						2	no(M2 and SIP pres)	2
80.7059936523	0	female	0	7	1957	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	9	9764	4184.7578125		28	white	78	8.099609375	73	28	37.5	204	3.8999023438		2.7998046875	147	6.9599609375					5		5
70.033996582	1	female	0	47	1687	CHF	COPD/CHF/Cirrhosis	3	8	$11-$25k	0	69542	49621.96875		20.25	white	111	13.099609375	80	32	35.8984375		4		1.5998535156	141					0	1	no(M2 and SIP pres)	1
62.6449890137	1	female	0	9	13	Colon Cancer	Cancer	1			0	9016	2677.66796875		10	white	80	8.8984375	70	25	37		2.7998046875	29	0.6999511719	142					7	7	<2 mo. follow-up	7
68.2769775391	1	male	0	6	111	Colon Cancer	Cancer	1	16		0	5046	3617.68359375		6	white	97	20	72	20	37.1953125		3.7998046875	0.3999633789	2.1997070313	136					2	2	no(M2 and SIP pres)	2
68.6409912109	1	female	0	19	470	ARF/MOSF w/Sepsis	ARF/MOSF	1	12		0	50918	32448.828125		23.3333282471	white	74	14.599609375	117	41	38.296875	415			0.8999023438	146	7.439453125					0	no(M2 and SIP pres)	0
76.3369750977	1	female	0	13	104	COPD	COPD/CHF/Cirrhosis	1	8	under $11k	0	9457	6602.02734375		11.5	white	87	9.599609375	122	36	38.5	340			0.8999023438	143	7.419921875						no(M2 and SIP pres)	3.076171875
59.2139892578	0	female	0	12	1919	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	33298	22645.96875		19	black	105	13.5	100	40	38.59375	130			1.7998046875	138	7.4794921875					1		1
62.1769714355	0	female	0	5	1907	CHF	COPD/CHF/Cirrhosis	2	6	under $11k	0	5648	3686.04296875		13	black	63	10.3984375	104	28	36.796875		2.099609375	0.299987793	2.3999023438	146					6		no(M2 and SIP pres)	4.5273971558
64.6319580078	1	female	0	14	33	CHF	COPD/CHF/Cirrhosis	2	12		0	14478	8823.1171875		19.3333282471	white	43	6.599609375	120	38	34.796875	418.5	3.599609375		1.2998046875	126	7.4892578125				0	1	<2 mo. follow-up	1
93.9139404297	1	female	1	7	7	COPD	COPD/CHF/Cirrhosis	2			0	13570	11662.15625		20.5	white	42	13.19921875	127	26	38.296875	234			1.3999023438	140	7.26953125					4	<2 mo. follow-up	4
70.8279418945	1	female	0	13	321	MOSF w/Malig	ARF/MOSF	1			0	14896	7133.4609375		22	white	56	14.298828125	102	40	38.09375	114	2.7998046875	0.5999755859	0.5999755859	138	7.4296875							2.4926757813
46.3489990234	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	100904	64948.59375		50	white	57	23.796875	102	12	37	268.3125	2.3999023438	39.296875	3.8999023438	138	7.419921875						<2 mo. follow-up	2.7622070313
61.1469726563	1	female	0	12	161	ARF/MOSF w/Sepsis	ARF/MOSF	2			9	23298	13658.859375		21	white	120	11	62	30	38	234.6875	3		6.19921875	140	7.3193359375							2.2729492188
35.7619934082	0	male	0	12	1886	ARF/MOSF w/Sepsis	ARF/MOSF	1	15	$11-$25k	0	14027	6408.08984375		21.5	white	53	14.5	106	22	38	212.21875	2.2998046875	1.5	1.0998535156	138	7.4697265625				2		no(M2 and SIP pres)	1.8389997482
78.4369506836	1	female	1	6	6	MOSF w/Malig	ARF/MOSF	2	14	$25-$50k	0	17635	6980.95703125		40	white	49	1.3999023438	140	24	39	138	1.7998046875	1.5998535156	1.0998535156	144	7.3193359375					0	<2 mo. follow-up	0
63.9339904785	1	male	0	18	926	ARF/MOSF w/Sepsis	ARF/MOSF	2	12		0	39951	23115.015625		29.6666564941	white	49	10.798828125	122	38	38.796875	174	2.599609375	0.8999023438	5.19921875	139	7.349609375				0			0.4947998524
40.6869812012	1	female	1	18	18	Lung Cancer	Cancer	1	14	>$50k	0	26951	17289.828125		15.6666641235	asian	83	5.7998046875	80	28	36.296875		2.7998046875	1.8999023438	1.6999511719	136					1	0	<2 mo. follow-up	0
87.7099609375	0	female	0	27	1848	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	under $11k	100	46354	16436.59375		31.75	white	61	17.59765625	107	28	36.1953125	124.484375	3.3999023438	0.7999267578	2.5	136	7.2998046875					3	adl>=4 (>=5 if sur)	3
65.5389404297	0	male	0	10	1846	CHF	COPD/CHF/Cirrhosis	1	19	>$50k	0	10474	6287.6640625		14	white	85	5.599609375	92	22	37.1953125	385.6875			1.5	136	7.5				0	0		0
81.5629882813	0	female	0	14	1842	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	15296	8135.9921875		13.6666641235	white	54	7.5	59	24	38.6953125	330			0.7999267578	129	7.439453125				1	0	no(M2 and SIP pres)	0
89.3139648438	1	male	1	28	28	COPD	COPD/CHF/Cirrhosis	2			9	26630	16067.7109375		11.5	white	123	10.8984375	62	28	38.09375	286.625	3.099609375		1.7998046875	148	7.5					0	<2 mo. follow-up	0
82.326965332	1	male	1	6	6	COPD	COPD/CHF/Cirrhosis	4			0	15828	5706.21484375		46	white	42	17.3984375	104	32	36.3984375	218		1.5998535156	2.6997070313	145	7.3291015625					6	<2 mo. follow-up	6
76.1259765625	0	male	0	5	1826	COPD	COPD/CHF/Cirrhosis	2	12	$25-$50k	0	4546	2898.50390625		11	white	107	3.2998046875	80	21	37.1953125	230			1.0998535156	131	7.3798828125				0	0	no(M2 and SIP pres)	0
91.8899536133	0	female	0	7	1813	CHF	COPD/CHF/Cirrhosis	2		>$50k	0	5870	3882.2109375		17	white	75	8.69921875	60	24	36.6953125	400	4.599609375		1.8999023438	135	7.259765625					3	no(M2 and SIP pres)	3
36.1639709473	0	male	0	44	1810	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	90237	73488.125		40.25	white	127	11	102	14	38.5	191.65625			0.8999023438	134	7.44921875					0	adl>=4 (>=5 if sur)	0
87.1399536133	1	female	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	2			0	19842	5105.078125		34	white	43	7.099609375	114	12	38.1953125	285	4	1.1999511719	2.099609375	143	7.439453125						<2 mo. follow-up	3.1215820313
76.801940918	1	female	0	13	713	COPD	COPD/CHF/Cirrhosis	2			0	32927	20705.53125		27	white	72	16.09765625	102	28	38.09375	177.53125			1.3999023438	138	7.509765625					1	no(M2 and SIP pres)	1
67.2609863281	1	female	0	8	49	COPD	COPD/CHF/Cirrhosis	1	14	$11-$25k	0	9286	5743.09375		8.5	black	113	6.8994140625	90	24	37.796875	421.625	3.2998046875	0.299987793	1.5	144	7.3798828125				1	1	<2 mo. follow-up	1
55.5149841309	1	male	0	3	410	Lung Cancer	Cancer	3	8	$11-$25k	0	4136	2525.01953125		6	white	100	11.69921875	92	20	36.6953125				0.7999267578	137					0	1	SIP>=30	1
67.7509765625	1	male	1	10	10	MOSF w/Malig	ARF/MOSF	1	8	under $11k	0	46516	22635.34375		43	white	57	12.19921875	145	14	36.8984375	211.65625		0.5	11.798828125	138	7.3193359375					1	<2 mo. follow-up	1
90.0729980469	1	female	0	8	240	ARF/MOSF w/Sepsis	ARF/MOSF	4			0	9664	7518.3671875		9	white	120	4.7998046875	59	16	36.1953125	425	3.599609375	0.1999816895	1.5	132	7.369140625				4	2	no(M2 and SIP pres)	2
72.5969848633	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	2	17	$11-$25k	0	65724	42684		50	white	50	28.09765625	120	12	36.6953125	100	2.599609375		3.5	129	7.3095703125					0	<2 mo. follow-up	0
84.5749511719	1	male	0	15	16	CHF	COPD/CHF/Cirrhosis	2			0	19696	12471.5234375		19.6666564941	white	107	8.19921875	64	32	36.09375		3.7998046875	1.5	2.099609375	145							<2 mo. follow-up	3.3823242188
89.04296875	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	>$50k	0	58008	38696.375		36	hispanic	59	12.5	120	33	38.59375	168		0.3999633789	1	146	7.3896484375					2	<2 mo. follow-up	2
69.6619873047	1	female	0	22	43	Lung Cancer	Cancer	2			0	41995	27412.65625		8.6666641235	white	117	9.298828125	80	25	36.5	340	3.1997070313	0.3999633789	1.0998535156	136	7.5						<2 mo. follow-up	3.0629882813
81.0789794922	1	female	0	31	42	COPD	COPD/CHF/Cirrhosis	1	12		0	55945	26017.203125		28.5	white	53	12.3984375	64	42	36.8984375	150	3.6997070313	0.7999267578	1.0998535156	145	7.3095703125					4	<2 mo. follow-up	4
76.2849731445	1	male	0	10	1335	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$11-$25k	0	12633	6874.45703125		12	white	58	13.099609375	60	24	36.59375	285.6875	2.2998046875	0.5999755859	1.5	139	7.3193359375				3	3	adl>=4 (>=5 if sur)	3
83.4689941406	1	female	0	7	76	COPD	COPD/CHF/Cirrhosis	1	14	$11-$25k	9	7015	4895.7890625		11	white	107	6.69921875	60	25	35.59375	404.3125			0.5999755859	138	7.3994140625				1	0	adl>=4 (>=5 if sur)	0
69.2159423828	1	male	0	5	422	CHF	COPD/CHF/Cirrhosis	3			0	5314	3484.171875		8	white	73	7.19921875	80	25	37.1953125	248		0.6999511719	2.8999023438	137	7.4599609375				0		no(M2 and SIP pres)	0.4947998524
69.1229858398	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	5	10		0	53798	40329.6875		36	white	110	6.69921875	70	12	38.296875	107.140625			6.19921875	142	7.4296875					4	<2 mo. follow-up	4
82.3569946289	1	female	0	241	1231	ARF/MOSF w/Sepsis	ARF/MOSF	0			26	209565	143218.5		11	black	137	21.8984375	100	20	37.796875	323.75	3.599609375	1	1.1999511719	135	7.3994140625							3.0576171875
64.8349609375	1	female	1	9	9	Coma	Coma	0	18	$11-$25k	89	14380	5589.5703125		12.5	asian	56	9.798828125	47	6	38.09375	393.3125	2.599609375		0.7999267578	136	7.4091796875					1	<2 mo. follow-up	1
84.4789428711	0	male	0	11	1637	COPD	COPD/CHF/Cirrhosis	4			0	12504	8726.3828125		10.5	white	105	10.19921875	68	24	36.8984375			0.5	1.7998046875	138	7.4296875						no(M2 and SIP pres)	4.2509765625
55.8959960938	1	female	1	33	33	Colon Cancer	Cancer	1	14		0	39582	26151.234375		14		127	8.099609375	60	22	37.6953125		4.099609375	0.3999633789	1.3999023438	139						5	<2 mo. follow-up	5
36.3609924316	0	male	0	19	1631	ARF/MOSF w/Sepsis	ARF/MOSF	3	12		0	49378	20026.453125		27.6666564941	white	57	8.5	100	34	39.296875	171.65625	2.2998046875	5	0.7999267578	148	7.439453125				4	3	no(M2 and SIP pres)	3
61.2399902344	1	female	1	28	28	Cirrhosis	COPD/CHF/Cirrhosis	3	8	under $11k	0	104725	64707.5		48.75	black	129	6.7998046875	70	16	36.09375		2.1997070313		0.7999267578	143					0	0	<2 mo. follow-up	0
62.0449829102	0	male	0	23	1621	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	102951	18028.296875		18.6666564941	white	77	9.19921875	80	25	36.6953125	203.3125	3.1997070313	0.7999267578	1.1999511719	135	7.4697265625				0	0	no(M2 and SIP pres)	0
30.0209960938	1	female	1	22	22	ARF/MOSF w/Sepsis	ARF/MOSF	0	13		0	257474	150595.625		35.3333129883	white	73	0.1999816895	104	32	38.1953125		2.3999023438		0.6999511719	141						0	<2 mo. follow-up	0
53.5929870605	1	female	0	6	1344	Lung Cancer	Cancer	1	15		0	7058	4624.3828125		15	white	103	13.69921875	100	20	36.796875		4.099609375	0.299987793	1	141					0	1	no(M2 and SIP pres)	1
83.1159667969	1	male	0	22	135	ARF/MOSF w/Sepsis	ARF/MOSF	3			0	27727	15532.484375		18.3333282471	white	53	14.5	63	24	36.09375	103.328125	3.1997070313	0.7999267578	1.0998535156	145	7.4794921875					4	adl>=4 (>=5 if sur)	4
47.6139831543	0	female	0	5	1547	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	under $11k	0	11252	4251.11328125		13	white	63	6.69921875	72	24	37.796875	137.5		0.5	0.8999023438	143	7.5693359375					1	no(M2 and SIP pres)	1
75.7809448242	1	female	0	12	49	MOSF w/Malig	ARF/MOSF	2			0	30913	15681.890625		20.5	white	51	58.1953125	59	26	35.296875	197.5	3.099609375	2.1997070313	2	132	7.4091796875						<2 mo. follow-up	2.9829101563
67.1019897461	1	male	1	22	22	CHF	COPD/CHF/Cirrhosis	3	14		0	26499	16922.296875		13	white	117	11.798828125	100	20	36.09375	368	4	0.7999267578	2.7998046875	135	7.51953125					2	<2 mo. follow-up	2
51.4549865723	0	female	0	14	1543	ARF/MOSF w/Sepsis	ARF/MOSF	2	13	under $11k	0	36074	15445.640625		31.3333282471	white	67	6.7998046875	62	8	36.09375	141.40625	2.599609375	1.3999023438	0.5999755859	134	7.3896484375					3	no(M2 and SIP pres)	3
84.4819946289	1	male	1	106	106	COPD	COPD/CHF/Cirrhosis	1	6	$11-$25k	0	227626	151603		25.75	white	107	16.3984375	120	32	37.796875	223			1.2998046875	146	7.3896484375				1	0	adl>=4 (>=5 if sur)	0
86.6169433594	1	male	0	13	1494	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	0	16228	8260.2890625		16.5	white	53	12.69921875	66	32	36.09375	280	4.5	1.7998046875	1.2998046875	143	7.4091796875				0	0	no(M2 and SIP pres)	0
69.0979614258	0	male	0	7	1528	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	under $11k	26	18468	13271.6875		19	white	63	7.3994140625	100	9	36.296875	113	2.8999023438	1	1.2998046875	135	7.4892578125							4.81640625
86.1879882813	1	female	1	23	23	Lung Cancer	Cancer	1	12	under $11k	0	26902	16868.90625		9.6666641235	black	100	8.69921875	100	25	36.09375		3	0.3999633789	0.6999511719	131						3	<2 mo. follow-up	3
82.3549804688	1	female	0	7	252	Coma	Coma	2	18	$25-$50k	100	5849	3759.3828125		8	white	113	6.2998046875	60	20	36.3984375				1	139						7	adl>=4 (>=5 if sur)	7
87.6109619141	1	male	0	87	129	CHF	COPD/CHF/Cirrhosis	5	8	under $11k	0	77925	50186.28125		8.75	white	107	9.3984375	60	20	36.59375	218.5			2.099609375	145	7.4794921875					1	adl>=4 (>=5 if sur)	1
67.5319824219	1	female	0	15	283	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	25469	9964.6796875		22	white	52	5.2998046875	64	8	37.796875	195	3		0.6999511719	134	7.1796875							2.0639648438
75.0969848633	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	$11-$25k	0	41196	27988.9375		49	white	52	26.796875	113	8	40.09375	317			2	145	7.5498046875						<2 mo. follow-up	2.0903320313
96.7059936523	1	male	0	7	93	COPD	COPD/CHF/Cirrhosis	3		under $11k	26	7407	4494.0625		11	white	103	3.2998046875	70	25	37	417.125	3.099609375	0.299987793	1.1999511719	138	7.3798828125					6	adl>=4 (>=5 if sur)	6
86.8059692383	1	male	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	1	20	>$50k	0	46091	40561.875		29.3333282471	white	43	9.5	66	12	38.09375	150	2.7998046875	0.5999755859	5.69921875	136	7.3095703125					1	<2 mo. follow-up	1
62.9299926758	1	male	1	19	19	ARF/MOSF w/Sepsis	ARF/MOSF	4			0	48246	18903.375		40.3333129883	white	111	14.69921875	115	28	37.8984375	150	2.3999023438		1	149	7.369140625						<2 mo. follow-up	2.6669921875
78.8719482422	0	male	0	30	1421	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$11-$25k	0	59878	45923.15625		24.75	white	117	7.5	50	8	38.3984375	128			1.0998535156	144	7.419921875					0		0
83.3699951172	1	male	0	35	150	ARF/MOSF w/Sepsis	ARF/MOSF	2	17		0	71015	43051.84375		23.5	white	55	18.796875	63	28	36	428	2.099609375	0.5	1.3999023438	135	7.5					0	no(M2 and SIP pres)	0
95.5099487305	1	male	1	8	8	Coma	Coma	1	15	$11-$25k	0	8418	4959.6328125		14	white	83	34.796875	100	30	38.59375		4.19921875	1.0998535156	1.3999023438	136						3	<2 mo. follow-up	3
76.6709594727	1	male	1	26	26	CHF	COPD/CHF/Cirrhosis	2	16	>$50k	9	28454	17808.53125		14.75	white	73	8.3984375	76	24	36.59375		3.2998046875	1.5	1.2998046875	136					1	0	<2 mo. follow-up	0
63.625	0	female	0	8	1349	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	9	11290	5561.3125		9	white	93	8.599609375	100	20	36.6953125	344.4375			0.7999267578	142	7.3193359375				0	1	no(M2 and SIP pres)	1
67.035949707	1	male	1	8	8	Colon Cancer	Cancer	1	8	under $11k	0	16195	9882.6484375		24	white	117	19.59765625	110	30	35.6953125	316.3125	2.6997070313	9.5	1.2998046875	136	7.4091796875				3	1	<2 mo. follow-up	1
100.1309814453	1	female	0	5	1082	CHF	COPD/CHF/Cirrhosis	3	4		0	4485	2759.310546875		6	black	77	6	60	15	36.09375		3.6997070313		1.0998535156	141							no(M2 and SIP pres)	3.3823242188
75.2579956055	1	male	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	34405	13343.0625		42.5	white	44	21.3984375	108	16	38.1953125	135			1.1999511719	145	7.3994140625					0	<2 mo. follow-up	0
66.9709472656	0	female	0	9	1305	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	under $11k	100	11884	5305.3515625		14.5	black	47	9.798828125	98	11	36.296875	486.625	4.5	0.5	0.5	168	7.3193359375					1	no(M2 and SIP pres)	1
82.2369995117	1	female	0	14	245	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	41176	18947.265625	25436.671875	22	white	73	14.69921875	72	20	35.796875	422.1875	3.2998046875		2.2998046875	142	7.4296875	126	44	2140	2	1	SIP>=30	1
87.6079711914	1	female	1	25	25	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	26	93347	58623.625	58592.0625	15.25	white	63	12.3984375	70	34	35.59375	315			1.8999023438	135	7.3798828125	258	90	775		1	<2 mo. follow-up	1
91.16796875	1	female	1	11	11	COPD	COPD/CHF/Cirrhosis	2	14	$11-$25k	9	22895	6213.33984375	20997.828125	24.5	white	63	10.8984375	49	36	35.796875	215	2.5	0.5	1.0998535156	138	7.3994140625	122	24	2900		6	<2 mo. follow-up	6
38.8119812012	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	0	17	$25-$50k	0	46577	28459.828125	29525.5	42	white	69	14.099609375	82	32	38.09375	71	2.2998046875		2.2998046875	136	7.3896484375	151	31	1975		0	<2 mo. follow-up	0
94.0419921875	1	female	0	13	74	COPD	COPD/CHF/Cirrhosis	3	12		0	12115	7034.94921875	7291.13671875	6.5	white	70	11.798828125	80	25	37	344	4	1.0998535156	1.5	134	7.5498046875	127	61	700	2	6	SIP>=30	6
96.0249633789	1	male	0	6	153	CHF	COPD/CHF/Cirrhosis	2	0	$11-$25k	0	5425	3100.5625	3094.23828125	11	white	60	5.599609375	80	20	36.09375				1.1999511719	129		109	18		0	1	no(M2 and SIP pres)	1
92.3529663086	1	female	0	5	1037	CHF	COPD/CHF/Cirrhosis	4	18	$25-$50k	9	4530	2524.76171875	2891.37890625	5	white	57	27.796875	80	20	36.09375	252.375			1.0998535156	132	7.4599609375	90	30	1100	4	3	no(M2 and SIP pres)	3
81.458984375	1	female	0	24	541	ARF/MOSF w/Sepsis	ARF/MOSF	5	12	under $11k	0	38340	16256.453125	24652.859375	22.6666564941	white	41	15.3984375	109	28	37.6953125	436.625	3	0.5999755859	1.6999511719	138	7.369140625	82	36	2340	2	2	no(M2 and SIP pres)	2
72.2549438477	1	male	0	7	9	Lung Cancer	Cancer	2			0	5886	3460.078125	4167.5	5.5	black	100	11.099609375	100	20	37				0.5999755859	136		172	11				<2 mo. follow-up	3.1450195313
64.0439453125	1	male	0	3	129	Colon Cancer	Cancer	2	12		0	2867	1655.6845703125	1640.6796875		white	57	11.599609375	80	20	37.296875			1.1999511719	1.1999511719	133		328	23		0		no(M2 and SIP pres)	0.4947509766
91.9339599609	1	female	1	15	15	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	under $11k	44	95204	62915.8125	57928.5	35	white	73	22.59765625	110	14	36.6953125	190	1.3999023438		4	129	7.369140625	77	62	1460		2	<2 mo. follow-up	2
81.508972168	0	male	0	17	1007	ARF/MOSF w/Sepsis	ARF/MOSF	2	17	>$50k	9	23306	12391.3984375	14378.75	12.3333282471	white	120	10.099609375	51	26	37.8984375	242.84375	3.1997070313	0.299987793	1.5998535156	149	7.4599609375	86	44			6	adl>=4 (>=5 if sur)	6
55.4829711914	1	male	0	4	692	Lung Cancer	Cancer	1	12	>$50k	0	15966	8098.78125	3559.55859375	14	white	97	6.099609375	64	16	36.6953125			0.8999023438	1.2998046875	141		189	16				no(M2 and SIP pres)	1.98828125
39.783996582	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	23300	8672.890625	14412.859375	52	white	55	25.796875	139	26	39.296875	67	1.8999023438	0.7999267578	0.8999023438	144	7.3193359375	72	42	1193		0	<2 mo. follow-up	0
47.1209716797	1	male	0	8	212	Cirrhosis	COPD/CHF/Cirrhosis	2	11	under $11k	0	18732	7620.12890625	14185.40625	24.5	white	52	1.0998535156	64	30	36.296875		2.5	7.8994140625	0.5999755859	139		110	15	1040	0	2	SIP>=30	2
62.8859863281	1	female	0	4	332	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	9	12771	4837.47265625	7684.828125	14	white	105	10.798828125	180	20	37.8984375	640	3.099609375	1.3999023438	0.7999267578	143	7.26953125	102	6	2750	0	4	no(M2 and SIP pres)	4
44.9229736328	1	female	1	9	9	MOSF w/Malig	ARF/MOSF	1	16	$11-$25k	0	23066	7157.05078125	19547.09375	39	white	54	9.5	145	12	38.796875	161.65625	2.599609375	0.299987793	0.6999511719	153	7.349609375	144	26	3155			<2 mo. follow-up	2.4384765625
70.7079467773	0	male	0	35	956	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	$11-$25k	0	165432	96053.8125	105092.8125	25.25	white	107	6.599609375	110	10	39.1953125	190			1.1999511719	149	7.439453125	136	18	4890	0	0	SIP>=30	0
58.8119812012	1	female	0	6	152	Lung Cancer	Cancer	2	18		0	6654	3721.7890625	4312.9375	11	white	81	6.7998046875	76	20	37.3984375				0.5999755859	137		115	10	4202	0	0	no(M2 and SIP pres)	0
86.7599487305	1	female	0	102	238	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	9	108592	62537.40625	64422.03125	12.25	white	77	11.19921875	80	20	36.09375	476.1875	2.5	0.5999755859	4.19921875	147	7.4091796875	77	107	400		2		2
82.1299438477	1	female	0	17	52	COPD	COPD/CHF/Cirrhosis	4	8	under $11k	0	44671	14975.4921875	39899.21875	19	white	49	18.796875	120	44	36.3984375	173.46875	3.599609375		1.8999023438	135	7.4296875	92	46	1520	2	1	<2 mo. follow-up	1
53.4699707031	0	female	0	12	941	ARF/MOSF w/Sepsis	ARF/MOSF	5	12	under $11k	0	23618	10149.859375	15127.375	19	white	103	6.19921875	49	24	38.3984375	152.5	3.099609375	9.19921875	0.5	149	7.3994140625	331	15	1260	1	0	SIP>=30	0
63.7229919434	1	male	0	9	52	Cirrhosis	COPD/CHF/Cirrhosis	2	9	under $11k	0	12741	6802.20703125	6108.9765625	17.5	white	63	13.5	70	20	36.59375		1.7998046875	6.5	2.7998046875	137		132	82	980	0	0	<2 mo. follow-up	0
72.3089599609	0	male	0	7	939	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	$11-$25k	0	32851	14498.5859375	23926.078125	13	white	62	9.798828125	55	28	36.3984375	121.65625	2.8999023438		1.1999511719	137	7.4697265625	123	25	1905	0	0	no(M2 and SIP pres)	0
91.8169555664	1	female	0	9	315	ARF/MOSF w/Sepsis	ARF/MOSF	2		under $11k	9	13455	5766.65625	10643.75	13.5	white	65	10.599609375	56	30	38.6953125	183.65625	2.3999023438		1.0998535156	135	7.3896484375	306	28	1350		7	adl>=4 (>=5 if sur)	7
67.408996582	0	male	0	13	900	ARF/MOSF w/Sepsis	ARF/MOSF	2	14		0	49973			25.5	white	105	9.8984375	102	24	38.5	171.40625	2.599609375	1.1999511719	1.1999511719	137	7.5	200	24	3400	0	0	no(M2 and SIP pres)	0
85.992980957	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	10742	4711.63671875	6813.66796875	14.5	white	107	18.19921875	68	30	36.6953125		3.099609375	1.0998535156	3.6997070313	150		179	99	2003		0	<2 mo. follow-up	0
78.5869750977	0	male	0	24	879	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	under $11k	0	31302	15784.8203125	10890.2734375	24.6666564941	white	49	15.599609375	70	24	40.09375	120	3.099609375	0.5	2.7998046875	156	7.19921875	355	85	1980		7	adl>=4 (>=5 if sur)	7
76.1419677734	0	female	0	6	875	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	7858	4060.5546875	4837.078125	7	white	87	18.5	80	20	36.6953125	488.3125			1.0998535156	138	7.359375	137	26	600	1		no(M2 and SIP pres)	1.1667480469
79.5069580078	1	female	0	4	207	CHF	COPD/CHF/Cirrhosis	4	14	$11-$25k	0	4092	2277.53125	1371.8291015625	8	white	73	7.19921875	60	15	35.796875				2	142		105	41	1275	0		no(M2 and SIP pres)	0.4947509766
50.1299743652	1	male	0	32	272	MOSF w/Malig	ARF/MOSF	2	12		0	103700	53768.34375	50489	28.5	other	51	0.8999023438	108	31	35.59375	245.6875	2.5	1	1	141	7.4091796875	133	17	2000	0	1	no(M2 and SIP pres)	1
73.4289550781	1	female	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	2			0	103441	55695.25	64998.5	51	white	61	23.19921875	130	10	38.6953125	270			1.1999511719	147	7.3896484375	155	46	2159			<2 mo. follow-up	2.2182617188
62.8089904785	1	male	1	53	53	ARF/MOSF w/Sepsis	ARF/MOSF	2	12		0	110359	65038.4375	83454.875	24.75	white	103	5.19921875	68	22	37.6953125	263.3125			3.5	131	7.4091796875	245	65	2395		0	<2 mo. follow-up	0
72.533996582	1	male	0	5	29	COPD	COPD/CHF/Cirrhosis	3	8		9	6225	3391.373046875	3447.21875	16	white	107	8.298828125	80	15	36.09375	484	2.5		2.3999023438	138	7.33984375	192	36	1300		4	<2 mo. follow-up	4
42.6999816895	0	male	0	4	845	COPD	COPD/CHF/Cirrhosis	3	14	under $11k	0	6088	1507.119140625	6243.46875	5	hispanic	74	6	72	24	36.796875	176.1875			0.7999267578	137	7.2890625	98	8	1650	0			0.4947509766
68.8819580078	1	male	0	7	177	COPD	COPD/CHF/Cirrhosis	4	13	$11-$25k	0	8507	4556.77734375	5845.58984375	7	white	101	7.599609375	60	28	36.09375	163.3125	3.6997070313	0.5999755859	0.8999023438	139	7.4697265625	227	12	1850	1	0	no(M2 and SIP pres)	0
71.7479858398	0	female	0	16	829	ARF/MOSF w/Sepsis	ARF/MOSF	1	16		0	68313	34881.21875	36946.6875	26	white	111	7.19921875	69	36	38.296875	196.65625	3.1997070313		2.7998046875	136	7.1591796875	272	36	2115	0	0	no(M2 and SIP pres)	0
74.7209472656	0	male	0	4	824	CHF	COPD/CHF/Cirrhosis	3	16	>$50k	0	5136	2833.505859375	2667.568359375	9	white	80	6.099609375	80	25	36.6953125	276.1875			1.7998046875	139	7.44921875	116	41				no(M2 and SIP pres)	2.1064453125
84.8209838867	1	female	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	2	18	>$50k	0	45150	35746.5	26955.625	32.5	white	48	10.3984375	134	10	38.296875	170			1.2998046875	143	7.359375	121	32	505		6	<2 mo. follow-up	6
68.3199462891	0	male	0	7	813	ARF/MOSF w/Sepsis	ARF/MOSF	1	12		0	15734	11297.625	8246.8828125	9.5	white	129	5	106	34	38.1953125	360	3.1997070313	1.3999023438	1.1999511719	142	7.44921875	95	24	3710	0	1	no(M2 and SIP pres)	1
77.592956543	1	male	0	14	17	ARF/MOSF w/Sepsis	ARF/MOSF	4	12		9	37632	24508.875	21132.046875	13.6666641235	white	120	14.298828125	74	38	38.09375		2.6997070313	0.299987793	3.7998046875	142		207	58	3100	3	1	<2 mo. follow-up	1
74.3299560547	1	male	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	6	12	$11-$25k	9	27511	17544.015625	9628.4140625	14.3333282471	white	76	5.3994140625	58	28	36.59375	361.875	2.8999023438	0.8999023438	1.0998535156	135	7.439453125	133	39	492			<2 mo. follow-up	5.783203125
83.208984375	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	$25-$50k	0	23733	15129.2265625	12450.2265625	35	white	52	7	120	29	36.796875	95.90625			0.8999023438	131	7.4892578125	95	17	4300	5	0	<2 mo. follow-up	0
53.7549743652	1	female	0	14	82	Cirrhosis	COPD/CHF/Cirrhosis	4	4	under $11k	0	20960	11320.421875	10513.734375	12.6666641235	white	67	7.2998046875	80	20	37	271.375	2.8999023438	6.5	1.5	140	7.4697265625	183	21	1200	5	6		6
84.492980957	1	female	0	86	206	ARF/MOSF w/Sepsis	ARF/MOSF	4			0	183705			37.25	white	53	8.099609375	60	8	38	278	2.599609375		0.6999511719	149	7.4599609375	169	19	349			adl>=4 (>=5 if sur)	3.7641601563
82.8639526367	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	1			41	26475	15379.203125	8938.9140625	24	white	65	12	131	52	38.59375	368	2.7998046875	0.5999755859	1.8999023438	150	7.419921875	168	78	1445			<2 mo. follow-up	3.0263671875
89.7409667969	0	female	0	9	765	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	17130	10323.2421875	9630.2265625	10	white	70	6	62	14	36.6953125	203.3125	4	1	1.3999023438	142	7.189453125	106	42	1710	1	0	no(M2 and SIP pres)	0
45.4069824219	1	female	0	62	182	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	241277	146111.75	127354.625	46.5	white	67	11.19921875	140	16	36.5	93.328125	2.7998046875	5.099609375	0.6999511719	141	7.439453125	55	11	1516		0	SIP>=30	0
86.2669677734	1	male	0	9	25	COPD	COPD/CHF/Cirrhosis	4	9	under $11k	0	9107	5198.6875	5056.62890625	13.5	white	110	9.798828125	100	25	36.09375	326.625	4		7	144	7.19921875	128	127	650	2	3	<2 mo. follow-up	3
76.0739746094	1	male	0	7	32	COPD	COPD/CHF/Cirrhosis	2	17		0	12470	7309.453125	6533.09765625	5	white	97	11.8984375	80	20	35	233.3125			1.0998535156	139	7.3994140625	139	39	550	6	7	<2 mo. follow-up	7
90.2779541016	1	female	0	15	42	ARF/MOSF w/Sepsis	ARF/MOSF	2	10		0	29200	18691.578125	18738.640625	17.3333282471	white	65	5.3994140625	64	16	38.09375	285.6875			2	140	7.3798828125	103	26	690	3	6	<2 mo. follow-up	6
44.3289794922	1	female	0	9	116	MOSF w/Malig	ARF/MOSF	2	18	$25-$50k	0	22641	14706.6015625	12632.046875	29	white	66	4.5	62	16	36.59375	356	3.1997070313	5	0.5999755859	141	7.369140625	130	8	4530	0		no(M2 and SIP pres)	0.4947509766
48.9799804688	0	female	0	13	695	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	65038	36985.9375	36788.5625	16.5	white	53	6.5	60	24	36.59375	161.21875	2.7998046875		0.6999511719	135	7.4697265625	99	7	1275	0	0	no(M2 and SIP pres)	0
85.4649658203	1	male	0	27	472	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	76784	52937.0625	44614.4375	33.25	white	57	11.69921875	70	10	38.1953125	176	2.2998046875	0.5	2.6997070313	132	7.359375	141	63	2170		1	adl>=4 (>=5 if sur)	1
81.0099487305	1	male	0	10	16	Lung Cancer	Cancer	1	16		0	12735	6927.98828125	7069.69921875	14	white	113	12.099609375	80	20	36.6953125		3.599609375	1.1999511719	1.5998535156	140		110	51			3	<2 mo. follow-up	3
89.5469970703	1	female	0	12	141	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	16186	8523.2421875	8228.2578125	15.5	white	107	12.3984375	80	25	36.09375	272		0.5999755859	2.099609375	144	7.3193359375	103	50	1400	1	3	adl>=4 (>=5 if sur)	3
66.3459472656	0	female	0	11	675	COPD	COPD/CHF/Cirrhosis	3	14	>$50k	0	12506	6952.18359375	8685.125	11.5	white	103	7.5	100	25	36.09375	304.75	4.2998046875		1	142	7.4296875	118	21	2575	1	2	no(M2 and SIP pres)	2
93.8949584961	1	male	0	7	114	COPD	COPD/CHF/Cirrhosis	5			0	8276	4589.81640625	5258.3671875	4	white	97	3.599609375	56	20	36.296875	320	3.1997070313		0.8999023438	141	7.3994140625	89	26	725				4.4140625
88.1069946289	0	male	0	11	670	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	11812	6656.2421875	6744.65625	11	white	70	6.19921875	80	20	36.09375	383.3125	2.599609375	0.6999511719	1.2998046875	148	7.439453125	120	36	1650	1	1	no(M2 and SIP pres)	1
48.8729858398	1	female	0	9	392	ARF/MOSF w/Sepsis	ARF/MOSF	1	12		0	54664	28733.109375	32420.15625	24	white	55	7.69921875	72	35	36.8984375	171.65625			0.6999511719	140	7.419921875	112	16	1470	0	0	no(M2 and SIP pres)	0
62.2529907227	0	male	0	16	642	ARF/MOSF w/Sepsis	ARF/MOSF	4	19		0	47166	34499.5625	27598.859375	29.6666564941	white	67	7.5	73	12	36.296875	152	3.099609375	0.3999633789	5.599609375	131	7.3896484375	317	146	2745		3	SIP>=30	3
35.175994873	1	male	0	18	196	MOSF w/Malig	ARF/MOSF	1	14	>$50k	0	86623	45066.53125	43258.9375	21	white	121	26.09765625	156	40	40.1953125		3.2998046875	0.3999633789	0.7999267578	132		130	10	4750	0	4	no(M2 and SIP pres)	4
84.5779418945	0	male	0	13	613	CHF	COPD/CHF/Cirrhosis	2	22		0	14980	8515	7564.96875	10.5	white	77	5.599609375	60	20	36.09375				2.3999023438	133		82	61		1	4	SIP>=30	4
74.7319946289	1	male	0	19	501	COPD	COPD/CHF/Cirrhosis	5	7		0	24493	13656.21875	12216.453125	13.6666641235	white	57	20.296875	70	25	36.6953125	277.75			2.099609375	132	7.3994140625	407	65	1350		3		3
79.3869628906	0	female	0	8	559	CHF	COPD/CHF/Cirrhosis	3			0	10367	6241.70703125	5594.46875	11.5	white	77	5	110	20	36.09375	392.5625			1.1999511719	135	7.44921875	112	21	1100				3.1455078125
33.7389831543	1	female	1	37	37	Cirrhosis	COPD/CHF/Cirrhosis	3	16	>$50k	0	156416	93311.875	85475.5	33.25	white	55	2.599609375	105	20	36.796875	420	1.5	0.7999267578	0.5999755859	141	7.4296875	86	13	1900	0	0	<2 mo. follow-up	0
84.1559448242	0	female	0	13	526	COPD	COPD/CHF/Cirrhosis	3	16	under $11k	0	30009	19574.5	16739.96875	31	white	62	6.7998046875	119	30	36.6953125	240			0.7999267578	138	7.4296875	312	25	1775	1	5	adl>=4 (>=5 if sur)	5
74.7489624023	1	male	1	7	7	Coma	Coma	2	16		100	22690	13871.03125	13232.1171875	13	white	111	12	73	30	39.8984375	166	3.599609375	0.7999267578	2.099609375	148	7.439453125	141	56	1660		1	<2 mo. follow-up	1
75.8819580078	1	male	0	14	268	ARF/MOSF w/Sepsis	ARF/MOSF	3			0	38838	28448.015625	23182.71875	27.3333282471	white	55	10.099609375	49	10	38.796875	84.4375	2.8999023438	1	6.69921875	139	7.359375	114	112	2395		0		0
77.3279418945	1	male	1	14	14	MOSF w/Malig	ARF/MOSF	2	16	$25-$50k	0	38514			11	white	63	1.5998535156	45	32	36.09375	412	2.3999023438	1.2998046875	1.7998046875	135	7.4091796875	216	41	685		0	<2 mo. follow-up	0
64.6319580078	0	female	0	11	495	Lung Cancer	Cancer	1	13	$25-$50k	0	13459	7567.1640625	6809.6875	13	white	97	11.69921875	80	25	36.6953125		2.3999023438	0.299987793	0.7999267578	132		528	13	2900	1	1	no(M2 and SIP pres)	1
63.2219848633	1	male	0	8	225	Cirrhosis	COPD/CHF/Cirrhosis	4	13	under $11k	0	11623	6085.77734375	5021.2578125	5.5	white	81	6.69921875	80	20	36.8984375		3.3999023438	4.69921875	0.7999267578	136		93	17		3	3	no(M2 and SIP pres)	3
70.0889892578	0	female	0	8	491	CHF	COPD/CHF/Cirrhosis	4	12	$11-$25k	0	8502	4805.1171875	5592.796875	9.5	white	70	12.099609375	60	20	36.5		3.1997070313		2.1997070313	131		99	54	1675	0	0	no(M2 and SIP pres)	0
82.5709838867	0	female	0	5	490	CHF	COPD/CHF/Cirrhosis	3	8		0	5274	2972.134765625	2830.978515625	20	white	73	3.6997070313	60	20	35.59375		3.2998046875		1.5	140		203	32	1350	2	2	no(M2 and SIP pres)	2
76.4959716797	0	male	0	3	473	COPD	COPD/CHF/Cirrhosis	2	10		0	3392	1745.9248046875	1798.7197265625		white	127	11.19921875	80	20	36.09375		3.599609375		3.8999023438	142		124	56		0		no(M2 and SIP pres)	0.4947509766
41.4619750977	1	male	1	3	3	MOSF w/Malig	ARF/MOSF	2	12	$25-$50k	0	17453	10567.65625	7348.6171875	35	white	111	0.0999908447	130	16	35.59375	145	2	2.6997070313	3	130	7.259765625	116	67	243			<2 mo. follow-up	2.099609375
59.6359863281	1	male	0	4	52	Cirrhosis	COPD/CHF/Cirrhosis	2	16	$25-$50k	0	5450	2994.232421875	2717.44921875	17	black	80	4.19921875	70	20	36.09375		1.6999511719	3.2998046875	1.1999511719	132		88	32		0		<2 mo. follow-up	0.4947509766
86.1379394531	1	female	0	18	20	Colon Cancer	Cancer	2			0	15685	9282.5546875	8388.8046875	5	black	100	13.3984375	112	20	36.09375		2.1997070313		0.6999511719	141		78	8		0		<2 mo. follow-up	0.4947509766
52.2519836426	1	female	0	17	173	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	37267	24023.640625	21515.75	18	white	103	15.3984375	121	6	37.796875	520	2.5	0.7999267578	10.099609375	147	7.33984375	185	67	2870	0		no(M2 and SIP pres)	0.4947509766
67.3789672852	0	male	0	9	453	COPD	COPD/CHF/Cirrhosis	6	11		0	14515	9983.328125	8710.15625	13.5	white	70	6.2998046875	73	30	35.8984375	228		0.5999755859	2.2998046875	136	7.2998046875	265	116		1	0	no(M2 and SIP pres)	0
75.6959838867	0	male	0	26	450	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	9	50793	30239.109375	26322.875	18.75	white	123	10.599609375	102	28	36.1953125		3.099609375		5.19921875	148		155	40	1255	1	0	no(M2 and SIP pres)	0
78.458984375	1	male	0	7	347	ARF/MOSF w/Sepsis	ARF/MOSF	2	3	$11-$25k	0	13683	9479.7421875	8309.5078125	4	white	97	5.69921875	100	20	38.8984375	195.21875			1.5998535156	138	7.5	137	22		0	0	no(M2 and SIP pres)	0
79.7559814453	0	male	0	10	428	MOSF w/Malig	ARF/MOSF	2	12	$25-$50k	0	17840	12445.296875	11083.6484375	16.5	white	72	7.2998046875	50	28	35.296875	508	3.3999023438	1.5998535156	0.8999023438	141	7.4599609375	160	28	1420	0	1	adl>=4 (>=5 if sur)	1
50.5239868164	0	female	0	47	421	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	176139	120280.3125	94567.375	29	white	60	7.8994140625	130	26	38	353.3125			6.19921875	134	7.3896484375	80	43	0				2.6069335938
80.410949707	1	female	0	9	182	CHF	COPD/CHF/Cirrhosis	6			0	10985	5983.171875	5310.1484375	8		80	4.599609375	80	20	36.09375		3.7998046875	0.5999755859	1.5	138		83	20	1				3.7236328125
84.7939453125	0	female	0	5	408	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	5262			8	white	80	9.3984375	50	20	36.09375				1.5	142		76	31	1450				2.41796875
75.3349609375	1	male	0	4	101	Colon Cancer	Cancer	1	20	$25-$50k	0	5624	3108.234375	1921.0791015625	6	white	107	9.599609375	76	16	37.09375			0.5	1.0998535156	144		63	17		0		no(M2 and SIP pres)	0.4947509766
76.6709594727	0	male	0	13	386	CHF	COPD/CHF/Cirrhosis	3	16	>$50k	0	30798	17669.5	16483.109375	29	white	77	6.7998046875	70	20	36.09375		3.6997070313	2.099609375	2.2998046875	138		120	35		0	0	no(M2 and SIP pres)	0
88.1939697266	0	female	0	13	356	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$25-$50k	9	19104	13220.28125	11556.3984375	11	white	59	24.69921875	60	24	35.796875		3.599609375	1.0998535156	2.2998046875	141		102	58	1650		3	no(M2 and SIP pres)	3
68.0139770508	1	female	1	17	17	ARF/MOSF w/Sepsis	ARF/MOSF	2	1		0	68718.5625	37504.25		45.6666564941	other	90	18.296875	100	10	37.296875	147.5	2.6997070313	0.5	3.1997070313	137	7.4296875					1	<2 mo. follow-up	1
58.2119750977	1	female	1	3	3	Cirrhosis	COPD/CHF/Cirrhosis	3			100	14696.9453125	8260.25		32	white	37	34.296875	35	12	35.796875	261	2.3999023438	8.798828125	3	122	7.26953125						<2 mo. follow-up	3.3979492188
69.7909545898	1	male	0	35	296	CHF	COPD/CHF/Cirrhosis	5			0	50310.6875	30847.046875		16	white	63		70	20	35.09375	566.625			1.2998046875	137	7.3994140625							3.3188476563
73.4019775391	1	male	1	11	11	MOSF w/Malig	ARF/MOSF	2	11	$11-$25k	26	80833.0625	46143.8125		43	white	137	1.7998046875	140	30	39.1953125	146.65625	1.2998046875	13.19921875	2.2998046875	139	7.3994140625					1	<2 mo. follow-up	1
72.9199829102	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	2		under $11k	0				43.5	white	132	16.59765625	116	25	38.5	98.875		0.5	1.7998046875	150	7.509765625					0	<2 mo. follow-up	0
78.3569946289	1	male	1	4	4	Coma	Coma	0		under $11k	0	29703.1875	19801.109375		49	white	63	32.59375	110	14	39.09375	110	2	10	5.19921875	127	7.349609375					0	<2 mo. follow-up	0
90.7539672852	1	female	0	5	211	CHF	COPD/CHF/Cirrhosis	2	7	under $11k	0	2153.6484375	1880.4892578125		12	black	115	1.6999511719	76	18	34.8984375		2.6997070313	0.299987793	0.7999267578	146					4	2	no(M2 and SIP pres)	2
33.850982666	1	male	0	22	152	MOSF w/Malig	ARF/MOSF	1			0	36510.125	26459.359375		17	white	79	7.69921875	60	10	36.296875	284.4375		0.5999755859	1	151	7.4599609375							1.6982421875
66.5379638672	1	male	0	33	43	CHF	COPD/CHF/Cirrhosis	3			0	15308.59375	13682.984375		8.25	white	59	8.5	54	20	35.296875				2.8999023438	131							<2 mo. follow-up	3.0239257813
74.8419799805	1	female	1	18	18	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	under $11k	0	72912.25	47838.625		42.3333129883	white	85	14.19921875	60	26	36.59375	157.5	1.6999511719	0.8999023438	2.8999023438	138	7.439453125					7	<2 mo. follow-up	7
40.2459716797	0	male	0	14	1982	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	9	46602.59375	32411.640625		17.6666564941	white	117	11.69921875	92	26	37.796875	352		0.8999023438	0.5999755859	135	7.4599609375				0	0	no(M2 and SIP pres)	0
49.8779907227	0	female	0	6	1977	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	under $11k	0	9162.546875	6519.2109375		13	black	90	6.69921875	68	10	36.1953125	271.375		1.0998535156	1	142	7.26953125				7	7	adl>=4 (>=5 if sur)	7
55.3649902344	1	male	0	4	831	Lung Cancer	Cancer	1	12	$11-$25k	0	3038.5	2171.873046875		11	white	73	7.8994140625	86	20	37.09375	476.1875			1.1999511719	141	7.4599609375				0	2	no(M2 and SIP pres)	2
43.2059936523	1	male	1	16	16	ARF/MOSF w/Sepsis	ARF/MOSF	4	6		61	49218.78125	33914.59375		33	black	60	9.5	130	34	37.296875	120	2	16.796875	1.7998046875	143	7.419921875					2	<2 mo. follow-up	2
49.1229858398	1	male	0	23	141	CHF	COPD/CHF/Cirrhosis	3	12	$25-$50k	0	32006.59375	22374.828125		26.6666564941	white	63	6.69921875	74	24	36.796875			2.5	1.2998046875	118					1	0		0
57.6479797363	1	female	0	21	322	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$25-$50k	0	45167.53125	31629.234375		27	white	78	11	112	40	38.5	290			1.0998535156	138	7.51953125				3	0		0
56.6049804688	0	female	0	3	1952	CHF	COPD/CHF/Cirrhosis	3			0	4187.19921875	2915.00390625		4	white	67	6.8994140625	68	20	36			0.5999755859	1.1999511719	139								1.9326171875
63.0419921875	1	male	0	236	1441	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	0	504659.5	338955		46	white	72	18.19921875	120	10	37.796875	267.5	1.7998046875	0.3999633789	1.3999023438	137	7.3896484375					0	adl>=4 (>=5 if sur)	0
53.4399719238	0	male	0	53	1950	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$25-$50k	55	88128.8125	63449.34375		32.5	white	65	16.69921875	125	31	38.1953125	152	3.3999023438	2.6997070313	7.3994140625	133	7.369140625					6	no(M2 and SIP pres)	6
66.9099731445	1	female	1	19	19	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	$11-$25k	9				44	other	72	11.5	120	40	38.09375	271.375			1.0998535156	138	7.44921875					0	<2 mo. follow-up	0
79.8189697266	1	male	1	17	17	MOSF w/Malig	ARF/MOSF	2			44	89738.9375	61880.625		41	white	63	0.3999633789	112	10	37.1953125	131.65625		0.5999755859	9.19921875	134	7.4697265625						<2 mo. follow-up	3.064453125
50.400970459	0	male	0	7	1931	Lung Cancer	Cancer	1	14	$11-$25k	0	4376.5	3473.138671875		5.5	other	83	2.6997070313	52	24	37.5			0.6999511719	1.5	133						5		5
39.4359741211	1	male	1	25	25	ARF/MOSF w/Sepsis	ARF/MOSF	0			0	111050.375	72371.5625		41.25	white	59	16.8984375	115	60	38.296875	226.65625		0.5999755859	1.0998535156	133	7.3798828125						<2 mo. follow-up	1.8627929688
55.8549804688	1	male	1	24	24	Cirrhosis	COPD/CHF/Cirrhosis	2			9	19714.9375	15110.1171875		10	white	90	11.19921875	94	18	34.3984375		2.7998046875	33	1.3999023438	126							<2 mo. follow-up	3.3227539063
78.8469848633	1	male	1	5	5	CHF	COPD/CHF/Cirrhosis	2			0	4319.6796875	3077.466796875		12	black	62	4.5	78	20	35.59375	338.0625			1.7998046875	141	7.4794921875						<2 mo. follow-up	2.1801757813
39.8409729004	1	male	1	8	8	Cirrhosis	COPD/CHF/Cirrhosis	5	10	$11-$25k	0	31942.234375	21611.328125		46.5	black	92	4.2998046875	110	14	36.6953125	207.5	1.7998046875	4.7998046875	1.7998046875	134	7.3994140625					1	<2 mo. follow-up	1
73.4129638672	1	female	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	0			44	57947.9375	39225.59375		50	black	111	9.5	102	13	35.796875	153.3125	2.6997070313	12.599609375	4.19921875	126	7.4091796875						<2 mo. follow-up	2.482421875
66.8669433594	1	male	1	18	18	ARF/MOSF w/Sepsis	ARF/MOSF	1			55	148144.625	92974.3125		52	black	58	24.296875	114	27	37	166		30	5.69921875	155	7.4091796875						<2 mo. follow-up	3.3989257813
75.5949707031	1	female	1	16	16	Lung Cancer	Cancer	1	10		0	13365.6953125	10269.4921875		7	white	91	7.5	96	20	35	371.375	2.3999023438	0.3999633789	0.7999267578	140	7.33984375				3	3	<2 mo. follow-up	3
47.3999938965	1	female	0	7	461	Colon Cancer	Cancer	1	15	>$50k	0	9032.296875	6259.30078125		6.5	white	93	5.19921875	68	24	37.3984375			0.3999633789	0.5	140					0	0	no(M2 and SIP pres)	0
57.8149719238	1	male	1	22	22	Lung Cancer	Cancer	1	10	$25-$50k	0	23437.9375	16626.1875		11.6666641235	white	88	19.09765625	100	18	36		2.8999023438	0.1999816895	0.8999023438	136					1	0	<2 mo. follow-up	0
71.5259399414	1	male	1	53	53	ARF/MOSF w/Sepsis	ARF/MOSF	4	7	$11-$25k	41	238583.125	160377.875		32.5	white	80	6.2998046875	110	39	36.09375	287.5	2.5	0.3999633789	2	152	7.3994140625					0	<2 mo. follow-up	0
72.035949707	1	female	0	23	923	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	0				10	white	123	11.69921875	78	25	35.8984375	310			2.099609375	136	7.3994140625				0	0	no(M2 and SIP pres)	0
73.576965332	0	male	0	9	1840	Colon Cancer	Cancer	1	24	>$50k	0	13001.9453125	8862.671875		15	white	97	13.19921875	66	12	36.6953125	436		0.6999511719	0.7999267578	133	7.3994140625							2.43359375
49.4399719238	1	female	0	6	128	Colon Cancer	Cancer	1	16	>$50k	0	5030.44921875	3832.70703125		13	hispanic	83	8.298828125	72	18	36.3984375			1	0.8999023438	135						0	no(M2 and SIP pres)	0
69.6239624023	1	male	0	15	143	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	>$50k	0	38503.1875	27377.5		25	white	67	12.5	110	14	38.59375	120.40625			2.1997070313	144	7.509765625					0	no(M2 and SIP pres)	0
52.0359802246	1	female	0	5	387	Colon Cancer	Cancer	1	21		0	4229.546875	2943.04296875		13	white	105	5.099609375	120	20	39			0.5	0.5999755859	142					0	0	no(M2 and SIP pres)	0
63.3569946289	1	male	0	8	89	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	15985.1953125	11313.640625		23.5	black	57	4	148	24	35.8984375	352.375		1.8999023438	2.6997070313	132	7.439453125							2.8442382813
72.8509521484	0	female	0	10	1798	COPD	COPD/CHF/Cirrhosis	2	12		0	8237.7421875	5929.55859375		13	white	100	6.69921875	100	22	36.59375	285.6875	3.3999023438	0.3999633789	0.6999511719	144	7.44921875				0	1	no(M2 and SIP pres)	1
65.0899658203	1	male	0	134	585	ARF/MOSF w/Sepsis	ARF/MOSF	1			44	361896	240649.75		48.5	white	120	29.19921875	118	36	35.796875	156.65625	2.8999023438	4.5	5.3994140625	134	7.359375					6	no(M2 and SIP pres)	6
67.6689453125	1	male	1	10	10	Coma	Coma	0	4	under $11k	37	39055.375	26184.453125		50	white	40	27.59765625	150	30	40.1953125	228		3.099609375	9.798828125	131	7.3095703125					0	<2 mo. follow-up	0
35.8439941406	0	female	0	48	1775	Coma	Coma	0	17	>$50k	44	82952.6875	57020.71875		23.75	white	75	18.3984375	130	7	38	396		0.5	0.8999023438	137	7.4794921875					0	SIP>=30	0
64.9969482422	0	male	0	7	1770	CHF	COPD/CHF/Cirrhosis	2	10	$11-$25k	0	7358.796875	5338.859375		3.5	white	100	6.099609375	78	20	36.3984375				1.5	144					0	0	no(M2 and SIP pres)	0
43.625	0	female	0	134	1759	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	$25-$50k	0	401867	269131.25		42.5	white	135	21.3984375	130	26	37.59375	250		0.7999267578	9	143	7.44921875				7	6	adl>=4 (>=5 if sur)	6
59.4279785156	0	female	0	88	1757	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	$11-$25k	0	284272	195666.125		32	white	59	24.19921875	122	40	38.59375	263.3125		1.3999023438	1.1999511719	145	7.349609375					1	adl>=4 (>=5 if sur)	1
35.6219787598	0	female	0	67	1757	ARF/MOSF w/Sepsis	ARF/MOSF	1	12		100	200353.75	132550.25		46.25	white	131	14.599609375	108	12	39.1953125	240		12.099609375	0.8999023438	156	7.5					4	adl>=4 (>=5 if sur)	4
60.5119934082	1	female	0	5	369	Lung Cancer	Cancer	1	12	$11-$25k	0	5159.94921875	3466.837890625		11	white	73	6.69921875	110	16	36.8984375			0.3999633789	0.5999755859	137					1	4	no(M2 and SIP pres)	4
76.035949707	1	male	0	68	1485	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$11-$25k	0	194034	119902.875		23.5	white	55	10.3984375	126	28	38.5	272	3	1.1999511719	3	149	7.4697265625					6	adl>=4 (>=5 if sur)	6
67.501953125	1	male	1	95	95	ARF/MOSF w/Sepsis	ARF/MOSF	0			0				47	white	44	14.298828125	168	27	39	116.25			2.099609375	142	7.3193359375							1.9936523438
44.508972168	1	male	0	7	563	Colon Cancer	Cancer	1	13	$11-$25k	0	7222.296875	5163.0390625		7	black	103	6.2998046875	64	16	37.296875			0.3999633789	1.0998535156	135					0	0		0
21.0429992676	1	female	1	4	4	Coma	Coma	0	15	$25-$50k	100	15271.6484375	12390.484375		42	white	46	12.298828125	134	10	32.5	112.5	3.599609375	0.7999267578	0.7999267578	175	7.599609375					0	<2 mo. follow-up	0
66.876953125	1	male	0	16	189	CHF	COPD/CHF/Cirrhosis	0	5	$11-$25k	0	24346.390625	18417.859375		11.6666641235	black	70	13.099609375	120	22	36.5				1.5998535156	135					0	0	SIP>=30	0
41.1609802246	1	female	0	5	253	Colon Cancer	Cancer	1			0	4960	3366.88671875		22	white	85	7.5	78	16	36.3984375			0.299987793	0.7999267578	140								1.6408691406
57.6729736328	0	male	0	9	1697	COPD	COPD/CHF/Cirrhosis	4	16	$25-$50k	0	12842.9453125	9616.5078125		16	white	111	7.3994140625	110	21	36.6953125	268	2.599609375		2.7998046875	155	7.3095703125					4	no(M2 and SIP pres)	4
46.1379699707	0	male	0	81	1681	ARF/MOSF w/Sepsis	ARF/MOSF	1			9	165522	113269.0625		41	white	151	22.59765625	136	25	38.8984375	116	3.2998046875	1.7998046875	0.8999023438	132	7.44921875							2.23046875
68.2049560547	1	female	0	15	1495	COPD	COPD/CHF/Cirrhosis	1	16		0	89705.9375	60473.875		25.6666564941	white	136	10.099609375	54	26	36.1953125	145.6875	3.1997070313		1.3999023438	133	7.359375					1	no(M2 and SIP pres)	1
56.3089904785	1	female	0	12	86	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	16926.09375	12640.9609375		16	white	81	11.298828125	118	32	37.09375	144.875		0.6999511719	1.0998535156	136	7.44921875				1	2	adl>=4 (>=5 if sur)	2
67.16796875	1	male	0	5	239	Colon Cancer	Cancer	1	19	$25-$50k	0	2869.349609375	2204.587890625		12	white	105	5.3994140625	72	20	36.59375			0.299987793	1	142					0	0		0
71.0969848633	1	male	0	8	67	Colon Cancer	Cancer	1	5	$11-$25k	0	6796.1484375	4837.203125		15.5	white	90	13.298828125	100	20	38		1.7998046875	2.3999023438	1	135						1	adl>=4 (>=5 if sur)	1
66.5329589844	1	male	0	53	941	ARF/MOSF w/Sepsis	ARF/MOSF	1	9		26	84241.9375	57762.9375		20.75	black	113	7.3994140625	64	22	35.296875	390.4375			1	139	7.3896484375					0	adl>=4 (>=5 if sur)	0
65.8449707031	1	male	0	11	21	CHF	COPD/CHF/Cirrhosis	2	8	$11-$25k	0	36142.5	23028.09375		36	white	56	7.5	96	26	34.8984375	173.3125			0.6999511719	130	7.509765625				0	0	<2 mo. follow-up	0
44.4569702148	1	female	0	23	1124	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	64678.375	43669.75		35.3333129883	white	71	13.19921875	120	40	39	169.375		0.5	1.1999511719	152	7.369140625					0	no(M2 and SIP pres)	0
46.800994873	1	female	0	24	81	MOSF w/Malig	ARF/MOSF	1	12	$25-$50k	0	100731.3125	67725		19.6666564941	white	70	0.299987793	80	24	36.09375	215	2.2998046875	1.3999023438	0.7999267578	138	7.4296875				0	0	no(M2 and SIP pres)	0
72.7389526367	1	male	0	14	103	COPD	COPD/CHF/Cirrhosis	3	6	$11-$25k	0	237319.75	164784.5		9.3333282471	white	57	7.3994140625	116	24	36.1953125	259.25			0.8999023438	135	7.349609375				0	0	SIP>=30	0
73.0569458008	1	male	0	13	127	MOSF w/Malig	ARF/MOSF	1	8	$11-$25k	0	26677.734375	17147.421875		24.5	white	69	20.296875	134	36	38	128.5625			1.2998046875	142	7.5					3	no(M2 and SIP pres)	3
53.4479980469	0	male	0	5	1623	CHF	COPD/CHF/Cirrhosis	1	10	$25-$50k	0	8706.6953125	5779.046875		12	white	81	10.5	76	20	36.1953125			0.5999755859	1.7998046875	140								1.7338867188
59.6929931641	1	male	0	8	55	CHF	COPD/CHF/Cirrhosis	4	7		0	6527.3984375	4549.47265625		13	white	65	12.599609375	94	20	35.09375	348		1.6999511719	1.6999511719	141	7.44921875				3	3	<2 mo. follow-up	3
49.2869873047	1	female	0	3	93	Lung Cancer	Cancer	1	18	>$50k	0	6130.1484375	3425.28125		9	white	93	50	92	18	36.8984375		2.599609375	0.299987793	0.8999023438	137					0	0	adl>=4 (>=5 if sur)	0
38.633972168	1	male	0	40	280	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	$11-$25k	0	64797.125	45844.5625		13.75	white	148	10.298828125	64	35	36	280.9375	2.6997070313	0.1999816895	8.19921875	129	7.3798828125				5	6	SIP>=30	6
68.0189819336	1	male	0	5	165	Colon Cancer	Cancer	1	7		0	3755.6484375	2598.203125		17	white	107	7	76	24	36.1953125			0.3999633789	1.6999511719	137					0	0	no(M2 and SIP pres)	0
45.8149719238	1	male	1	3	3	Cirrhosis	COPD/CHF/Cirrhosis	2			100	20466.234375	13310		42	white	0	7.19921875	0	22	36.3984375	155.6875	1.8999023438		4.19921875	152	7.25						<2 mo. follow-up	2.1298828125
37.3959960938	0	male	0	9	1593	ARF/MOSF w/Sepsis	ARF/MOSF	0	7		0	27632.4375	17343.8125		28	black	61	6.8994140625	126	10	38.3984375	223.3125	2.7998046875	0.5999755859	1.0998535156	153	7.4794921875					0	no(M2 and SIP pres)	0
74.5979614258	0	male	0	6	1593	CHF	COPD/CHF/Cirrhosis	3			26	3740.498046875	3070.244140625		14	black	101	8	100	24	35.5	356		6.7998046875	1.6999511719	146	7.4599609375							3.6372070313
65.833984375	1	male	1	7	7	Coma	Coma	1	11	$11-$25k	44	24014.984375	16735.875		32	black	75	6.7998046875	11	10	39.296875	386.625	3.099609375	0.5999755859	1.5	142	7.4296875					0	<2 mo. follow-up	0
77.6369628906	1	female	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	9904.2421875	6551.90625		11.5	white	37	26	96	38	35.796875	108.328125			1.6999511719	141	7.1298828125						<2 mo. follow-up	4.7861328125
38.2749938965	0	female	0	145	1572	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	37	218732.875	141284.625		35.5	black	147	17.59765625	134	12	38.5	160	2.2998046875	1.2998046875	0.5999755859	130	7.359375						adl>=4 (>=5 if sur)	2.2563476563
50.3959960938	1	female	1	14	14	MOSF w/Malig	ARF/MOSF	1	10	$11-$25k	0	134989.125	83926.1875		33.3333129883	white	109	39.1953125	106	28	36.59375	160	2.6997070313		1.0998535156	137	7.4794921875					5	<2 mo. follow-up	5
40.9989929199	1	male	0	14	444	CHF	COPD/CHF/Cirrhosis	3	11		0	13750.1171875	9702.71875		9	black	120	5.2998046875	85	22	36	300	2.099609375	0.3999633789	3.2998046875	142	7.44921875				0	0	no(M2 and SIP pres)	0
39.8299865723	0	female	0	9	1525	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	under $11k	0	28210.1875	19233.46875		22	black	142	6.3994140625	114	28	38.296875	160	2.599609375	0.5	1.1999511719	137	7.4794921875				0	0	no(M2 and SIP pres)	0
41.9189758301	0	male	0	5	1524	Colon Cancer	Cancer	1			0	4684.546875	2984.447265625		14	black	73	5.69921875	104	24	38.296875		2.8999023438	0.1999816895	1.1999511719	139								1.8041992188
31.282989502	1	female	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	6	12		44	52990.125	34947.84375		40	white	105	19.3984375	124	30	38.1953125	303.3125	2.599609375	20	2.5	145	7.4892578125					3	<2 mo. follow-up	3
69.9849853516	1	female	0	8	87	Colon Cancer	Cancer	1	16	>$50k	0	7079.296875	5065.12890625		6	white	122	31.09765625	76	28	35.796875		2.6997070313	0.0999908447	0.5999755859	137	7.4794921875				2	0	adl>=4 (>=5 if sur)	0
69.6649780273	0	female	0	9	1510	COPD	COPD/CHF/Cirrhosis	3	11		0	4562.49609375	3465.2734375		10	white	107	9.599609375	84	22	36.3984375	214.28125	3.3999023438	0.299987793	1.5998535156	136					0			0.4947998524
48.7229919434	0	female	0	32	1488	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	under $11k	44	115659.5	75410.1875		35.25	black	55	4.099609375	130	14	39.796875	288	2.7998046875	0.1999816895	10	145	7.439453125					0		0
61.4049987793	1	female	0	5	784	Lung Cancer	Cancer	1	16	$25-$50k	0	5310.94921875	3328.5		9	white	120	20.59765625	86	20	36.1953125			0.299987793	1.0998535156	141					0	0	no(M2 and SIP pres)	0
64.8299560547	1	male	0	62	724	ARF/MOSF w/Sepsis	ARF/MOSF	2	12		0	213969.625	141854		39	white	145	5.599609375	186	8	38	91		0.8999023438	0.6999511719	142	7.369140625					3	adl>=4 (>=5 if sur)	3
29.3029937744	1	female	0	48	336	MOSF w/Malig	ARF/MOSF	2	12	under $11k	0	78111.0625	49858.84375		20	white	56	1.0998535156	134	38	39.296875	414.25	2.2998046875	5.8994140625	0.8999023438	135	7.419921875					3	SIP>=30	3
43.9039916992	0	male	0	14	1437	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	>$50k	0	63622.125	38628.3125		40.3333129883	white	111	13.19921875	68	10	38.296875	172.5		4.3994140625	1	134	7.3994140625						no(M2 and SIP pres)	1.9741210938
40.7469787598	1	male	0	9	46	Cirrhosis	COPD/CHF/Cirrhosis	3	7	$11-$25k	0	10535.3984375	6943.80078125		9	white	103	4.3994140625	100	20	36.796875		2.5	1.5	1.5	127					0	1	<2 mo. follow-up	1
45.8949890137	1	male	0	8	377	CHF	COPD/CHF/Cirrhosis	2	9	under $11k	0	18237.390625	13212.015625		9.5	white	75	7.8994140625	76	16	35.796875	272			0.6999511719	134	7.4794921875				0			0.4947998524
60.3889770508	0	male	0	25	1422	ARF/MOSF w/Sepsis	ARF/MOSF	0	14		0	61711.6875	42741.71875		15	white	125	18.59765625	124	9	39	348	2.6997070313		0.8999023438	141	7.5					0	no(M2 and SIP pres)	0
72.8489990234	1	male	0	27	105	COPD	COPD/CHF/Cirrhosis	3			0	73245.6875	49878.3125		23.5	black	79	9.5	156	40	37.59375	217.84375	2.5	0.299987793	1	139	7.439453125					5	adl>=4 (>=5 if sur)	5
74.367980957	0	female	0	12	1409	MOSF w/Malig	ARF/MOSF	1		under $11k	0	15472.34375	10627.0859375		19.5	black	57	11.099609375	70	28	36.6953125	412	2.7998046875	0.8999023438	1.6999511719	143	7.33984375						no(M2 and SIP pres)	2.50390625
61.8999938965	1	male	1	106	106	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0				23	white	81	14.19921875	124	33	35.09375	193.3125	3.3999023438	1.5	4.3994140625	130	7.4794921875					1	adl>=4 (>=5 if sur)	1
67.0719604492	1	male	0	4	94	Lung Cancer	Cancer	1	16	$25-$50k	0	1635.75	1285.18359375		7	white	90	6.8994140625	72	22	36.6953125			1.2998046875	1	141					0	0	no(M2 and SIP pres)	0
40.8299865723	1	male	0	12	73	Cirrhosis	COPD/CHF/Cirrhosis	4			9	10073.6953125	7346.5		9	black	83	13	108	20	36.296875	323.75	1.0998535156	13.5	1.1999511719	146	7.4697265625							3.6713867188
57.3549804688	0	male	0	39	1364	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	37	104662.625	67909.6875		30.5	black	63	10.798828125	126	24	38.8984375	224	1.6999511719	16.09765625	1.8999023438	149	7.3896484375						SIP>=30	2.34375
56.4019775391	1	male	1	15	15	Cirrhosis	COPD/CHF/Cirrhosis	3	14	>$50k	0	37778.875	24318.890625		27	white	63	6.2998046875	68	26	36.3984375	210	2.1997070313	5.099609375	1	142	7.44921875				0	0	<2 mo. follow-up	0
39.0139770508	1	female	0	10	552	Colon Cancer	Cancer	1	16	$25-$50k	0	15749.1953125	9910.6796875		13.5	hispanic	85	9.3984375	76	20	36.296875		3.7998046875	0.5999755859	0.5999755859	142					1		no(M2 and SIP pres)	1.1668996811
72.7039794922	1	male	0	21	207	ARF/MOSF w/Sepsis	ARF/MOSF	2	4		0	49507.21875	33661.8125		26.3333282471	white	132	21.796875	126	23	38.6953125	110	2.2998046875	0.299987793	0.6999511719	133	7.4296875					0	no(M2 and SIP pres)	0
37.5059814453	1	male	1	9	9	Coma	Coma	1	12	$11-$25k	61	69511.3125	44734.5625		29.5	white	113	4.5	44	6	36.8984375	547.5			0.8999023438	154	7.4296875						<2 mo. follow-up	2.0087890625
81.5329589844	1	female	0	11	26	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$11-$25k	26	25805.1875	17326.84375		24	white	107	10.298828125	126	30	38.59375	240	2.7998046875	0.1999816895	0.7999267578	143	7.3896484375					1	<2 mo. follow-up	1
31.033996582	1	female	0	14	47	MOSF w/Malig	ARF/MOSF	1	8	$11-$25k	55	62115.28125	39471.71875		29.6666564941	white	110	11.599609375	124	32	39	300	1.8999023438	0.3999633789	1.5	146	7.3994140625					5	<2 mo. follow-up	5
78.7869873047	1	male	1	74	74	ARF/MOSF w/Sepsis	ARF/MOSF	0	12		41				37.5	white	83	25.09765625	120	4	38.3984375	157.5	2.3999023438	1.1999511719	1.6999511719	137	7.3095703125					0		0
47.9179992676	1	male	0	5	37	Cirrhosis	COPD/CHF/Cirrhosis	2	10	under $11k	0	3757	2664.83203125		4	black	118	15.599609375	91	44	37.8984375		2.3999023438	22	1.0998535156	136					0	0	<2 mo. follow-up	0
58.0369873047	1	male	1	16	16	Coma	Coma	1			100				24	white	109	14.298828125	130	28	39	270	1.7998046875	0.7999267578	1.6999511719	141	7.349609375						<2 mo. follow-up	2.5361328125
77.4259643555	1	male	0	21	697	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$11-$25k	0	42596.34375	28186.9375		26.3333282471	white	63	15.798828125	60	0	34.8984375	343.3125	2.5		5.5	131	7.5					1	no(M2 and SIP pres)	1
64.9609985352	1	female	0	42	564	MOSF w/Malig	ARF/MOSF	0	11	under $11k	37				14.5	black	137		106	30	38.5	350	2		2	132	7.4697265625					1	adl>=4 (>=5 if sur)	1
88.1719970703	1	male	1	7	7	Coma	Coma	1			55	17919.734375	12661.3359375		15	white	89	14.69921875	54	14	37.09375	433.3125			1.0998535156	135	7.5595703125					4	<2 mo. follow-up	4
29.6209869385	1	female	0	15	19	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	>$50k	89	53349.375	34999		34.6666564941	white	75	2.6997070313	50	29	35.296875	256	2.6997070313	0.5999755859	0.5	118	7.44921875					7	<2 mo. follow-up	7
74.9649658203	1	female	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	35012.96875	22773.625		38.5	white	67	16.3984375	150	48	36.296875	223.3125	2.2998046875	1.0998535156	1.5998535156	135	7.4091796875					5	<2 mo. follow-up	5
44.908996582	1	male	1	24	24	ARF/MOSF w/Sepsis	ARF/MOSF	3	12		26	55018			17.3333282471	white	119	5.69921875	114	27	36.59375	140.8125		15	5	154	7.4794921875	104	78	3560		0	<2 mo. follow-up	0
80.6899414063	1	female	1	4	4	Coma	Coma	2	6	$11-$25k	100	67555			40	white	97	17.5	65	8	38	362.8125			5.5	141	7.439453125	274	110	625			<2 mo. follow-up	3.0395507813
34.8529968262	0	female	0	29	1077	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	$25-$50k	0	67010			21	white	109	10.099609375	124	33	38	164.4375	3.099609375	1.1999511719	0.5	137	7.4599609375	130	14	3555		7	no(M2 and SIP pres)	7
54.8419799805	0	male	0	10	1076	ARF/MOSF w/Sepsis	ARF/MOSF	1	15	$11-$25k	0	30104	19874.359375	17731	15.5	black	116	14.298828125	112	26	36.3984375	186.65625	2.3999023438	0.6999511719	1.3999023438	140	7.4892578125	279	31	3025	1	0	no(M2 and SIP pres)	0
64.1289672852	0	male	0	16	1074	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	41	38587			17.6666564941	white	105	12.69921875	160	26	38.59375	125	2.6997070313	0.6999511719	0.5999755859	141	7.4599609375	222	14	1785		0	no(M2 and SIP pres)	0
25.1139984131	0	female	0	12	1069	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	$11-$25k	0	40468			17	black	107	15	120	44	38.296875	63.328125			0.6999511719	138	7.3798828125	69	7	1270	0	0	no(M2 and SIP pres)	0
69.1639404297	1	male	1	87	87	ARF/MOSF w/Sepsis	ARF/MOSF	2	7	under $11k	44	217056	145305	126986	39.75	white	55	7.8994140625	104	22	37.796875	122		0.5	1.2998046875	147	7.4296875	191	15	1975		0	adl>=4 (>=5 if sur)	0
25.6449890137	0	male	0	20	1047	COPD	COPD/CHF/Cirrhosis	1	14	$11-$25k	0	49765			22	white	76	16.8984375	126	32	37.6953125	105			1	137	7.4794921875	134	22	3320		0	no(M2 and SIP pres)	0
60.2299804688	0	male	0	7	1046	CHF	COPD/CHF/Cirrhosis	3	14	>$50k	0	12106			6	white	79	10	70	20	36.796875			0.8999023438	1.5	142		153	22		0	0	no(M2 and SIP pres)	0
69.910949707	1	male	0	7	56	CHF	COPD/CHF/Cirrhosis	3			0	3738			5.5	white	73	8.3984375	66	28	36			0.7999267578	3.599609375	136		196	92	1030			<2 mo. follow-up	2.9311523438
69.5409545898	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	0			100	58201			53	white	41	2.3999023438	126	18	35.796875	115	2	6.599609375	2	133	7.3291015625	42	31	360			<2 mo. follow-up	2.7041015625
72.1069946289	1	male	1	126	126	COPD	COPD/CHF/Cirrhosis	2	9	$11-$25k	0	412406	299965.75	246904	31.75	white	49	10.5	134	35	36.09375	39		0.3999633789	0.3999633789	128	7.419921875	169	12	1835		0	adl>=4 (>=5 if sur)	0
77.2209472656	1	female	1	4	4	MOSF w/Malig	ARF/MOSF	2	12	under $11k	26	59938			40	white	73	1.7998046875	116	32	35.3984375	92.296875		19.59765625	3.7998046875	128	7.44921875	177	106	4090		1	<2 mo. follow-up	1
68.4019775391	1	male	0	13	43	Colon Cancer	Cancer	4	16	>$50k	0	24885			16.5	white	73	3	114	24	36.796875		2	13.798828125	0.6999511719	129		160	9	3050	5	1	<2 mo. follow-up	1
26.0449981689	0	male	0	31	1029	ARF/MOSF w/Sepsis	ARF/MOSF	2	9		0				40.75	black	48	0.0999908447	124	11	35.296875	444	1.1999511719	0.5999755859	1.5998535156	133	7.369140625	76	23	1430		5	no(M2 and SIP pres)	5
68.1039428711	0	female	0	19	1029	CHF	COPD/CHF/Cirrhosis	2	8	under $11k	0	24701			7	black	106	60	74	22	36.3984375	417.375			6.3994140625	142	7.3193359375	70	59		2	2	SIP>=30	2
65.8449707031	1	male	0	4	61	Lung Cancer	Cancer	1	5	$11-$25k	0	4475				black	105	5.8994140625	86	24	37.6953125			0.3999633789	0.5999755859	131		151	6			0		0
70.5949707031	1	male	0	17	26	MOSF w/Malig	ARF/MOSF	1	17		0	44516			21.6666564941	white	73	51.3984375	106	36	36.5	126.515625	2.5	1.5998535156	1.1999511719	150	7.4794921875	100	34	1810		1	<2 mo. follow-up	1
49.5219726563	0	female	0	9	1026	MOSF w/Malig	ARF/MOSF	1	14	$25-$50k	0	53838			16.5	white	57	12.798828125	116	28	38	276			1.0998535156	130	7.3896484375	176	20	2065	0	1	no(M2 and SIP pres)	1
79.2169799805	0	female	0	71	1023	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	$11-$25k	0	175574	120693.125	87405	40.25	white	46	4.3994140625	74	10	38.8984375	197.5	1.6999511719		0.8999023438	135	7.419921875	115	17	1830		0	SIP>=30	0
56.6319885254	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	9	77474			41.5	white	139	16	114	32	38.59375	324		0.5999755859	0.5	136	7.44921875	278	19	5190		0	<2 mo. follow-up	0
29.0949859619	0	male	0	6	1014	CHF	COPD/CHF/Cirrhosis	3	10		0	2940			7	black	70	4	80	28	36.09375			3.6997070313	1.1999511719	139		88	13	3670	0	0	SIP>=30	0
47.3949890137	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	4			44	27011	18225.9375	15042	31	black	55	17.59765625	100	9	35.6953125	120		2.5	6.3994140625	132	7.439453125	163	52	0			<2 mo. follow-up	3.375
79.6709594727	1	male	0	28	515	ARF/MOSF w/Sepsis	ARF/MOSF	1		under $11k	0	57108	34602.71875	33933	25.25	white	100	14.69921875	118	24	36.6953125	276.625			1.0998535156	135	7.4697265625	107	18	1445		6	adl>=4 (>=5 if sur)	6
84.1399536133	1	female	1	21	21	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	105122	61753.4375	64790	35	white	66	32.6953125	64	29	35.796875	134	2		1.5998535156	132	7.3994140625	110	21	380		1	<2 mo. follow-up	1
36.3809814453	0	male	0	18	989	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	41443	27296.5	26221	22	white	65	20.3984375	136	12	39.59375	208	1.8999023438	0.3999633789	0.8999023438	135	7.4091796875	72	7	2010	5	4	SIP>=30	4
43.6059875488	0	male	0	15	985	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	>$50k	0	47040			29	black	59	17	116	16	38.796875	145.4375	2.8999023438	0.6999511719	1.0998535156	137	7.4794921875	128	19	1250		0	no(M2 and SIP pres)	0
76.8409423828	1	female	1	29	29	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	197568	125466.125	105323	50.25	white	55	39.59375	104	10	36.59375	164		1.5998535156	1.8999023438	133	7.33984375	253	122	618		0	<2 mo. follow-up	0
62.1569824219	0	female	0	18	977	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	under $11k	0	43691	27075.0625	25739	22	black	107	14.298828125	124	10	35.6953125	127.5	3.2998046875	0.5	2.5	131	7.51953125	103	128	3145			no(M2 and SIP pres)	3.6245117188
36.924987793	1	female	1	28	28	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$11-$25k	0	151066	95726.5	83119	33.25	white	129	19.19921875	136	12	39.09375	124	1.7998046875	0.8999023438	0.3999633789	140	7.3896484375	118	11	1485		0	<2 mo. follow-up	0
41.907989502	1	female	1	23	23	MOSF w/Malig	ARF/MOSF	1	13	$11-$25k	0	113704	73262.5625	57339	28.3333282471	white	123	20	135	33	38.796875	212.5	2.2998046875	1	0.6999511719	143	7.529296875	98	14	1615		4	<2 mo. follow-up	4
65.6779785156	1	male	0	16	230	ARF/MOSF w/Sepsis	ARF/MOSF	4	2	under $11k	0	30435	20161.296875	19058	16.3333282471	black	128	22.09765625	150	40	36.5	288		1.2998046875	2.599609375	135	7.3095703125	214	45	2110	4	0	no(M2 and SIP pres)	0
21.5929870605	1	male	0	20	342	ARF/MOSF w/Sepsis	ARF/MOSF	0			44	35222	22459.453125	20857	21.3333282471	white	80	9.3984375	75	8	37.796875	368			0.5	142	7.419921875	117	4	4520			Coma or Intub	1.9145507813
51.0909729004	0	male	0	60	940	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	under $11k	0	167620	98773.0625	104292	28.25	white	108	5.3994140625	135	35	38.3984375	142.5	1.5	8.5	1.0998535156	145	7.3994140625	52	20	2180	1	2	SIP>=30	2
69.7059936523	0	male	0	11	933	CHF	COPD/CHF/Cirrhosis	3	6	$25-$50k	0	23536	15357.625	10738	24	white	57	7.19921875	145	24	36.3984375			2.7998046875	1.3999023438	130		92	46	1700	1	7	no(M2 and SIP pres)	7
70.8309936523	1	male	0	25	270	ARF/MOSF w/Sepsis	ARF/MOSF	3	4	under $11k	0	39684	25477.640625	31305	12.5	other	68	12	100	36	35	256.625			0.8999023438	137	7.4697265625	173	30	2435		6	adl>=4 (>=5 if sur)	6
62.5459899902	1	male	0	13	189	MOSF w/Malig	ARF/MOSF	4	14	$25-$50k	0	40684	25259.921875	27094	32.5	white	115	0.6999511719	30	11	36.3984375	188.5625	3.099609375	0.8999023438	1	136	7.4697265625	96	18	4470	1	6	adl>=4 (>=5 if sur)	6
68.5829467773	1	male	1	6	6	Lung Cancer	Cancer	1	21		9	9984	5991.34375	6257	7	white	64	67.09375	80	28	39				1.3999023438	140		11	26	1000			<2 mo. follow-up	2.2724609375
55.9669799805	0	female	0	22	913	ARF/MOSF w/Sepsis	ARF/MOSF	0	14		0	81191	48240.375	52100	25.6666564941	white	135	10.69921875	65	30	38	233			0.5999755859	137	7.4296875	99	10	5195		0	no(M2 and SIP pres)	0
63.7319946289	0	female	0	47	903	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	143396	83986.8125	83146	38.75	white	57	26	125	20	38.6953125	78.75	2.599609375		0.5999755859	133	7.2998046875	173	20	900		0	no(M2 and SIP pres)	0
58.3759765625	1	female	0	9	287	Cirrhosis	COPD/CHF/Cirrhosis	2	12		0	29065	19337.34375	18850	19	white	120	3.1997070313	125	10	36	236	2.5	3.2998046875	0.7999267578	140	7.3291015625	121	13	1165	0	0	no(M2 and SIP pres)	0
60.2849731445	1	female	0	4	593	Colon Cancer	Cancer	1	9	under $11k	0	2439	2092.802734375	2254	8	white	85	6.099609375	68	14	37.6953125		3.6997070313	0.3999633789	1.3999023438	144		128	16		0		SIP>=30	0.4947509766
72.0029907227	1	female	1	11	11	Coma	Coma	1	14		89	29982	18713.8125	16394	23	white	108	11.5	105	22	36.6953125	260			0.5999755859	137	7.4599609375	136	11	2705		1	<2 mo. follow-up	1
38.833984375	1	male	0	7	78	Lung Cancer	Cancer	1	16	$25-$50k	0	12767	7167.6796875	5134	5	white	97	8.69921875	76	10	35.59375		3.8999023438	1.1999511719	1.1999511719	139		82	4				SIP>=30	1.8913574219
63.2609863281	1	male	1	5	5	Coma	Coma	3			94	18203	10571.1015625	8207	43	black	161	9.798828125	50	14	38.6953125	366.625			1.5	152	7.419921875	144	12	2780			<2 mo. follow-up	2.7045898438
39.5349731445	0	female	0	15	879	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$25-$50k	0	47511	29027.078125	32729	26.3333282471	black	113	9.3984375	125	10	37.796875	346.625	3.3999023438	2.099609375	1	142	7.44921875	190	13	2990	5	6	no(M2 and SIP pres)	6
76.4159545898	1	female	0	7	141	ARF/MOSF w/Sepsis	ARF/MOSF	3			0	13907	8406.4140625	8812	14	black	75	12.298828125	60	14	36	493.3125			6.2998046875	137	7.5390625	108	53	0				3.3657226563
55.3589782715	1	female	1	18	18	Lung Cancer	Cancer	2	11	$11-$25k	9	20520	13153.953125	12673	15.6666641235	black	69	17.8984375	138	22	36.5		2.1997070313	0.6999511719	0.5999755859	144		203	6				<2 mo. follow-up	3.7563476563
49.0239868164	1	male	0	6	9	Cirrhosis	COPD/CHF/Cirrhosis	4	13		0	5844	3874.12109375	5229	8	black	69	3.3999023438	64	16	36.296875		2.6997070313		0.8999023438	124		78	11	1750	0	0	<2 mo. follow-up	0
45.242980957	0	female	0	18	832	ARF/MOSF w/Sepsis	ARF/MOSF	2			0	67484	39542.9375	41029	18.6666564941	white	108	19.59765625	65	8	36.1953125	388		0.3999633789	8.298828125	136	7.3291015625	146	54	835				2.7587890625
67.2529907227	1	male	1	9	9	COPD	COPD/CHF/Cirrhosis	1	17	$25-$50k	0	37006	21821.015625	23331	29	white	112	6.5	125	28	35.8984375	110.203125			0.5	138	7.509765625	145	21	3535		6	<2 mo. follow-up	6
54.5949707031	1	male	0	5	420	Colon Cancer	Cancer	1	16	>$50k	0	13289	6735.859375	3071	11	white	72	4.7998046875	45	20	36.296875		3.8999023438	0.5	1.0998535156	139		104	7		0	0	no(M2 and SIP pres)	0
65.7959594727	1	female	1	11	11	Lung Cancer	Cancer	1	12	$11-$25k	0	10715	7155.78125	7148	9.5	white	67	10	119	26	37.6953125		2.099609375	0.8999023438	0.3999633789	134		174	3		4	0	<2 mo. follow-up	0
70.2509765625	1	female	0	16	262	ARF/MOSF w/Sepsis	ARF/MOSF	3	11		9	68825	38212.21875	37550	16	black	102	14	45	12	38.296875	344			0.8999023438	132	7.439453125	189	13	2135	0	0	no(M2 and SIP pres)	0
59.3539733887	1	male	0	3	315	COPD	COPD/CHF/Cirrhosis	3	11	$25-$50k	0	2370	1662.341796875	1842	8	white	100	8.5	75	18	36.5	256.5	4.099609375	0.3999633789	1	139	7.4091796875	79	13	900	0	0	no(M2 and SIP pres)	0
51.1699829102	0	female	0	13	807	MOSF w/Malig	ARF/MOSF	1	14	$11-$25k	0	26200	16062	14772	22.5	white	62	2.5	125	33	37.796875	404	2.599609375	1.6999511719	2.1997070313	149	7.4091796875	74	25	1550	1	1	SIP>=30	1
63.6739807129	0	female	0	10	806	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	$25-$50k	0	27389	15589.3984375	18273	15	white	73	4.3994140625	64	32	38.3984375	138.3125			0.8999023438	134	7.44921875	210	15	1940	0		no(M2 and SIP pres)	0.4947509766
79.5809936523	1	male	1	4	4	Coma	Coma	2			100	36162	21214.640625	19782	35	white	20	12.298828125	0	0	37.796875	154	3.3999023438	0.7999267578	1.5	135	7.4091796875	255	31	1310			<2 mo. follow-up	4.392578125
60.6569824219	0	male	0	27	801	Cirrhosis	COPD/CHF/Cirrhosis	3	4		0	116117	66416	60614	25.5	white	112	18.19921875	135	33	38.3984375	243.3125	2	1.2998046875	0.5999755859	145	7.419921875	118	15	1705		0	no(M2 and SIP pres)	0
69.4509887695	1	female	0	20	81	ARF/MOSF w/Sepsis	ARF/MOSF	3		under $11k	0	45707	26465.71875	29656	22.6666564941	black	62	6.3994140625	60	10	36.09375	170			0.5999755859	139	7.419921875	115	10	3025		6	adl>=4 (>=5 if sur)	6
44.4409790039	1	female	0	5	96	Cirrhosis	COPD/CHF/Cirrhosis	2	10	under $11k	0	5385	3102.68359375	3011	10	black	73	8.8984375	115	24	35.59375	623.75	2	6.19921875	1	128	7.4697265625	91	6	750	1		no(M2 and SIP pres)	1.1667480469
70.4909667969	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0		13936.1015625	16877	39	white	38	15.599609375	75	20	36.796875	131.40625	2.099609375	3.8999023438	4.69921875	144	7.419921875	89	49	120			<2 mo. follow-up	1.9504394531
61.8289794922	1	female	1	30	30	COPD	COPD/CHF/Cirrhosis	4	21	>$50k	0	43942	27844.796875	28191	17.25	white	57	15.3984375	145	38	35.796875	230		0.5999755859	1.3999023438	142	7.3896484375	92	44	985		2	<2 mo. follow-up	2
77.0129394531	0	female	0	57	776	ARF/MOSF w/Sepsis	ARF/MOSF	1	12		0	177611	102840.75	100930	44.25	white	47	17.5	75	32	38.6953125	134	1.8999023438	0.6999511719	1.0998535156	132	7.439453125	107	18	1659		0	SIP>=30	0
63.282989502	1	male	0	17	82	Colon Cancer	Cancer	1	18	>$50k	0	23392			18.6666564941	white	128	5	52	20	36.6953125		3.8999023438	0.6999511719	1.2998046875	137		81	9	3200		0		0
70.0479736328	1	male	0	13	122	ARF/MOSF w/Sepsis	ARF/MOSF	0	9	under $11k	0	56994	33252.28125	35871	43.5	white	108	11.69921875	115	24	38	297.3125	3.099609375	0.5999755859	0.8999023438	133	7.4697265625	133	19	2045		1	no(M2 and SIP pres)	1
54.5429992676	1	male	0	10	192	Lung Cancer	Cancer	1	5	$25-$50k	0	17099	10467.5703125	10611	11	white	97	8.5	86	20	36.8984375		4.2998046875	0.5999755859	0.8999023438	142		133	14		0	0	no(M2 and SIP pres)	0
60.6539916992	1	male	0	21	67	ARF/MOSF w/Sepsis	ARF/MOSF	1	8		0	71922	39465	42149	29	white	68	12.69921875	135	6	38.1953125	188.3125			1.7998046875	131	7.4599609375	154	41	3860	0	0	no(M2 and SIP pres)	0
50.0119934082	0	male	0	3	764	Lung Cancer	Cancer	1	20	>$50k	0	6388	3168.7421875	1350	11	white	95	5.099609375	78	20	36.59375		3.599609375	0.5999755859	1.0998535156	140		104	8	5625			no(M2 and SIP pres)	1.8657226563
47.6279907227	1	male	0	76	521	MOSF w/Malig	ARF/MOSF	1	12		0	376664	207720	198047	45.25	white	125	18.5	105	13	37.8984375	165	1.7998046875	1.6999511719	4.7998046875	146	7.33984375	75	59	1660		0	adl>=4 (>=5 if sur)	0
65.9359741211	1	female	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	1	15	under $11k	0	62017	36789.21875	37194	36	black	112	18.296875	125	44	38.8984375	120	2.6997070313	0.3999633789	2.099609375	145	7.189453125	417	45	1445		0	<2 mo. follow-up	0
58.2809753418	0	female	0	9	759	COPD	COPD/CHF/Cirrhosis	3	13		0	10409	6518.16796875	7685	10	white	104	10.8984375	70	20	36.3984375	316	4	0.5999755859	0.6999511719	137	7.3994140625	147	22	2200	1	2	no(M2 and SIP pres)	2
71.1699829102	0	female	0	53	756	ARF/MOSF w/Sepsis	ARF/MOSF	3		under $11k	0	248546	142914.625	144234	43.75	black	78	36.09375	75	8	36.1953125	286.625	2.5	0.5999755859	1.8999023438	149	7.439453125	293	54	2265		1	SIP>=30	1
66.6119995117	1	male	0	9	333	MOSF w/Malig	ARF/MOSF	2	17	$25-$50k	0	15178	9082.953125	9389	15	other	57	0.299987793	115	24	35	226.65625			0.8999023438	133	7.5	385	23	1000	0	2	adl>=4 (>=5 if sur)	2
30.2449951172	1	male	1	4	4	Coma	Coma	1			100	11320	6489.47265625	6158	30	black	0	12.298828125	0	40	34.8984375	45	2.5	0.6999511719	1.1999511719	136	7.3193359375	134	67	1130			<2 mo. follow-up	1.5695800781
50.367980957	1	female	1	24	24	Coma	Coma	1	18	$11-$25k	0	56208	34438.6875	34426	23	black	138	24.19921875	155	36	36.5	152.5	1.0998535156	1.5	2.2998046875	131	7.4892578125	123	30	638		7	<2 mo. follow-up	7
80.4739990234	0	female	0	47	751	ARF/MOSF w/Sepsis	ARF/MOSF	0	18	>$50k	26	204836	121360.25	126090	33.25	white	110	10.298828125	120	40	38.6953125	152.5			0.5	139	7.4892578125	189	25	2805		0	adl>=4 (>=5 if sur)	0
59.4609985352	0	female	0	13	747	Colon Cancer	Cancer	1	10	$25-$50k	0	19294	11926.1015625	11618	13	white	72	5.8994140625	75	16	36.5			0.3999633789	0.6999511719	143		77	13	1475	0	1	no(M2 and SIP pres)	1
77.2129516602	0	male	0	38	748	MOSF w/Malig	ARF/MOSF	2	17	$25-$50k	44		103211.875	96555	31	white	62	7.599609375	145	10	39.09375	175	2.5	4	2	147	7.509765625	149	77	1520		0	no(M2 and SIP pres)	0
63.8519897461	1	female	0	6	25	Lung Cancer	Cancer	2	7	under $11k	0	7383	4555.85546875	5467	9	white	67	12.19921875	76	24	38.1953125	600	2.7998046875		0.7999267578	131	7.4697265625	51	3	2525		6	<2 mo. follow-up	6
65.0379638672	1	female	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	3	12		44	67810	38456.71875	35168	46	black	48	9.099609375	115	24	35.796875	363.3125	2.1997070313	3	5.69921875	143	7.4296875	137	51	23		1	<2 mo. follow-up	1
51.8739929199	0	male	0	11	728	Cirrhosis	COPD/CHF/Cirrhosis	2			0	18135	11270.7421875	11102	9	white	85	6.2998046875	75	20	36.1953125		2.3999023438	0.7999267578	1.2998046875	140		72	29					2.5927734375
65.5	1	female	1	6	6	MOSF w/Malig	ARF/MOSF	2	12	under $11k	26		46616.8125	45603	47	white	118	0.0999908447	135	25	38.1953125	200	2.099609375	0.6999511719	3	133	7.359375	248	124	1805		1	<2 mo. follow-up	1
74.0809936523	1	female	0	10	589	COPD	COPD/CHF/Cirrhosis	2	7	under $11k	0	10223	6574.703125	7437	9.5	white	108	14.798828125	70	18	36.796875	308		0.5999755859	0.8999023438	137	7.4697265625	280	27		1	2	no(M2 and SIP pres)	2
62.2529907227	0	male	0	9	725	COPD	COPD/CHF/Cirrhosis	3	5	$11-$25k	0	8922	5818.30859375	6201	10.5	white	86	11.599609375	88	22	37	256	3.3999023438	0.5	1.2998046875	143	7.369140625	147	22	2000	0		no(M2 and SIP pres)	0.4947509766
25.9549865723	0	female	0	13	720	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	>$50k	0				15	white	72	15.8984375	55	14	36.1953125	219.03125		0.6999511719	0.6999511719	138	7.3994140625	126	14	2580	0	0	no(M2 and SIP pres)	0
65.0079956055	1	male	0	7	315	CHF	COPD/CHF/Cirrhosis	3			0		4747.20703125	4657	6.5	white	110	8.19921875	80	20	37	404.75	3.2998046875	1.1999511719	1.0998535156	139	7.4697265625	81	21	2300				2.5322265625
38.1359863281	1	female	0	12	46	MOSF w/Malig	ARF/MOSF	3	12	$25-$50k	0	35399	21580.125	21693	27.5	white	113	3.5	125	35	36.1953125	185.6875		1.7998046875	2.1997070313	140	7.3896484375	149	33	1225	1	0	<2 mo. follow-up	0
62.208984375	1	male	0	9	601	COPD	COPD/CHF/Cirrhosis	2	11	under $11k	0	37356	23096.703125	22627	18	white	98	10.3984375	95	24	36.8984375	223.3125	3.099609375	1.2998046875	1.5	139	7.359375	94	31	2760	0	0	no(M2 and SIP pres)	0
53.8179931641	1	male	0	44	431	ARF/MOSF w/Sepsis	ARF/MOSF	1	12		0	87681	51575.96875	56810	19.25	white	107	79.390625	88	20	37.6953125	205.6875	3.2998046875	0.7999267578	1.6999511719	140	7.4296875	97	13	3370	0	0	no(M2 and SIP pres)	0
47.6959838867	1	male	1	5	5	MOSF w/Malig	ARF/MOSF	1	12	$25-$50k	0	32557	18351.90625	17679	52	black	50	7.5	140	20	41.1953125	62	2.7998046875	1.0998535156	4.599609375	149	7.419921875	269	73	1320		2	<2 mo. follow-up	2
69.3659667969	1	male	0	19	469	ARF/MOSF w/Sepsis	ARF/MOSF	2	0	under $11k	0	41611	23837.875	24459	19.6666564941	white	68	20.8984375	125	12	37.3984375	184	2.099609375	0.1999816895	0.6999511719	142	7.3896484375	89	17	795			SIP>=30	2.8608398438
61.9299926758	1	male	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	3	13	under $11k	61	139557	79442	81775	37.3333129883	white	70	7.69921875	80	28	36.6953125	154	1.7998046875	1.0998535156	2	138	7.3994140625	303	51	2825		0	<2 mo. follow-up	0
74.3739624023	1	female	1	18	18	COPD	COPD/CHF/Cirrhosis	2		under $11k	0	24211			13	white	66	7	110	32	36.6953125	226.0625	3.1997070313		0.5	138	7.3798828125	260	8	4525		2	<2 mo. follow-up	2
76.2379760742	1	male	1	27	27	COPD	COPD/CHF/Cirrhosis	6	3		0	69596	42462.75	45356	21	white	105	19.3984375	75	28	36	170		0.7999267578	1.3999023438	148	7.4091796875	283	64	1470		6	<2 mo. follow-up	6
66.1629638672	1	female	0	5	23	Lung Cancer	Cancer	1	12	$25-$50k	0	3425	2377.103515625	2767	8	white	100	11.599609375	120	28	36.59375		2.6997070313	0.5	0.5999755859	141		61	17		1		<2 mo. follow-up	1.1667480469
54.9489746094	0	female	0	46	672	ARF/MOSF w/Sepsis	ARF/MOSF	1		under $11k	0	174126			25.75	black	118	5.19921875	65	6	36.5	396	3.1997070313	0.5	0.6999511719	139	7.509765625	132		2675		1	adl>=4 (>=5 if sur)	1
71.9639892578	1	female	1	31	31	ARF/MOSF w/Sepsis	ARF/MOSF	0			0	256844	137596.625	120536	44.25	white	52	24	115	18	37.8984375	98.328125	2		0.7999267578	133	7.3994140625	129	34	1290			<2 mo. follow-up	2.0346679688
47.350982666	1	male	0	5	339	Lung Cancer	Cancer	1	12		0	3470	2491.943359375	2469	4	white	70	12.19921875	116	20	36.6953125				0.8999023438	139		71	15		1	2	no(M2 and SIP pres)	2
43.0579833984	1	male	0	4	250	Lung Cancer	Cancer	1	12	$25-$50k	0	9909	5033.58203125	3959	12	white	68	9.3984375	102	16	36.3984375		3.3999023438	0.3999633789	0.5	141		88	5	7455	0	0	no(M2 and SIP pres)	0
55.2609863281	1	male	1	7	7	MOSF w/Malig	ARF/MOSF	1	12	$11-$25k	0	24646	14752.671875	12783	21.5	white	68	10	110	29	37.796875	270	2.2998046875	0.3999633789	1.5998535156	154	7.33984375	119	38	2795		6	<2 mo. follow-up	6
49.5279846191	0	female	0	11	659	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	under $11k	0	66030	37520.5625	38252	32	white	115	15.8984375	125	45	38.5	233.3125	2.599609375		0.6999511719	137	7.439453125	132	6	3555		0	no(M2 and SIP pres)	0
56.2979736328	0	male	0	64	646	ARF/MOSF w/Sepsis	ARF/MOSF	1	12		0	227291	151162.875	154709	46	white	45	19	125	14	39.09375	77		0.7999267578	0.8999023438	131	7.3193359375	346	18	2912		1	SIP>=30	1
56.5939941406	1	female	0	9	128	MOSF w/Malig	ARF/MOSF	2	16		0	21295	12869.15625	13625	16	black	113	6.2998046875	193	32	36.296875	118.359375			0.6999511719	135	7.3994140625	195	21	3700	1	0	adl>=4 (>=5 if sur)	0
60.900970459	1	female	1	19	19	ARF/MOSF w/Sepsis	ARF/MOSF	2	7		9	99519			39	white	147	0.1999816895	135	30	35.796875	412	2.599609375	11.8984375	2.599609375	142	7.3994140625	164	105	2060		6	<2 mo. follow-up	6
60.867980957	0	male	0	6	641	CHF	COPD/CHF/Cirrhosis	2	4	under $11k	0	9822	6247.32421875	6229	23	white	68		65	16	35.796875			0.6999511719	1.3999023438	140		122	20	3350	2		adl>=4 (>=5 if sur)	1.8388671875
41.116973877	0	female	0	27	637	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	under $11k	9	113278	66799.8125	68660	27	black	68	11.8984375	65	10	39	300			1.0998535156	135	7.4892578125	205	21	2765		1	adl>=4 (>=5 if sur)	1
56.8949890137	0	male	0	8	632	CHF	COPD/CHF/Cirrhosis	3			0	18632			20	black	72	8.599609375	60	12	35.6953125	223.78125		1.5	1.8999023438	143	7.419921875	121	38	2365				2.8930664063
20.4819946289	0	male	0	35	627	ARF/MOSF w/Sepsis	ARF/MOSF	1	14		0	200937	114746.375	112610	36.75	white	138	28.5	145	10	38.796875	236	2.099609375	15.19921875	1	140	7.439453125	136	30	3540	0		no(M2 and SIP pres)	0.4947509766
87.9259643555	1	female	0	49	465	COPD	COPD/CHF/Cirrhosis	3	15	$11-$25k	9	50071	33320.03125	35008	16.75	white	60	11.8984375	65	30	38	272	4	0.3999633789	0.5999755859	124	7.4091796875	108	10	3800		1	adl>=4 (>=5 if sur)	1
32.6239929199	0	male	0	5	622	CHF	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	9490	5901.4140625	5805	17	black	79	11.19921875	130	25	36.1953125		4.19921875	1.1999511719	1.3999023438	141		96	21	2275	0	0		0
41.5819702148	0	male	0	9	620	ARF/MOSF w/Sepsis	ARF/MOSF	0			0	36979			20	white	68	14.298828125	125	42	39	124.484375	2.7998046875	0.6999511719	0.8999023438	138	7.4296875	106	29	1525				2.4272460938
45.1639709473	1	female	1	14	14	MOSF w/Malig	ARF/MOSF	1			0	83679	48635.375	46222	33.3333129883	black	65	15.19921875	125	14	39.5	132.5	2	2.099609375	1.2998046875	136	7.3896484375	81	12	1750			<2 mo. follow-up	2.408203125
69.7189941406	1	male	0	5	68	Lung Cancer	Cancer	4	3	under $11k	0	4335			8	white	76	5.099609375	88	28	36.796875			1.5	0.5999755859	127		184	9			0		0
70.8559570313	0	male	0	14	610	ARF/MOSF w/Sepsis	ARF/MOSF	2	11		0	29607	19447.828125	20150	10.3333282471	white	117	10.3984375	105	28	36.3984375	138.75		0.5	1.3999023438	136	7.4599609375	142	36	3280	2	3	SIP>=30	3
44.7689819336	0	female	0	12	608	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	>$50k	9	41805	23602.1875	21833	37	white	115	31.296875	145	31	36.59375	246.65625	2.5	0.8999023438	0.3999633789	131	7.4091796875	89	5	6820		0	no(M2 and SIP pres)	0
59.0059814453	1	male	0	11	413	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	>$50k	37	51587	31702.046875	29248	42.5	other	105	2.1997070313	135	32	38.296875	280		1.5	4.7998046875	127	7.3095703125	446	102	282		6		6
63.4879760742	1	female	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	0	11		0	55969	32768.09375	31940	36	black	58	16.296875	105	28	36	158	1.5998535156	5.69921875	3.6997070313	130	7.349609375	30	35	70		5	<2 mo. follow-up	5
60.8299865723	0	male	0	38	599	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	$25-$50k	44		55461.40625	61053	24.5	white	155	9.298828125	50	26	35.5	409.5	3.099609375		1.7998046875	147	7.4599609375	139	43	2195		0	adl>=4 (>=5 if sur)	0
48.3369750977	0	male	0	4	597	Lung Cancer	Cancer	2	13		0	7371	4496.9921875	2540	17	black	79	10	74	20	36.5		4.099609375	0.5999755859	1	143		112	9	4550			SIP>=30	1.8444824219
71.5869750977	1	male	0	12	78	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	under $11k	9	36480	22031.25	20923	20.5	black	120	40	115	26	35.1953125	360	1.8999023438	1	1.1999511719	137	7.3896484375	111	13	2405		6		6
58.0619812012	0	male	0	3	592	CHF	COPD/CHF/Cirrhosis	3	11	$11-$25k	0				9	black	90	6.19921875	64	20	36.59375	130			1.7998046875	138	7.3896484375	109	28	4315	0	0		0
63.3049926758	0	female	0	12	590	COPD	COPD/CHF/Cirrhosis	2	10	under $11k	0	50617	27886.453125	35712	35.5	white	58	5.8994140625	60	22	36.09375	136.71875			1	138	7.349609375	100	13	1760	0	5	no(M2 and SIP pres)	5
34.5489807129	1	female	1	4	4	Coma	Coma	0		under $11k	100	21703	13767.328125	12530	36	other	30	10.3984375	180	33	36.09375	350	2.599609375	0.1999816895	0.5999755859	120	7.5595703125	224	4	7360		0	<2 mo. follow-up	0
38.9159851074	1	female	0	10	395	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	under $11k	9	15182	10071.1640625	10648	14.5	black	82	24.69921875	105	12	36			0.0999908447	1.2998046875	134		84	28	1460	6	5	adl>=4 (>=5 if sur)	5
66.2229614258	1	male	0	41	204	ARF/MOSF w/Sepsis	ARF/MOSF	2		under $11k	41	85318	52149.25	65274	30	black	65	46.296875	80	32	38.296875	265	3.1997070313	0.6999511719	1.5	133	7.4296875	95	24	1680			no(M2 and SIP pres)	2.4462890625
72.66796875	1	male	0	4	177	CHF	COPD/CHF/Cirrhosis	3	14	under $11k	26		4063.841796875	3017	12	white	52	17.296875	55	18	35.796875	91.65625		1.2998046875	1.1999511719	134	7.279296875	73	14	4400	7	7	adl>=4 (>=5 if sur)	7
52.2049865723	0	female	0	36	577	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	under $11k	44	86035	53994.65625	61818	25.75	black	55	12.5	125	0	38.09375	340	2.099609375	0.6999511719	0.8999023438	137	7.3798828125	154	11	3330		0		0
67.8959960938	1	male	0	9	92	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	under $11k	100		13553	15362	24.5	white	72	14.298828125	95	29	36.796875	98.328125			0.7999267578	142	7.4599609375	156	31	765		0	adl>=4 (>=5 if sur)	0
84.4349975586	1	female	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	$11-$25k	44				31	white	27	18.19921875	180	22	38.1953125	243.3125			1.5998535156	142	7.3095703125	211	26	0		0	<2 mo. follow-up	0
71.2579956055	1	male	1	5	5	Coma	Coma	2	11	$11-$25k	94		10750.5703125	9085	37	black	115		75	12	36.1953125	433.3125			1.1999511719	145	7.4091796875	178	16	1725			<2 mo. follow-up	2.3549804688
69.6509399414	1	female	0	28	265	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	44	43552	26990.46875	30490	15.75	white	48	12.19921875	125	26	36.1953125	869.375			2.8999023438	158	7.3095703125	272	79	925		7	adl>=4 (>=5 if sur)	7
65.0159912109	0	female	0	13	546	COPD	COPD/CHF/Cirrhosis	2			9	33672	19349.921875	22102	27	black	125	17.8984375	75	26	36.3984375	196.65625			1	144	7.2998046875	512	18	3945	2	0	no(M2 and SIP pres)	0
70.2809448242	1	female	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	4	16		100	68397	37768.3125	41464	38	white	68	12.3984375	115	9	38.8984375	331.375		1.0998535156	5	144	7.4892578125	210	123	60		7	<2 mo. follow-up	7
63.1489868164	1	female	0	7	54	Lung Cancer	Cancer	1	12	$11-$25k	0	9809	5832.0078125	5343	13	black	107	10	80	28	36.296875		3.099609375	0.5	0.5999755859	130		248	9	4800	4	3	<2 mo. follow-up	3
65.6069946289	1	male	1	4	4	Cirrhosis	COPD/CHF/Cirrhosis	2	8	$11-$25k	0	14532			31	hispanic	42	19.296875	65	33	33.6953125	34	3.2998046875	32.3984375	7.3994140625	147	7.279296875	102	88	570			<2 mo. follow-up	1.7995605469
57.0289916992	1	male	0	17	48	Lung Cancer	Cancer	1	0	under $11k	0	16234	10966.8984375	12575	5.6666641235	white	105	7.19921875	150	22	36.59375		2.8999023438	0.8999023438	0.7999267578	139		99	7	2725		1	<2 mo. follow-up	1
59.3979797363	0	male	0	20	536	ARF/MOSF w/Sepsis	ARF/MOSF	2	12		0	38214	23649.03125	24873	24.3333282471	white	73	4.19921875	55	8	36	226.65625	2.2998046875	0.5	0.6999511719	141	7.3798828125	77	16	1175		6	adl>=4 (>=5 if sur)	6
85.2539672852	0	female	0	4	535	CHF	COPD/CHF/Cirrhosis	2	10	$11-$25k	0	5269	3610.66796875	3689	7	white	111	7.599609375	50	16	35.796875	210.1875			1	138	7.439453125	78	14	700	0	0	no(M2 and SIP pres)	0
66.8939819336	0	male	0	35	534	CHF	COPD/CHF/Cirrhosis	2	15	$11-$25k	41	42993	29988.34375	34828	17.25	white	52	10.798828125	105	26	40	210	3.3999023438	0.7999267578	1.6999511719	141	7.439453125	100	66	1210		0	no(M2 and SIP pres)	0
52.4599914551	1	female	1	9	9	Cirrhosis	COPD/CHF/Cirrhosis	2	14		41	119149	67033.5	64675	43	white	62	19.5	135	40	35.59375	145	2.6997070313	7.599609375	1.7998046875	135	7.4794921875	238	43	711		2	<2 mo. follow-up	2
55.8709716797	1	female	1	4	4	Lung Cancer	Cancer	1	12		0	3932	2679.876953125	3388	7	white	107	12.798828125	88	28	36	135			0.7999267578	125	7.3798828125	149	19	1700			<2 mo. follow-up	2.458984375
31.2249908447	1	male	0	4	330	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	$25-$50k	44	27355	16787.515625	17752	17	white	72	7.5	110	26	36.5	361.875	3.2998046875	0.5999755859	0.3999633789	140	7.4794921875	126	1	2675		7	adl>=4 (>=5 if sur)	7
87.2959594727	0	female	0	15	515	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	under $11k	26	29832			21.6666564941	white	105	25.19921875	115	32	37.8984375	97.953125	2.599609375	0.5	1.5	147	7.419921875	153	33	1930		0	no(M2 and SIP pres)	0
41.9489746094	1	female	0	12	30	Lung Cancer	Cancer	1	12		0	14354	9377.4453125	9969	11.5	hispanic	106	10.5	119	28	37.8984375				0.5	145		117	4	1200	0	1	<2 mo. follow-up	1
27.2939910889	0	female	0	12	510	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	37	43502	27744.921875	28170	20	black	111	10	105	36	38.296875	384		1.5	0.6999511719	135	7.359375	185	8	2950		0	no(M2 and SIP pres)	0
54.7519836426	0	male	0	18	510	ARF/MOSF w/Sepsis	ARF/MOSF	0		$11-$25k	0	49333	29308.0625	32056	26.3333282471	black	135	6.5	65	12	36.296875	326.625			0.7999267578	144	7.3798828125	93	5	2425		0	adl>=4 (>=5 if sur)	0
65.4099731445	1	male	1	18	18	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	>$50k	44	158768	86304.1875	96859	47.6666564941	white	117	22.5	125	40	35.59375	165			3	131	7.3896484375	128	125	2160		4	<2 mo. follow-up	4
62.400970459	1	male	1	4	4	MOSF w/Malig	ARF/MOSF	2			0	21075	12266.71875	12473	33	white	58	7.099609375	105	32	36.3984375	96.65625		3.7998046875	1.0998535156	141	7.349609375	106	34	1555			<2 mo. follow-up	2.6025390625
71.7369995117	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	under $11k	0	33091			47	black	45	15.8984375	115	38	36	293.3125		1.5998535156	3.2998046875	145	7.3193359375	297	96	288		7	<2 mo. follow-up	7
71.1919555664	0	female	0	30	486	COPD	COPD/CHF/Cirrhosis	1	12	>$50k	0	61413			13.25	white	95	9.099609375	160	26	36.09375	359.25		0.6999511719	0.6999511719	135	7.509765625	137	17	7160	0			0.4947509766
70.0969848633	0	male	0	13	483	ARF/MOSF w/Sepsis	ARF/MOSF	0	9	under $11k	0	22644			16	white	78	10.099609375	75	25	36.09375	356.625	2.7998046875	0.6999511719	0.7999267578	141	7.4091796875	91	18	2040	6	0	adl>=4 (>=5 if sur)	0
44.3889770508	0	female	0	114	479	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	9	256454			42.75	white	63	13.69921875	65	8	36.09375	373.3125		1	0.5999755859	138	7.44921875	192	65	2480		2	SIP>=30	2
40.8409729004	0	male	0	26	476	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	under $11k	0	82428			21.25	white	102	33.09375	105	24	36.3984375	196.65625			3.5	146	7.419921875	122	35	4140	1	1	SIP>=30	1
68.9229736328	1	female	0	8	95	Lung Cancer	Cancer	2	12	under $11k	0	9227			8.5	white	94	1.5	118	32	35.5		2.599609375	2.2998046875	0.3999633789	143		87	19	2700	0	5		5
47.8929748535	1	male	1	18	18	Coma	Coma	4	10	under $11k	9	71025			43	black	75	13.8984375	65	13	36.5	344	3.3999023438	1.3999023438	8.19921875	138	7.3798828125	193	66	0	3	0	<2 mo. follow-up	0
69.0869750977	1	female	0	15	70	COPD	COPD/CHF/Cirrhosis	2	9	$25-$50k	0	14097			10.3333282471	white	73	7.7998046875	76	24	36.8984375	242.84375	3	0.5999755859	0.6999511719	139	7.369140625	227	14				adl>=4 (>=5 if sur)	2.9399414063
39.6709899902	0	male	0	19	461	ARF/MOSF w/Sepsis	ARF/MOSF	2	16		0	88980			30	white	108	24.296875	75	12	38	230	1.7998046875		7.5	130	7.439453125	330	73	90		4	no(M2 and SIP pres)	4
66.8669433594	0	male	0	15	459	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	$25-$50k	9	57345			32.6666564941	white	107	11.599609375	50	22	36.6953125	155			0.8999023438	135	7.4697265625	103	23	2625		0	adl>=4 (>=5 if sur)	0
57.658996582	1	female	1	31	31	ARF/MOSF w/Sepsis	ARF/MOSF	2			0	191281			48.25	white	72	10.3984375	75	8	39	120	2	0.6999511719	1.0998535156	140	7.3994140625	68	17	1770		0	<2 mo. follow-up	0
75.3049926758	1	female	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	139100			37	black	138	10	135	25	37.796875	167.5			6	136	7.3994140625	101	58	0		5	<2 mo. follow-up	5
38.3569946289	0	male	0	14	442	ARF/MOSF w/Sepsis	ARF/MOSF	0	15		0	28330			14.3333282471	black	113	43.3984375	125	29	38	187.5	2.5	1.3999023438	6.69921875	139	7.3291015625	112	87	2055	0	0		0
79.4199829102	1	male	1	52	52	ARF/MOSF w/Sepsis	ARF/MOSF	3	13		9	134458			31.75	white	118	20.5	53	36	38.1953125	236.65625	2.099609375	0.3999633789	1	134	7.44921875	92	31	1540		6	<2 mo. follow-up	6
66.5459594727	1	male	0	40	165	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	162193			34.75	white	142	5.7998046875	115	28	38.59375	227.5	2.6997070313		0.6999511719	138	7.4296875	121	18	2360		0	no(M2 and SIP pres)	0
70.7349853516	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	1			100	20379			34	white	49	5.5	0	0	39.296875	177	2.8999023438	0.5	1.1999511719	147	7.5498046875	312	28	4065			<2 mo. follow-up	3.3344726563
77.3579711914	0	female	0	10	433	ARF/MOSF w/Sepsis	ARF/MOSF	1			9	87387			27.5	white	115	14	105	24	37.796875	340	2.6997070313		0.7999267578	136	7.4697265625	189	25	1935				2.6953125
59.6139831543	1	female	0	8	173	Colon Cancer	Cancer	1	15	>$50k	0	17474			10	white	77	10.798828125	80	16	38.09375		4.5	0.6999511719	0.7999267578	145		88	12	7275	0			0.4947509766
51.0689697266	0	male	0	50	424	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	under $11k	0	153904			33.25	hispanic	118	5.599609375	115	24	35.59375	120.40625	3	0.5	0.7999267578	135	7.419921875	91	10	2020			no(M2 and SIP pres)	2.1372070313
68.4409790039	1	male	1	4	4	MOSF w/Malig	ARF/MOSF	2	17	>$50k	44	22156			46	white	58	10.3984375	135	22	38.296875	111.421875		0.5999755859	0.7999267578	136	7.3798828125	170	14	1520		7	<2 mo. follow-up	7
77.0869750977	1	male	0	19	65	CHF	COPD/CHF/Cirrhosis	2			0	39533			26.3333282471	white	70	9.3984375	80	30	35		2.8999023438	1.5	1	131		99	26	1560				2.9536132813
63.2439880371	1	female	0	11	66	Coma	Coma	2	10		0	13705			13	white	77	12.798828125	130	24	37.09375	323.75		0.3999633789	0.5	134	6.9892578125	97	15			1	adl>=4 (>=5 if sur)	1
53.7279968262	1	male	1	7	7	MOSF w/Malig	ARF/MOSF	1	11	under $11k	37	33447			36	black	55	16.8984375	145	31	38.1953125	162.5	2.7998046875	0.3999633789	1.0998535156	142	7.369140625	117	32	527		1	<2 mo. follow-up	1
76.8239746094	0	female	0	29	404	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	130680			23	white	75	13.798828125	115	38	35.3984375	338.0625		0.6999511719	0.6999511719	134	7.5	185	22	2410		1	adl>=4 (>=5 if sur)	1
70.660949707	0	male	0	37	404	MOSF w/Malig	ARF/MOSF	1	16		44	70272			18.75	white	65	10.3984375	115	29	38.59375	243.3125		1	1.7998046875	138	7.509765625	117	24	4410	0	0	no(M2 and SIP pres)	0
72.7339477539	1	female	0	70	140	COPD	COPD/CHF/Cirrhosis	1	14	under $11k	26	186634			31.5	black	95	27.796875	125	38	37.59375	263.3125	4.19921875		1	140	7.4599609375	192	28	1065		0	SIP>=30	0
66.3049926758	1	female	0	10	66	Colon Cancer	Cancer	2	2	under $11k	0	8695			6	black	111	19.5	124	22	36.296875				0.5999755859	143		236	15		2	4	no(M2 and SIP pres)	4
63.742980957	1	male	1	8	8	Cirrhosis	COPD/CHF/Cirrhosis	1	12	$25-$50k	0	9053			11.5	white	73	12.5	148	24	36.1953125		2.599609375	6.099609375	0.8999023438	129		172	31	465		6	<2 mo. follow-up	6
46.1879882813	1	female	0	9	153	Coma	Coma	2			9	9301			9.5	black	107	9.5	72	24	36.3984375		3.7998046875	0.3999633789	0.5	141		210	3	1975				2.6689453125
59.0689697266	0	female	0	7	391	COPD	COPD/CHF/Cirrhosis	1	12	$11-$25k	0	7544			8.5	black	80	18.3984375	80	20	36.59375	314.25			1.1999511719	141	7.3798828125	109	33	1925	0			0.4947509766
33.7629699707	0	male	0	14	389	ARF/MOSF w/Sepsis	ARF/MOSF	0			0	61906			22.3333282471	white	108	6.8994140625	115	32	38.5	304	1.7998046875		6.7998046875	142	7.3798828125	96	72	2225				2.2768554688
74.9349975586	0	male	0	14	388	ARF/MOSF w/Sepsis	ARF/MOSF	0	16		0	37297			18.3333282471	white	118	10.8984375	55	12	35.8984375	190		1.5998535156	1.5998535156	136	7.3994140625	154	29	7560		0	no(M2 and SIP pres)	0
85.0159912109	0	female	0	4	382	CHF	COPD/CHF/Cirrhosis	3	8	$11-$25k	0	3918			4	white	83	7.7998046875	75	18	36.796875	304			0.8999023438	143	7.4091796875	125	23				no(M2 and SIP pres)	2.35546875
34.7569885254	0	male	0	17	380	ARF/MOSF w/Sepsis	ARF/MOSF	1	8		44	51410			23.3333282471	black	72	6.7998046875	125	8	38.796875	230	2.5		1	137	7.359375	89	6	1910		0	no(M2 and SIP pres)	0
56.9119873047	1	male	0	12	82	CHF	COPD/CHF/Cirrhosis	3	7	under $11k	0	13279			10.5	white	63	7.099609375	75	28	36.09375		3.6997070313	1	3.1997070313	143		84	75	2400	6		no(M2 and SIP pres)	4.52734375
67.5699462891	1	male	0	20	55	Colon Cancer	Cancer	1		>$50k	0	21601			8	white	110	6.8994140625	100	24	37.5			0.6999511719	0.6999511719	138		105	14	6500	0	0	<2 mo. follow-up	0
83.1069946289	1	female	1	35	35	ARF/MOSF w/Sepsis	ARF/MOSF	1	4	under $11k	26	141681			36	black	68	6.19921875	125	30	36.59375	122.21875			3	136	7.3193359375	118	57	1525		2	<2 mo. follow-up	2
34.9839782715	1	male	0	5	31	CHF	COPD/CHF/Cirrhosis	3	11	$11-$25k	0	6339	4722.0546875	1178.4091796875	15	black	73	10.19921875	105	32	36.59375	409.5	3.599609375	0.3999633789	1.2998046875	136	7.419921875				0	0	<2 mo. follow-up	0
42.7159729004	1	male	0	6	791	CHF	COPD/CHF/Cirrhosis	2	6	under $11k	0	4538	3398.337890625	1333.529296875	14	white	97	11.3984375	115	22	36	457.125	3.599609375	0.7999267578	1.1999511719	131	7.4091796875				5	5	adl>=4 (>=5 if sur)	5
28.4349975586	0	male	0	19	2011	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	under $11k	0	28546	21811.09375	7453.73828125	26	white	135	8.298828125	126	10	36.6953125	200	3.2998046875	0.5	0.6999511719	137	7.4296875					6	no(M2 and SIP pres)	6
32.8099975586	1	male	1	8	8	Cirrhosis	COPD/CHF/Cirrhosis	4			0	22651			55.5	other	123	9.8984375	136	30	35.8984375		2.5	2.6997070313	0.5999755859	137							<2 mo. follow-up	3.158203125
37.8949890137	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	0	35796	26760.671875	11480.7265625	50	white	55	13.69921875	113	32	38.09375	88.109375	2.599609375	3.3999023438	0.5999755859	131	7.5498046875					0	<2 mo. follow-up	0
73.5329589844	1	female	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	251017	187147.5	75303.3125	42.3333129883	white	125	18.8984375	118	9	36.6953125	239.3125	1.8999023438	0.7999267578	0.7999267578	131	7.439453125				3	0	<2 mo. follow-up	0
72.1449584961	1	female	1	5	5	MOSF w/Malig	ARF/MOSF	2	12	under $11k	0	4432	3190.625	1561.619140625	24	white	115	9.3984375	106	30	36	418.5625	2.599609375	0.1999816895	0.6999511719	126	7.2099609375					6	<2 mo. follow-up	6
67.5999755859	0	female	0	45	1979	ARF/MOSF w/Sepsis	ARF/MOSF	2		under $11k	0	61206	45495.75	15383.1328125	26.25	black	63	15.099609375	140	40	35.3984375	126.6875	1.8999023438	0.5	2.2998046875	129	7.44921875					1	no(M2 and SIP pres)	1
56.1479797363	1	male	0	31	374	MOSF w/Malig	ARF/MOSF	3	12	$25-$50k	0	54778	39451.75	17885.515625	26.25	white	63	0.0999908447	120	24	38.5		3.099609375	0.5999755859	0.8999023438	126					0	0	no(M2 and SIP pres)	0
62.657989502	1	female	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	26	76847	56111.875	28400.53125	47.6666564941	white	113	5	133	12	36.1953125	120	2.1997070313	4.19921875	1.3999023438	135	7.4091796875					1	<2 mo. follow-up	1
67.1019897461	1	male	0	4	1776	CHF	COPD/CHF/Cirrhosis	6	10	under $11k	0	3856	2844.55859375	1087.8994140625	5	black	77	6.5	50	20	35.796875	275.1875			1.6999511719	144	7.419921875							3.169921875
76.9749755859	1	female	1	21	21	MOSF w/Malig	ARF/MOSF	2	4	under $11k	0	68081	49404.15625	25860.390625	56	white	55	61.1953125	119	14	36.296875	266.625	1.7998046875	0.6999511719	0.3999633789	143	7.25					0	<2 mo. follow-up	0
67.1019897461	1	male	0	23	969	ARF/MOSF w/Sepsis	ARF/MOSF	6	8	$11-$25k	9	23710	18728.4375	5432.46875	9.6666641235	black	105	18.8984375	115	20	37.3984375	351.5625	1.2998046875	0.299987793	2.6997070313	144	7.419921875					5		5
65.7739868164	1	male	0	3	24	Lung Cancer	Cancer	1	15	$25-$50k	0	2269	1606.259765625	834.599609375	24	white	75	7.19921875	138	32	36	214.96875	3.3999023438	0.299987793	0.7999267578	135	7.419921875				2		<2 mo. follow-up	1.8389997482
63.0249938965	1	male	0	39	521	Coma	Coma	2			55	55836	43521.78125	21557.703125	16.25	white	124	13	126	32	38.1953125				1.8999023438	140								3.4887695313
71.424987793	1	male	0	3	965	CHF	COPD/CHF/Cirrhosis	3	8	under $11k	0	2265	1679.8623046875	829.6298828125	17	white	88	10	98	24	36.3984375	189.5	3.2998046875	2.8999023438	1.5	134	7.369140625						no(M2 and SIP pres)	2.6040039063
37.299987793	1	female	1	6	6	MOSF w/Malig	ARF/MOSF	1	14	under $11k	26	39395			24	black	63	0.5999755859	108	22	36.296875		2.2998046875	13.099609375	2.5	128						4	<2 mo. follow-up	4
75.2309570313	0	female	0	39	1904	ARF/MOSF w/Sepsis	ARF/MOSF	0	12		0	48176	38014.46875	9029.46875	22.25	white	180	18.59765625	116	10	38.09375	262.5	4.099609375	0.6999511719	0.8999023438	135	7.3994140625					0	adl>=4 (>=5 if sur)	0
36.2219848633	0	female	0	14	1892	Cirrhosis	COPD/CHF/Cirrhosis	4			9	12878			10.6666641235	black	147	13.19921875	114	13	37.796875	294.625	3.2998046875	2.7998046875	0.5	141	7.3798828125					1	no(M2 and SIP pres)	1
56.8539733887	1	female	0	15	236	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	$11-$25k	0	12699	9728.1484375	2626.26953125	15.6666641235	white	131	12.69921875	83	31	35.6953125	314.8125	2.1997070313	0.1999816895	2.5	133	7.3896484375				5	6	no(M2 and SIP pres)	6
62.9399719238	1	female	0	10	32	CHF	COPD/CHF/Cirrhosis	4	11	under $11k	0	11791	9143.828125	2908.068359375	11.5	white	110	6.19921875	62	34	36.296875	396.25	3.1997070313	0.5	1.3999023438	136	7.44921875				3	5	<2 mo. follow-up	5
50.9019775391	1	male	0	6	59	CHF	COPD/CHF/Cirrhosis	5	10	under $11k	0	4139	3192.3515625	1036.26953125	11	black	106	6.099609375	66	25	36	347.5625	3.7998046875	1.6999511719	1.8999023438	130	7.439453125				2	2	<2 mo. follow-up	2
44.366973877	1	female	1	7	7	Coma	Coma	1	9	under $11k	44	34994	27346.515625	6801.59765625	46	white	119	9.19921875	122	44	38.296875	310	3.2998046875	0.299987793	0.5999755859	136	7.51953125					6	<2 mo. follow-up	6
72.1309814453	0	female	0	10	1859	COPD	COPD/CHF/Cirrhosis	4	12	under $11k	0	7997	5999.328125	2242.419921875	12.5	white	76	6.099609375	114	24	36.59375	202	3.3999023438	0.8999023438	1	136	7.349609375					4	adl>=4 (>=5 if sur)	4
70.2419433594	0	female	0	6	1857	CHF	COPD/CHF/Cirrhosis	4	3		0	4524	3394.244140625	1397.369140625	12	black	106	9.798828125	98	22	36	369.5	4.599609375	0.6999511719	1.0998535156	142	7.3896484375				0	0	no(M2 and SIP pres)	0
77.4459838867	1	female	0	24	144	Colon Cancer	Cancer	2	10	under $11k	0	17083	13181.4921875	3600.279296875	12.3333282471	white	96	7.099609375	96	20	37		3.2998046875	0.6999511719	1.0998535156	136					3	0	SIP>=30	0
67.5589599609	1	male	0	12	44	ARF/MOSF w/Sepsis	ARF/MOSF	2		$11-$25k	9	30357	22907.75	6930.06640625	17.5	white	139	17.5	100	24	35.09375	115	2.599609375	0.8999023438	8	134	7.4091796875				0	0	<2 mo. follow-up	0
55.8299865723	1	female	0	12	124	Cirrhosis	COPD/CHF/Cirrhosis	2	12	under $11k	0	8649	6666.078125	2036.4697265625	2.5	white	76	5.8994140625	94	22	37.59375		2	6	0.7999267578	129					0	0	no(M2 and SIP pres)	0
77.7389526367	1	male	1	32	32	ARF/MOSF w/Sepsis	ARF/MOSF	1		under $11k	61	74682	53243	54324.0625	32.75	white	102	14.19921875	117	36	39.8984375	433.3125	2.3999023438	0.299987793	0.5999755859	130	7.4794921875					1	<2 mo. follow-up	1
22.203994751	0	female	0	202	1837	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	290573	223134.375	234875.875	35	white	144	17.8984375	189	28	37.796875	157.5	3	0.5999755859	0.5999755859	133	7.6591796875					6	adl>=4 (>=5 if sur)	6
73.3249511719	1	female	0	5	1070	CHF	COPD/CHF/Cirrhosis	5	14	under $11k	0	3602	2656.419921875	2451.349609375	9	black	119	7.599609375	78	24	36	386.1875	3.3999023438	0.299987793	3.6997070313	139	7.369140625				0	1	no(M2 and SIP pres)	1
67.2739868164	1	female	1	18	18	MOSF w/Malig	ARF/MOSF	3			44	55395	39613.875	37132.875	53.6666564941	white	54	12.3984375	130	24	38.296875	98.796875	1.6999511719	2.599609375	1.5	132	7.44921875						<2 mo. follow-up	4.1484375
53.4699707031	1	male	1	31	31	Lung Cancer	Cancer	1	13	$25-$50k	100	64508	45421.34375	47679.96875	40	other	142	11	68	10	38.1953125	300	3.099609375	0.7999267578	0.8999023438	138	7.5					1	<2 mo. follow-up	1
64.3199462891	1	female	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	2	7	under $11k	44	49996	34270.71875	34682.03125	58.5	black	47	28	79	8	35.3984375	166	2.3999023438	0.7999267578	1.2998046875	134	7.3193359375					6	<2 mo. follow-up	6
78.258972168	1	female	1	9	9	COPD	COPD/CHF/Cirrhosis	1		under $11k	0	24767	20170.4375	18509.71875	43	white	67	27.5	172	40	37.8984375	145	2.8999023438	0.6999511719	1.0998535156	135	7.19921875					0	<2 mo. follow-up	0
76.133972168	0	male	0	21	1803	COPD	COPD/CHF/Cirrhosis	2	8	$11-$25k	0	25041	19356.9375	17746.765625	17	white	106	23.3984375	109	8	37.8984375	61.09375	4.2998046875	1	1.2998046875	136	7.2197265625						adl>=4 (>=5 if sur)	3.283203125
37.6669921875	0	male	0	10	1798	ARF/MOSF w/Sepsis	ARF/MOSF	1	7	under $11k	0	8869	6339.27734375	6359.578125	14	white	103	10.099609375	106	26	37.3984375	240	2.5	0.5	0.5	140	7.3994140625				0	0	no(M2 and SIP pres)	0
46.0369873047	1	male	1	27	27	ARF/MOSF w/Sepsis	ARF/MOSF	2			0	93619	64251.28125	64284	51.75	white	111	4.3994140625	108	14	37.59375	191	1.8999023438	0.6999511719	2.099609375	134	7.44921875						<2 mo. follow-up	2.671875
58.400970459	1	female	0	7	346	Cirrhosis	COPD/CHF/Cirrhosis	4	14	under $11k	0	5292	3863.125	3674.46875	9	white	99	3.2998046875	80	20	36.1953125		2.6997070313	0.6999511719	3.6997070313	135					1		SIP>=30	1.1668996811
56.4679870605	1	male	1	18	18	ARF/MOSF w/Sepsis	ARF/MOSF	3			9	53228	41687.21875	40337.5625	44.6666564941		69	9.798828125	138	32	38.1953125	186.375	1.5998535156	14.599609375	2.599609375	133	7.419921875						<2 mo. follow-up	3.189453125
42.674987793	1	female	1	4	4	Coma	Coma	2	12	under $11k	100	7940	6883.0859375	6103.546875	14	black	38	6.19921875	153	10	36.59375	387.125	3.3999023438	0.7999267578	9	144	7.189453125					0	<2 mo. follow-up	0
63.492980957	0	male	0	14	1752	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	0	28506	22617.5	21181.609375	24	white	73	20.796875	114	12	38.1953125	208.5625	2.1997070313	1.3999023438	1.7998046875	140	7.4599609375					0	no(M2 and SIP pres)	0
20.5889892578	0	female	0	13	1739	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	0	16083	11785.3828125	11721.6171875	12	black	83	12.298828125	155	36	39	336	4.099609375	0.5999755859	11.19921875	135	7.349609375				1	0	no(M2 and SIP pres)	0
56.391998291	0	female	0	4	1736	CHF	COPD/CHF/Cirrhosis	4	9	under $11k	0	3863	2772.78515625	2513.419921875	13	black	97	6.599609375	114	24	35.3984375	261.875		0.5	1.1999511719	136	7.44921875				0		no(M2 and SIP pres)	0.4947998524
66.4889526367	1	male	0	8	351	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	under $11k	0	12177	9755.1796875	9127.0078125	13	white	82	23.296875	111	24	36.1953125	289.9375	3.8999023438	0.5	1.0998535156	132	7.25				0	1		1
48.3589782715	1	female	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	4	7	under $11k	0	50534	40139.25	37470.53125	47.3333129883	white	43	11.19921875	164	36	39.796875	89	2.3999023438	1.8999023438	0.6999511719	137	7.3896484375					0	<2 mo. follow-up	0
60.566986084	0	female	0	3	1670	Cirrhosis	COPD/CHF/Cirrhosis	6	10	under $11k	0	2917	2180.845703125	2257.158203125	9	white	87	6.599609375	87	20	36.6953125		2.3999023438	1.2998046875	1.1999511719	137							no(M2 and SIP pres)	3.0483398438
45.6969909668	1	female	0	5	355	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	4335	3087.14453125	3103.1484375	13	black	69	5.5	78	18	36.59375	400	3.6997070313	0.1999816895	1.8999023438	142	7.419921875						no(M2 and SIP pres)	2.2543945313
63.4629821777	1	male	1	20	20	Lung Cancer	Cancer	2	11	$11-$25k	0	18784	15695.421875	15219.296875	16.6666564941	white	68	10.798828125	120	32	36.296875	276.1875		0.6999511719	0.7999267578	132	7.5				0	0	<2 mo. follow-up	0
81.8669433594	1	female	0	5	623	COPD	COPD/CHF/Cirrhosis	4	10	under $11k	0	3919	2813.005859375	2688.9296875	15	white	83	13.19921875	94	16	35.5	257.125	3.599609375	0.5	1.2998046875	136	7.369140625				1		SIP>=30	1.1668996811
64.908996582	1	female	1	5	5	MOSF w/Malig	ARF/MOSF	2	13	under $11k	9	15017	10283.28125	10912.4296875	19	white	41	0.0999908447	180	24	36.296875		2.3999023438	1.3999023438	1.7998046875	133						2	<2 mo. follow-up	2
35.0609741211	1	female	0	18	118	MOSF w/Malig	ARF/MOSF	1	14	$25-$50k	0	19369	13598.03125	15257.46875	20.6666564941	white	72	0.1499938965	96	22	38.296875				0.5999755859	136					1	0	no(M2 and SIP pres)	0
69.9379882813	0	male	0	29	1639	ARF/MOSF w/Sepsis	ARF/MOSF	0			0	28396	22406.625	20418.484375	13.5	white	68	9.69921875	73	32	37.59375	300.375	2.1997070313	2.099609375	2	138	7.44921875				0		no(M2 and SIP pres)	0.4947998524
40.7779846191	0	male	0	4	1633	CHF	COPD/CHF/Cirrhosis	3	10	under $11k	0	2707	2048.6640625	1994.8291015625	8	black	118	8	110	40	35.09375	269.5	4	2.099609375	1.3999023438	140	7.4091796875						SIP>=30	2.509765625
81.9059448242	1	female	0	33	1489	CHF	COPD/CHF/Cirrhosis	3		under $11k	0	57319	41473.84375	43395.53125	29	white	103	10.19921875	64	16	36.09375	281.875	4.5	1.2998046875	1.1999511719	134	7.4892578125					5	SIP>=30	5
62.3409729004	1	female	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	36127	28923.578125	27897.40625	28.3333282471	white	38	4.7998046875	120	24	37.59375		2.599609375	17.8984375	10.3984375	134							<2 mo. follow-up	3.2797851563
77.8449707031	1	male	0	33	44	MOSF w/Malig	ARF/MOSF	1		under $11k	0	29913	21028.96875	21573.84375	17.75	white	70	0.6999511719	112	42	39.796875	523.75	2.7998046875	1.6999511719	0.7999267578	138	7.5390625					6	<2 mo. follow-up	6
48.6539916992	1	male	1	20	20	Lung Cancer	Cancer	2	14	under $11k	0	18367	13296.734375	12566.8671875	16	white	80	8.5	110	26	35.6953125	352.375	2.1997070313	0.3999633789	0.5999755859	130	7.4599609375				5	5	<2 mo. follow-up	5
62.7869873047	1	male	0	23	52	Cirrhosis	COPD/CHF/Cirrhosis	4		under $11k	0	39033	28216.25	29448.171875	18.6666564941	white	69	4.5	107	9	36.09375	345.6875	1.8999023438	18.19921875	1.5	146	7.4697265625				4	2	<2 mo. follow-up	2
92.7389526367	1	female	0	13	719	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	17435	12993.5234375	12674.6171875	17		69	9.099609375	60	24	36	164			1.8999023438	139	7.4091796875				1			1.1668996811
76.1039428711	1	male	0	5	207	CHF	COPD/CHF/Cirrhosis	3	5	under $11k	0	3831	2746.97265625	2869.408203125	11	black	73	5.69921875	111	22	36.5		4.69921875	1.3999023438	1.8999023438	141					3	1	no(M2 and SIP pres)	1
83.1759643555	1	male	0	10	614	CHF	COPD/CHF/Cirrhosis	2	10	under $11k	0	7450	5479.36328125	5147.1796875	6	black	96	4.69921875	73	24	35	395.1875	3.099609375	1.3999023438	1.5998535156	134	7.4091796875				4	0	SIP>=30	0
59.6929931641	1	male	1	13	13	MOSF w/Malig	ARF/MOSF	1	12	under $11k	9				44.5	white	57	23.796875	114	30	35.3984375	278.3125	2.8999023438	2.5	1.8999023438	135	7.51953125				0	6	<2 mo. follow-up	6
62.4529724121	1	male	0	4	1458	COPD	COPD/CHF/Cirrhosis	2	11	under $11k	0	3041	2167.22265625	1959.439453125	8	black	106	6.69921875	126	24	36.3984375	261.875	3.8999023438	0.5	1.0998535156	139	7.44921875				1	0	no(M2 and SIP pres)	0
71.6279907227	0	female	0	24	1508	ARF/MOSF w/Sepsis	ARF/MOSF	2	13		0	36492	27719.890625	27041.734375	24.6666564941	white	66	8.099609375	0	28	36.796875	272	3	0.6999511719	1.1999511719	130	7.3896484375					0	no(M2 and SIP pres)	0
55.424987793	0	female	0	8	1503	ARF/MOSF w/Sepsis	ARF/MOSF	0		under $11k	0	19233	15846.8671875	14417.9296875	23.5	white	125	27.796875	109	28	35.6953125	464	2.5	7.8994140625	1.5998535156	133	7.419921875					0	no(M2 and SIP pres)	0
35.1379699707	0	female	0	15	1498	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$11-$25k	9	38924	27626.375	26279.78125	36.3333129883	white	67	17.59765625	118	24	38.09375	112.71875	2	1.7998046875	0.7999267578	137	7.5498046875					1	SIP>=30	1
51.5919799805	0	female	0	26	1487	Cirrhosis	COPD/CHF/Cirrhosis	2	14	under $11k	0	10544	17940.6875	18192.109375	11	white	57	26.296875	76	20	36.5		2.3999023438	17.296875	1.3999023438	131					1	0	no(M2 and SIP pres)	0
58.2449951172	1	female	1	13	13	Coma	Coma	1	11	$11-$25k	100	98007	80836.6875	74093.5625	49.5	black	125	15.3984375	107	29	35.5	57	2.7998046875	2.2998046875	1.2998046875	130	7.4697265625					5	<2 mo. follow-up	5
41.6129760742	1	male	0	4	716	Cirrhosis	COPD/CHF/Cirrhosis	3	12	under $11k	0	3803	2692.359375	2550.9296875	13	white	57	7.19921875	145	20	36.5	357.125	3	2.599609375	0.5999755859	134	7.4794921875							2.7602539063
41.508972168	1	female	0	23	180	Coma	Coma	0	12	$11-$25k	44	53733	35883.5	41107.28125	38.6666564941	black	65	28.5	140	43	39.1953125	448.875	2.2998046875	1.7998046875	1.1999511719	145	7.3896484375					0	no(M2 and SIP pres)	0
30.8859863281	1	male	1	40	40	ARF/MOSF w/Sepsis	ARF/MOSF	1	16		0	169997	111276.875	127505.375	58.25	white	65	6.19921875	120	30	38.796875	116.65625	2.2998046875	2.5	10.599609375	148	7.3798828125					0	<2 mo. follow-up	0
71.8899536133	1	female	0	5	783	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	5999	3557.890625	3993.138671875	20	white	75	4.3994140625	68	26	36.59375	291.25	3.599609375	0.6999511719	0.7999267578	138	7.3896484375				2	0	no(M2 and SIP pres)	0
54.6279907227	1	male	0	35	226	MOSF w/Malig	ARF/MOSF	2	9	under $11k	9	68558	45297.65625	55132.90625	30	black	56	1.1999511719	138	12	39	220	2.2998046875	3.3999023438	1.8999023438	138	7.4091796875				4	5	SIP>=30	5
28.5069885254	0	male	0	12	1435	ARF/MOSF w/Sepsis	ARF/MOSF	1	11		0	36646	21162.4375	23650.359375	43.5	black	121	21.19921875	69	22	36.296875	173.3125	2.6997070313	0.5	5.2998046875	134	7.4091796875					0	no(M2 and SIP pres)	0
66.9099731445	1	female	0	12	673	MOSF w/Malig	ARF/MOSF	1	11	under $11k	0	27529	17784.28125	19595.609375	20.5	white	103	7.69921875	103	30	36.796875	247.5	2.6997070313	0.8999023438	1.7998046875	133	7.4091796875				0	0	no(M2 and SIP pres)	0
31.2029876709	0	male	0	5	1427	ARF/MOSF w/Sepsis	ARF/MOSF	4	13	under $11k	37	7541	4971.60546875	5624.46875	23	white	77	18	114	34	36.796875	574	2.8999023438	0.5999755859	0.7999267578	137	7.349609375				0		no(M2 and SIP pres)	0.4947998524
82.5869750977	1	female	1	164	164	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	under $11k	26	289468	231848.75	271467.25	52	white	162	12.3984375	130	12	36.6953125	325.6875		1.5998535156	2	131	7.349609375					2	adl>=4 (>=5 if sur)	2
69.6369628906	1	male	0	5	6	MOSF w/Malig	ARF/MOSF	2	15	$11-$25k	9	11128	7264.68359375	8283.25	30	white	64	12.3984375	131	39	36.1953125	133.3125	2.099609375	1	0.8999023438	135	7.5390625				6		<2 mo. follow-up	4.5273971558
34.1159973145	1	female	0	5	98	Cirrhosis	COPD/CHF/Cirrhosis	4	7	under $11k	0	9156	6053.80078125	7153.4765625	27	hispanic	104	6.3994140625	107	28	38.1953125	257.125	2.6997070313	2.599609375	0.8999023438	139	7.509765625				0		Coma or Intub	0.4947998524
28.2299957275	0	female	0	38	1409	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	under $11k	0	46400	30953.796875	33497.40625	16.25	hispanic	81	4.19921875	124	32	38.796875	480.9375	2.7998046875	1.0998535156	0.6999511719	135	7.439453125				0	0	no(M2 and SIP pres)	0
62.2609863281	0	male	0	53	1395	ARF/MOSF w/Sepsis	ARF/MOSF	2			55	88038	57035.40625	62331.4375	43.25	white	61	20.09765625	118	40	38	440	2	1	0.5999755859	138	7.44921875							3.3129882813
54.9819946289	1	male	0	33	393	ARF/MOSF w/Sepsis	ARF/MOSF	2		under $11k	0	59155	39054.875	42843.21875	36	white	129	21.8984375	178	34	36.796875	172	1.8999023438	0.5999755859	3.2998046875	134	7.509765625					6		6
73.1529541016	0	male	0	9	1385	ARF/MOSF w/Sepsis	ARF/MOSF	1	9		0	21349	14302.0546875	15387.4375	10.5	white	70	14.298828125	63	28	36.8984375	395.1875	2.8999023438	0.6999511719	6.69921875	148	7.509765625						SIP>=30	3.2358398438
75.0969848633	0	male	0	3	1383	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	1680	1162.4287109375	1247.849609375	7	white	99	9.099609375	93	20	35.6953125	338.0625			1.6999511719	142	7.44921875				0	0		0
80.2679443359	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	44	19288	8867.4921875	10029.359375	64	white	0	19.3984375	0	0	36.6953125	54	2	3.599609375	4.3994140625	130	7.1494140625					7	<2 mo. follow-up	7
84.0659790039	1	female	0	5	1067	CHF	COPD/CHF/Cirrhosis	3	8	under $11k	0	3843	2547.4453125	2624.568359375	14	white	94	9.298828125	74	28	36	385.6875			1.5998535156	140	7.609375					4	no(M2 and SIP pres)	4
59.1489868164	1	male	0	16	331	ARF/MOSF w/Sepsis	ARF/MOSF	5	9	under $11k	0	21386	14476.8515625	14940.1484375	10.6666641235	black	123	20	100	24	38		2.599609375	0.299987793	1.7998046875	138					2	3		3
76.9639892578	1	female	1	32	32	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	$25-$50k	0	122608	80382.25	90175.1875	38.5	white	65	21.8984375	62	12	36.1953125	300	2.599609375	0.8999023438	1.5	131	7.369140625					0	<2 mo. follow-up	0
42.5979919434	1	male	1	11	11	Lung Cancer	Cancer	3	12	under $11k	0	51666	33604.75	35407.09375	58.5	white	137	14	113	30	35.09375	55	1.0998535156	5.5	0.3999633789	134	7.3994140625					6	<2 mo. follow-up	6
61.9299926758	1	male	0	12	56	COPD	COPD/CHF/Cirrhosis	3	6	under $11k	9	20880	12499.5859375	13685.4453125	21	white	117	9.599609375	133	48	35.5	195.8125	3.2998046875	1.3999023438	0.7999267578	137	7.359375				2	1	<2 mo. follow-up	1
37.2539978027	0	male	0	9	1351	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	under $11k	0	15118	10010.734375	11255.734375	18.5	white	76	33.3984375	118	32	38.3984375	286.625	2.7998046875	3.2998046875	0.6999511719	130	7.4296875				1	1	no(M2 and SIP pres)	1
71.2989501953	1	male	0	4	134	ARF/MOSF w/Sepsis	ARF/MOSF	3	10		9	13484	7040.21484375	8658.796875	27	white	81	9.19921875	138	20	36.59375	283.3125	2.8999023438	0.299987793	8.3984375	135	7.4296875				1	1	no(M2 and SIP pres)	1
52.1479797363	1	female	0	59	72	MOSF w/Malig	ARF/MOSF	3	16		0	174127	113074.8125	134350.5	46.5	white	58	0.0699920654	141	32	39	215	2.7998046875	0.7999267578	1.5998535156	155	7.419921875					0		0
61.3109741211	1	male	0	3	218	Lung Cancer	Cancer	1	10	$11-$25k	0	4140	2697.58984375	2850.9296875	8	white	97		101	22	36.296875		4.2998046875	0.5	1.3999023438	135					0		no(M2 and SIP pres)	0.4947998524
66.7789916992	1	female	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	33506	21843.0625	23683.796875	50	white	126	28	130	30	35.3984375	138	2	3.099609375	0.5	127	7.4296875					0	<2 mo. follow-up	0
61.4349975586	0	female	0	11	1325	COPD	COPD/CHF/Cirrhosis	2		under $11k	0	21128	13303.34375	15684.6484375	32.5	white	74	35	126	10	36.59375	240	2.7998046875	0.5	0.5999755859	144	7.33984375					0	no(M2 and SIP pres)	0
70.79296875	1	male	0	5	668	CHF	COPD/CHF/Cirrhosis	5	12	under $11k	0	3689	2464.546875	2637.859375	7	white	107	5.8994140625	53	22	35.6953125		4.3994140625	0.6999511719	1.3999023438	141	7.419921875				0	1	no(M2 and SIP pres)	1
69.3799438477	1	female	0	7	55	CHF	COPD/CHF/Cirrhosis	2	13		0	10879	5274.47265625	6358.31640625	18	white	59	5.5	136	22	36.59375		2.5	1.5	1.1999511719	130					1	0	<2 mo. follow-up	0
67.3099975586	1	female	1	22	22	MOSF w/Malig	ARF/MOSF	1	16	$25-$50k	0	18881	13809.0859375	18162.3125	21	white	99	8.19921875	114	20	35.796875		2.7998046875	1.0998535156	4.099609375	136		83	62	850	1	2	<2 mo. follow-up	2
60.6489868164	1	female	0	7	92	COPD	COPD/CHF/Cirrhosis	4	8	$11-$25k	0	6610	4424.2109375	4562.7890625	3	white	105	24.5	114	24	36.3984375	214.8125	4.2998046875	0.6999511719	0.7999267578	138	7.4296875	348	19	2300	4		no(M2 and SIP pres)	3.1831054688
74.5109863281	1	male	0	6	18	Colon Cancer	Cancer	3	6	under $11k	0	7807	5308.98046875	5546.046875	17	white	99	25.69921875	107	24	36.3984375	228.5625	2.599609375	1.1999511719	0.6999511719	135	7.3994140625	84	15	1200	5	4	<2 mo. follow-up	4
60.9829711914	1	female	0	14	97	Colon Cancer	Cancer	1	10		0	14493	10190.1796875	13020.5078125	16.6666564941	white	77	7.8994140625	110	24	36.1953125		3	1.5	0.8999023438	131		220	11	1350	3	0	SIP>=30	0
64.8599853516	0	male	0	40	1055	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	44	110427	72151	83565.1875	51.5	white	118	8.099609375	64	12	38.6953125	187.5	2	8	0.7999267578	136	7.419921875	79	12	4825		1	no(M2 and SIP pres)	1
77.7359619141	1	female	1	18	18	MOSF w/Malig	ARF/MOSF	1		under $11k	44	29169	19525.78125	25135.484375	25.3333282471	black	117	9.3984375	77	36	36.3984375				0.7999267578	126		112	16	1850		5	<2 mo. follow-up	5
80.7389526367	0	female	0	18	1036	COPD	COPD/CHF/Cirrhosis	1	8	under $11k	0	26876	16527.171875	20001.34375	20.6666564941	white	116	10.5	72	8	36.59375	195	2.6997070313	1.1999511719	1.2998046875	139	7.3896484375	137	22	1760	0	0	no(M2 and SIP pres)	0
79.2579956055	1	male	0	10	37	Lung Cancer	Cancer	1	12	under $11k	26	8220	6202.9140625	7946.5078125	10	black	68	4.7998046875	71	24	36.3984375	240	3.2998046875	0.5	0.8999023438	137	7.349609375	97	12			5	<2 mo. follow-up	5
67.8689575195	1	male	0	16	87	Lung Cancer	Cancer	4	10	under $11k	0	14776	10952.4765625	13473.75	13	black	107	11.099609375	107	28	35.3984375		3.2998046875	0.299987793	1.1999511719	147		161	7	1200	5		no(M2 and SIP pres)	3.8549804688
77.8699951172	1	female	0	34	232	ARF/MOSF w/Sepsis	ARF/MOSF	1	0	under $11k	0	59632	37024.96875	45438.25	33.25	black	61	18.3984375	124	9	36.6953125	133.3125	3	1.8999023438	8.8984375	154	7.4794921875	165	111	744		0	adl>=4 (>=5 if sur)	0
67.0829467773	0	male	0	48	1009	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	0	88688	58003.0625	67012	38.75	white	64	6.099609375	75	9	37.796875	280	3.1997070313	1.0998535156	1.3999023438	137	7.4892578125	168	30	1698	0	1	no(M2 and SIP pres)	1
57.1389770508	1	female	1	35	35	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	124947	80193.3125	92762.125	49.25	white	58	23.296875	111	10	40.59375	337.125	3	0.7999267578	9.099609375	134	7.259765625	229	104	0		6	<2 mo. follow-up	6
53.8889770508	0	female	0	28	1002	Coma	Coma	2	12	under $11k	94	46212	31023.3125	34375.78125	26.75	white	124	14.5	113	38	38.3984375	214	2.6997070313	0.5	2	141	7.44921875	329	21	3580		6	SIP>=30	6
29.3309936523	1	female	1	36	36	MOSF w/Malig	ARF/MOSF	2	15	under $11k	0	94641	60107.875	70521.5	49.75	white	107	19.69921875	122	11	36	320	1.8999023438	0.3999633789	1.8999023438	126	7.439453125	84	52	518		2	<2 mo. follow-up	2
47.9729919434	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	0	16		41	34317	21957.046875	26373.546875	50	white	30	43.3984375	40	12	37.8984375	126.65625	2.1997070313	5.19921875	8.3984375	132	7.3193359375	112	92	0		0	<2 mo. follow-up	0
78.1789550781	1	female	1	46	46	ARF/MOSF w/Sepsis	ARF/MOSF	5	12		9	118516	75014.6875	86490	53.25	white	39	36.796875	180	36	36.59375	148	2.5	0.299987793	0.5999755859	133	7.3994140625	305	27	1006		7	<2 mo. follow-up	7
80.4629516602	0	female	0	18	978	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	30255	16452.5	20282.84375	24.6666564941	white	124	9.798828125	45	42	37.796875	105	2.7998046875	0.5999755859	1	137	7.4599609375	124	17	2945		1	no(M2 and SIP pres)	1
44.941986084	1	male	0	35	259	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	9	57429	39990.09375	42535.84375	26.5	white	67	9.5	126	24	35.796875	217.125	1.7998046875	0.3999633789	1.5998535156	129	7.4599609375	576	32	3715	0	1	SIP>=30	1
59.492980957	0	male	0	5	960	COPD	COPD/CHF/Cirrhosis	4	7	under $11k	0	5043	2951.974609375	3561.478515625	14	hispanic	102	10.599609375	108	24	36.5	237.5			1.0998535156	138	7.4091796875	167	19	3700	3	0	no(M2 and SIP pres)	0
37.258972168	0	male	0	5	958	CHF	COPD/CHF/Cirrhosis	1	9	under $11k	0	5429	3599.8046875	3759.638671875	19	white	110	12.798828125	80	24	35.59375	276.1875	3.8999023438	1	1.2998046875	144	7.4296875	80	25	2900	1	1		1
74.0859985352	0	male	0	13	948	Cirrhosis	COPD/CHF/Cirrhosis	2	10	under $11k	9	12917	9056.015625	11956.375	15	white	83	6.69921875	76	20	35.09375	323.75	2.6997070313	4.8994140625	2.599609375	150	7.4599609375	176	102	1530	6	4	no(M2 and SIP pres)	4
45.9519958496	1	female	0	32	138	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	under $11k	0	67736	45461.9375	51155.0625	19	white	40	8	66	30	35.796875	138.09375	3.1997070313	2.099609375	7.5	130	7.3896484375	108	64	0	1		no(M2 and SIP pres)	1.1667480469
41.8369750977	1	male	1	10	10	Coma	Coma	0	8		61	30086	20112.015625	22636.90625	36.5	white	66	10.599609375	80	8	38	282.5	2.6997070313	1.5	0.5999755859	135	7.3994140625	108	18	1430		1	<2 mo. follow-up	1
62.2509765625	0	female	0	4	937	CHF	COPD/CHF/Cirrhosis	3	11	under $11k	0	4692	2274.033203125	2857.44921875	10	white	100	8.5	79	24	36.3984375	376.1875	3.8999023438	0.6999511719	1.5998535156	138	7.5	113	25	2900	0	2	no(M2 and SIP pres)	2
40.924987793	1	female	0	17	125	Cirrhosis	COPD/CHF/Cirrhosis	1	12	$25-$50k	0	17371	12434.0390625	15521.875	21.6666564941	white	56	2.099609375	110	20	36.5		2	10	0.6999511719	125		93	5	2475	1	3	SIP>=30	3
43.8879699707	0	female	0	20	904	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	37	35501	23562.078125	27524.828125	24.3333282471	white	127	19	104	36	37.6953125	297.125	2.7998046875	1	0.5999755859	136	7.3994140625	101	13	2881		6	adl>=4 (>=5 if sur)	6
58.9239807129	0	female	0	9	896	COPD	COPD/CHF/Cirrhosis	1	11	under $11k	0	8432	5708.62890625	5903.7890625	7.5	white	69	16.19921875	64	24	36.59375	319			0.5999755859	143	7.3798828125	90	11		0	1	no(M2 and SIP pres)	1
67.9779663086	1	female	1	5	5	CHF	COPD/CHF/Cirrhosis	1	8		37	68460	43711.40625	50218.5	44	white	64	12.5	67	35	36.8984375	250			0.6999511719	134	7.4794921875	191	22	2258			<2 mo. follow-up	2.5458984375
78.5129394531	1	female	0	21	58	ARF/MOSF w/Sepsis	ARF/MOSF	0			37	30168	20644.109375	25320.375	31	white	111	16.19921875	136	12	35.8984375	130	2	0.5999755859	1.8999023438	133	7.3798828125	73	61	2790			<2 mo. follow-up	3.9838867188
84.2789916992	1	female	0	54	65	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	under $11k	41	68870	47045.5	55787.3125	26	white	125	25.796875	131	26	36.6953125	400	2.1997070313	5.19921875	2.599609375	146	7.2998046875	191	87	4825		1		1
55.8249816895	1	female	1	6	6	Cirrhosis	COPD/CHF/Cirrhosis	3	12	under $11k	0	10498	6723.60546875	7964.65625	20	black	101	6.5	170	28	36.6953125		2.8999023438	20.8984375	0.3999633789	132		327	15			0	<2 mo. follow-up	0
38.5979919434	1	female	0	25	44	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	0	53366	37353.78125	43934.875	23	white	78	27.8984375	120	10	35.5	595.125	1.5998535156	0.3999633789	3.6997070313	135	7.44921875	89	40	0		5	<2 mo. follow-up	5
57.532989502	1	female	0	7	223	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	9775	6172.23046875	6936.95703125	18.5	black	146		71	39	36.5	165	4.19921875	1.5	0.8999023438	143	7.33984375	135	14	4078	1	2	no(M2 and SIP pres)	2
39.049987793	1	female	0	4	39	Cirrhosis	COPD/CHF/Cirrhosis	2	12	under $11k	0	3991	2759.333984375	3354.55859375	11	white	70	2.3999023438	104	20	37.59375		2.2998046875	7	0.5	133		78	2	950	0	0	<2 mo. follow-up	0
61.3719787598	1	male	1	4	4	Coma	Coma	0	17	under $11k	100	10455	5621.265625	7498.19921875	48	white	49	11.3984375	60	18	39.8984375	156	2.7998046875	1.7998046875	1.2998046875	137	7.1298828125	216	23	1554		0	<2 mo. follow-up	0
23.4929962158	1	female	1	4	4	Coma	Coma	0	12	under $11k	100	13030	8057.01171875	8885.734375	53	white	0	14.69921875	0	16	37.6953125	55	1.6999511719	0.5999755859	2.8999023438	121	7.26953125	257	38			0	<2 mo. follow-up	0
44.0549926758	1	male	0	9	602	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	7828	5585.0234375	7064.7265625	8.5	white	95	9.69921875	69	20	36.296875	442.8125	4.099609375	1	1.0998535156	136	7.44921875	123	10	2900	0		no(M2 and SIP pres)	0.4947509766
60.0489807129	1	female	0	7	14	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	5874	4007.1875	5133.1484375	8	white	85		114	24	36.09375	136			0.8999023438	136	7.2998046875	129	9	2175	3	5	<2 mo. follow-up	5
60.8129882813	0	male	0	51	847	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	$25-$50k	0	139666	90593.75	106514.5	57.25	white	144	14.298828125	138	13	36.6953125	134.65625	2.099609375	1.6999511719	5.19921875	134	7.26953125	178	63	1126		7	adl>=4 (>=5 if sur)	7
72.6209716797	1	female	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	93984	60547.65625	74304.75	64	white	54	18.59765625	117	35	39.5	328.5625	2	3.1997070313	3.5	130	7.359375	187	44	853		1	<2 mo. follow-up	1
55.783996582	1	male	0	9	130	Lung Cancer	Cancer	3	9	$11-$25k	0	9178	6278.0234375	8268.859375	14	white	68	15.298828125	107	30	36.59375		2.6997070313	0.7999267578	0.7999267578	136		286	6	2050	1	1	no(M2 and SIP pres)	1
74.6499633789	1	male	0	14	36	MOSF w/Malig	ARF/MOSF	1	11		0	15429	10809.7265625	15069.8984375	13.6666641235	white	102	43.1953125	107	36	36.09375				3	138		94	33	1950	0	0	<2 mo. follow-up	0
83.6439819336	0	male	0	12	819	ARF/MOSF w/Sepsis	ARF/MOSF	3	12		0	14988	10007.953125	10994.609375	18	white	117	11.099609375	100	21	37.59375	203.6875	3.2998046875	0.5999755859	3.599609375	146	7.439453125	103	63	2540	0	3	no(M2 and SIP pres)	3
62.2919921875	0	male	0	3	817	Cirrhosis	COPD/CHF/Cirrhosis	3	12	under $11k	0	2223	1608.5732421875	1986.0595703125		white	87	2.6997070313	69	22	36.3984375		2.1997070313	1.2998046875	0.8999023438	133		91	5				no(M2 and SIP pres)	2.4311523438
65.3499755859	1	male	0	5	44	Lung Cancer	Cancer	3	12	$11-$25k	9	3482	2540.12890625	3109.509765625	13	white	113		76	20	36.5				1.0998535156	146		65	16			4	<2 mo. follow-up	4
70.8579711914	0	female	0	9	795	COPD	COPD/CHF/Cirrhosis	2			0	15318	9469.109375	10553.8125	29	white	58	11.3984375	65	24	37.8984375	152	2.1997070313	0.299987793	0.5999755859	141	7.509765625	121	20	2005	6	3	SIP>=30	3
77.2949829102	1	male	1	33	33	ARF/MOSF w/Sepsis	ARF/MOSF	3	10	under $11k	37	99954	64701.15625	76104.625	52.5	white	119	21.5	115	8	38.1953125	305.6875	2.099609375	5.5	1.8999023438	149	7.4599609375	245	80	2510		7	<2 mo. follow-up	7
71.8139648438	0	female	0	10	790	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	17482	11167.8828125	12565.5390625	38	white	122	30.296875	300	12	36.296875	225	2	0.299987793	0.5999755859	138	7.3896484375	171	28	2465		7	adl>=4 (>=5 if sur)	7
63.6389770508	1	male	0	8	758	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	under $11k	0	10863	6378.34375	7041.328125	18	white	77	12.599609375	129	30	36	296	2.7998046875	0.5	1	131	7.5390625	96	10	2800	0	0	no(M2 and SIP pres)	0
27.9149932861	0	male	0	32	775	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	$11-$25k	0	51737	34929.4375	42677.5625	29.75	white	69	25.296875	112	11	39.59375	116	2.2998046875	0.299987793	0.8999023438	144	7.419921875	121	16	1206		0	no(M2 and SIP pres)	0
59.5039978027	1	male	1	6	6	Coma	Coma	3	12	under $11k	100	28075	18682.875	23228.484375	61	white	56	12.099609375	65	30	34.09375	48	1.3999023438	1	1.5	148	7.3291015625	259	15	855		0	<2 mo. follow-up	0
67.076965332	0	female	0	22	746	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	50276	32878.03125	40735.40625	45.3333129883	white	57	16	127	10	36.1953125	152	1.5998535156	3.2998046875	1.5998535156	135	7.419921875	287	19	1185	2	1	no(M2 and SIP pres)	1
46.3549804688	1	male	0	5	260	Lung Cancer	Cancer	2	12	under $11k	0	5674	3828.984375	4581.27734375	28	white	103	10.298828125	126	16	36.1953125		3.6997070313	0.299987793	1.0998535156	130		90	12		0	0	no(M2 and SIP pres)	0
30.3029937744	0	male	0	24	725	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	52302	32196.765625	36270.9375	35.6666564941	white	57	7.3994140625	133	8	35.59375	278	3	2.099609375	0.299987793	137	7.529296875	86	18	700		7	adl>=4 (>=5 if sur)	7
37.1879882813	1	male	1	55	55	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	158605	99295.6875	118364	38	white	138	13.798828125	129	10	38.3984375	66	3	12.298828125	0.7999267578	135	7.4697265625	147	11	2385		2	<2 mo. follow-up	2
72.6899414063	1	male	0	25	111	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	37	24423	16853.59375	19758.65625	11.5	white	99	18.5	100	24	36.8984375	137.5	3	1	2.2998046875	142	7.349609375	232	46	1175		6	adl>=4 (>=5 if sur)	6
61.6289978027	0	male	0	6	710	ARF/MOSF w/Sepsis	ARF/MOSF	1		under $11k	9	11989	7518.26953125	8195.2265625	18	hispanic	77	8.19921875	82	24	36.59375	230.53125	3.099609375	1.3999023438	1.1999511719	139	7.3798828125	105	14	2260		0		0
64.2329711914	0	female	0	6	710	COPD	COPD/CHF/Cirrhosis	4	6	under $11k	0	5989	4009.634765625	4146.26953125	4	white	64	7.8994140625	62	22	36.6953125	266.625	3.8999023438	0.6999511719	0.7999267578	148	7.3994140625	152	18	2950	1		no(M2 and SIP pres)	1.1667480469
49.9989929199	0	female	0	15	702	ARF/MOSF w/Sepsis	ARF/MOSF	4	11	under $11k	0	18604	11809.921875	12744.15625	18.3333282471	black	115	7.599609375	68	24	36.1953125	351.375	2.2998046875	0.299987793	2.3999023438	129	7.359375	74	45	1569		5	no(M2 and SIP pres)	5
74.4939575195	1	female	0	13	163	MOSF w/Malig	ARF/MOSF	1			9	18677	12616	13826.8671875	16	white	77	15.8984375	78	22	35.59375		2.3999023438	0.5	3.6997070313	136		85	73	2400				3.8828125
56.6019897461	1	male	0	19	401	COPD	COPD/CHF/Cirrhosis	2		under $11k	0	42496	26078.953125	29160.46875	28.3333282471	white	120	21.09765625	120	8	38.8984375	203.3125	2.2998046875	0.3999633789	0.6999511719	146	7.3994140625	112	17	1693		1	no(M2 and SIP pres)	1
69.3659667969	1	male	1	19	19	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$11-$25k	0	64100	33446.375	40356.75	50.3333129883	white	55	10.19921875	199	10	39.3984375	110	2	4.599609375	2.099609375	138	7.359375	116	42	1124		1	<2 mo. follow-up	1
49.6559753418	1	female	1	18	18	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	under $11k	0	63202	39159.90625	43919	43.3333129883	white	70	27	126	12	36.59375	133.3125	2.599609375	1.0998535156	3.2998046875	128	7.4091796875	347	66	1089		1	<2 mo. follow-up	1
69.5409545898	0	male	0	5	661	CHF	COPD/CHF/Cirrhosis	3	6	under $11k	0	8421	4101.359375	5252.06640625	20	black	100	7.5	118	24	36		4	1.2998046875	1.1999511719	136		100	14		0	1	no(M2 and SIP pres)	1
74.660949707	0	female	0	19	660	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	56813	35549.25	43941.03125	39	white	45	13.3984375	127	10	35.8984375	185	1.7998046875	8.298828125	1.1999511719	145	7.3896484375	304	25	1938		0	no(M2 and SIP pres)	0
62.9869995117	0	male	0	15	650	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	21499	14114.6015625	15353.0859375	15.6666641235	white	114	13.5	113	20	36.3984375	452	2.2998046875	0.3999633789	1.3999023438	144	7.2998046875	282	46	2420	6	6	adl>=4 (>=5 if sur)	6
48.75	1	male	0	67	447	Coma	Coma	0		$11-$25k	100	87147	58913.9375	69487.25	22.25	black	114	12.798828125	126	52	38.59375	280		0.5999755859	2.7998046875	152	7.44921875	181	54	1645		0	adl>=4 (>=5 if sur)	0
46.3439941406	0	male	0	16	633	COPD	COPD/CHF/Cirrhosis	1	11	under $11k	0	32986	20115.125	22038.078125	29.6666564941	white	110	8.798828125	65	8	38.3984375	108.328125	3	1.3999023438	0.8999023438	155	7.3095703125	118	18	1506		1	no(M2 and SIP pres)	1
43.6609802246	1	female	0	6	117	Colon Cancer	Cancer	1	12	under $11k	0	8078	5345.1171875	6745.9375	14	hispanic	78	11	74	20	36.8984375				0.8999023438	136		107	8	3400	1	4	adl>=4 (>=5 if sur)	4
71.7729492188	1	male	0	78	213	Coma	Coma	1	16	$11-$25k	55	154189	87083.3125	100583.625	39.75	white	123	11.298828125	114	26	39.1953125	148.375	3.099609375	0.7999267578	1.5	139	7.44921875	160	33	1555		0	adl>=4 (>=5 if sur)	0
65.2809448242	0	male	0	14	628	MOSF w/Malig	ARF/MOSF	2	8	$11-$25k	37	27779	17367.59375	20223.3125	22.6666564941	white	119	19.19921875	111	10	36.5	80	3.3999023438	0.299987793	1.7998046875	138	7.419921875	292	35	4150		0	no(M2 and SIP pres)	0
89.5819702148	1	male	0	10	179	Lung Cancer	Cancer	2		under $11k	9	7092	4953.8046875	6743.546875	6	black	65	5.69921875	69	24	36.09375	220	3.099609375	0.7999267578	0.7999267578	136	7.4697265625	98	10			1	adl>=4 (>=5 if sur)	1
68.3719482422	1	female	0	7	551	CHF	COPD/CHF/Cirrhosis	3	3	under $11k	0	9644	5550.4375	6353.3984375	20	black	125	8	133	24	36.3984375		3	0.8999023438	2.099609375	137		169	48	3867	0		no(M2 and SIP pres)	0.4947509766
68.3939819336	0	female	0	21	618	COPD	COPD/CHF/Cirrhosis	3	10	under $11k	0	20174	13773.984375	15103.9296875	8.6666641235	white	104	16.796875	112	22	36.59375	296		0.7999267578	0.8999023438	135	7.5	96	22	900	0	0	no(M2 and SIP pres)	0
56.941986084	1	female	0	68	410	CHF	COPD/CHF/Cirrhosis	4	12	$25-$50k	0	151280	87473.1875	101284.4375	39.25	white	66	15.298828125	146	40	36	177.125	3.099609375	1.0998535156	0.8999023438	146	7.3095703125	229	20	1900		3	adl>=4 (>=5 if sur)	3
39.8409729004	0	male	0	4	603	Cirrhosis	COPD/CHF/Cirrhosis	3	10	under $11k	0	3907	2596.857421875	2932.0390625	7	white	101	3.7998046875	72	16	36.6953125		2.5	4.8994140625	0.6999511719	136		107	8				no(M2 and SIP pres)	3.5180664063
45.0079956055	0	female	0	17	602	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	44	27270	17162.203125	18743.21875	30	hispanic	116	9.8984375	104	11	37.6953125	118.328125	2.7998046875	0.5999755859	0.5	141	7.369140625	95	5	1963		7	adl>=4 (>=5 if sur)	7
61.6539916992	1	male	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	39699	20316.453125	24179.203125	44.5	black	162	10.298828125	113	12	38.59375	172			2.8999023438	138	7.3994140625	151	49	4455		0	<2 mo. follow-up	0
86.3959960938	1	male	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	0		under $11k	0	22576	14125.9296875	15899.078125	25	black	114	19	111	40	35.796875	190	3	0.6999511719	2.7998046875	144	7.4091796875	204	50	910		0	<2 mo. follow-up	0
42.4339904785	1	male	1	11	11	Cirrhosis	COPD/CHF/Cirrhosis	5	13		0	20016	12737.4921875	14695.09375	21	white	118	8.5	120	28	37.6953125	306.625	2.5	14.69921875	0.6999511719	145	7.4892578125	74	10	4655		0	<2 mo. follow-up	0
68.9659423828	0	male	0	25	573	CHF	COPD/CHF/Cirrhosis	6	12		0	29136	19419.546875	23130.34375	12.5	white	113	7.099609375	96	24	35.296875		2.8999023438	0.5999755859	2.2998046875	137		66	35	3550	4	3	SIP>=30	3
64.2379760742	0	female	0	10	569	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	36752	23325.296875	26899.40625	19.5	black	109	10.8984375	111	40	37.6953125	142.5			0.8999023438	135	7.3896484375	131	6	883	0	0	no(M2 and SIP pres)	0
48.8729858398	0	male	0	36	566	ARF/MOSF w/Sepsis	ARF/MOSF	5	10	under $11k	9	66240	0	0	19	black	121	19.796875	63	64	35.5	288	2.3999023438	1.6999511719	0.7999267578	141	7.4697265625	257	12	5725		0	no(M2 and SIP pres)	0
76.8239746094	0	female	0	6	565	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	7858	4810.71484375	5371.16796875	19	black	71	18.3984375	80	20	36	308.6875			1.1999511719	140	7.439453125	108	23		0	1	no(M2 and SIP pres)	1
85.951965332	0	male	0	4	564	CHF	COPD/CHF/Cirrhosis	1	6	under $11k	0	3808	2535.59765625	2596.009765625	7	black	125	3.8999023438	72	22	36.296875	309.5			1.1999511719	146	7.4296875	108	27	2075	5	4	no(M2 and SIP pres)	4
53.2619934082	0	male	0	136	553	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	>$50k	0	416335			45	white	119	14.599609375	131	33	40.09375	131.09375			1.5998535156	151	7.4794921875	180	26	2735		1	adl>=4 (>=5 if sur)	1
55.3459777832	1	male	0	12	53	CHF	COPD/CHF/Cirrhosis	4	12	under $11k	9	9537	6663.328125	7567.6875	12	white	73	7.599609375	64	24	35.59375	442.8125	2.7998046875	1.8999023438	1.0998535156	136	7.509765625	73	26	2375		5	<2 mo. follow-up	5
64.7039794922	1	male	0	13	143	Cirrhosis	COPD/CHF/Cirrhosis	4	6	under $11k	0	13719	9278.84375	10212.3359375	13.5	white	108	6.8994140625	96	22	35.3984375		2.599609375	4.7998046875	0.5	126		94	1		1	2	SIP>=30	2
66.1819458008	0	female	0	17	541	ARF/MOSF w/Sepsis	ARF/MOSF	1			9	43734	30188.296875	33609.8125	17	white	109	14.69921875	125	22	36.5	353.3125	1.7998046875	0.5	1.5	132	7.369140625	107	12	3120			SIP>=30	3.142578125
44.2029724121	0	female	0	19	536	Cirrhosis	COPD/CHF/Cirrhosis	5	11	under $11k	9	67791	45628.75	53735.25	18.3333282471	white	60	9.5	118	40	36.1953125	285.6875	2.3999023438	2.1997070313	1.3999023438	130	7.3798828125	124	50	966		7	no(M2 and SIP pres)	7
68.0709838867	0	male	0	15	531	Cirrhosis	COPD/CHF/Cirrhosis	6	9	under $11k	0	47397	31747.09375	40763.03125	41.3333129883	white	69	15.5	67	10	35.6953125	502	1.8999023438	1.7998046875	0.6999511719	136	7.419921875	182	13	1915		2	adl>=4 (>=5 if sur)	2
53.8259887695	0	female	0	10	530	COPD	COPD/CHF/Cirrhosis	0	10	$11-$25k	0	21187	12924.28125	14137.765625	29.5	white	69	24	126	22	36.6953125	220		0.5999755859	1.1999511719	137	7.369140625	160	40	1560	0	4		4
48.2739868164	1	female	1	45	45	Coma	Coma	0	10	$25-$50k	94	91330	60467.90625	69929.5	44	white	120	17.59765625	71	26	38.6953125	190	2.6997070313	0.7999267578	5.599609375	144	7.3193359375	99	65	1517		0	<2 mo. follow-up	0
74.1359863281	0	female	0	44	507	COPD	COPD/CHF/Cirrhosis	6	4	under $11k	9	71806	47299.75	51366.78125	23.25	black	117	4.19921875	60	22	36.296875	196	2.099609375	0.1999816895	2.2998046875	138	7.3193359375	117	62	1150	5	0	adl>=4 (>=5 if sur)	0
30.3899993896	1	male	0	6	26	Cirrhosis	COPD/CHF/Cirrhosis	1	11	under $11k	0	6106	4069.7421875	5218.546875	10	white	71	17.8984375	84	20	36.8984375		2.3999023438	20.3984375	1	127		70	13		1	0	<2 mo. follow-up	0
26.3599853516	0	female	0	48	506	COPD	COPD/CHF/Cirrhosis	4	11	under $11k	0	95201	59971.8125	67958.5	25.25	black	69	10.298828125	61	10	37.8984375	190	3.099609375	1.3999023438	1.0998535156	143	7.3896484375	118	11	4375		4	SIP>=30	4
54.1929931641	1	male	0	10	55	COPD	COPD/CHF/Cirrhosis	3	11	under $11k	0	12546	7809.68359375	8627.9765625	13	white	97	13.69921875	72	20	36.296875	252.375			1.0998535156	138	7.369140625	141	25	2150	3	4	<2 mo. follow-up	4
74.3929443359	1	female	0	11	16	Lung Cancer	Cancer	1	15	under $11k	0	13282	8855.1875	11715.9296875	17.5	white	65	11.298828125	107	26	36.6953125		2.8999023438	0.8999023438	0.7999267578	133		77	18		0	2	<2 mo. follow-up	2
73.9899902344	0	female	0	5	463	Colon Cancer	Cancer	1	12	$11-$25k	9	4497	3107.41015625	4095.87890625	13	white	70	9.19921875	64	28	37.59375	485.6875	2.5	2.2998046875	0.5999755859	135	7.419921875	170	9	3075	1	1	no(M2 and SIP pres)	1
101.8479614258	0	female	0	3	447	CHF	COPD/CHF/Cirrhosis	4	12	under $11k	0	3497	1888.509765625	2297.228515625		white	83	9.798828125	72	20	35.796875	225.90625	3.099609375	0.6999511719	1.8999023438	132	7.419921875	92	25		0	4		4
36.133972168	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	94	28437	17370.5	20058.328125	58.5	black	52	7.7998046875	232	43	39.09375	67	2.5	0.3999633789	0.5	144	7.3095703125	172	16	584		7	<2 mo. follow-up	7
73.0379638672	0	male	0	29	436	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$11-$25k	0	108958	67792	75865.125	32.25	white	106	8.798828125	67	10	38	263.3125	2.599609375	1	0.7999267578	135	7.419921875	120	12	1711		1	no(M2 and SIP pres)	1
81.2729492188	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	6	12	$11-$25k	100	15340	9386.203125	10665.7734375	46	white	46	32.09375	61	16	35.6953125	248.5625	1.5998535156	1.0998535156	5.599609375	148	7.359375	172	89	0		6	<2 mo. follow-up	6
73.9159545898	0	female	0	9	433	CHF	COPD/CHF/Cirrhosis	5	10	under $11k	0	6936	5204.47265625	5641.5078125	7.5	black	123	4.19921875	70	24	35.8984375		2.599609375	0.6999511719	1.2998046875	137		151	20		1	0	adl>=4 (>=5 if sur)	0
78.592956543	0	female	0	16	425	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	37	63650	40586.125	47436.3125	22.3333282471	white	53	9.5	107	40	36.3984375	280.3125	2.599609375	0.5	0.5999755859	131	7.4697265625	96	12	3035		1	no(M2 and SIP pres)	1
64.2189941406	1	male	1	4	4	Colon Cancer	Cancer	2	10	under $11k	26	4376	2553.58203125	3305.37890625	8	black	49	10.69921875	107	24	35.8984375		1.5998535156	9.19921875	1.2998046875	137		25	58				<2 mo. follow-up	2.6982421875
46.5349731445	0	female	0	13	422	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	17345	10715.5078125	13619.1171875	24	black	103	17.19921875	136	32	39.296875	247.59375	3.099609375	0.5	0.6999511719	133	7.5	72	9	1275	6	5	no(M2 and SIP pres)	5
79.2719726563	0	male	0	14	398	ARF/MOSF w/Sepsis	ARF/MOSF	4	0	under $11k	9	20713	12282.90625	13829.3828125	11.3333282471	hispanic	68	39.59375	68	24	36.09375		2.5	5.2998046875	2.3999023438	129		272	62	1230			no(M2 and SIP pres)	6.33984375
66.6149902344	0	male	0	6	391	Lung Cancer	Cancer	2	13	under $11k	0				3	black	143	8	100	20	36.6953125		4.19921875	0.6999511719	1.3999023438	138		101	18		0	1	SIP>=30	1
71.342956543	0	male	0	13	386	COPD	COPD/CHF/Cirrhosis	2	10	under $11k	0	17512	11379.140625	12422.234375	13	white	111	7	118	24	35.8984375	212.5	3.6997070313	0.299987793	1.5998535156	137	7.2890625	122	48	2650	0		no(M2 and SIP pres)	0.4947509766
84.5069580078	1	female	1	71	71	Coma	Coma	2		under $11k	0	162084			41.5	black	115	10.3984375	75	10	36	203.125	1.8999023438	2	0.6999511719	127	7.4599609375	152	11	1970		4	adl>=4 (>=5 if sur)	4
37.6999816895	0	male	0	7	360	COPD	COPD/CHF/Cirrhosis	2	11	under $11k	0	13431			12	white	103	11.5	113	22	37.1953125	168.5625	2.3999023438	0.8999023438	0.7999267578	138	7.2998046875	183	28		0		no(M2 and SIP pres)	0.4947509766
54.9129943848	1	male	0	13	340	CHF	COPD/CHF/Cirrhosis	4	9	under $11k	0	24833			22	white	111	6.599609375	75	16	35.796875				2.2998046875	139		301	40	1420	6	6	SIP>=30	6
33.9659729004	0	male	0	11	358	Coma	Coma	1	12	under $11k	37	34737			14.5	white	101	13.69921875	61	24	36.296875	473.75			0.8999023438	130	7.44921875	125	19	2240		4	no(M2 and SIP pres)	4
68.2029418945	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	5	10		0	17767				white	33	13.69921875	161	10	37.5	90.546875	1.5	1.3999023438	2.8999023438	138	7.369140625	233	62	75			<2 mo. follow-up	4.1640625
72.2379760742	0	female	0	6	349	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	7178			13	white	99	13.19921875	100	24	35.796875	165.21875	3.2998046875	1.6999511719	0.6999511719	140	7.3994140625	128	10		1			1.1667480469
83.6629638672	0	male	0	6	2029	CHF	COPD/CHF/Cirrhosis	2	8	under $11k	0	2453	2665.650390625	0	6	white	76	9.8984375	63	24	35.796875	366.625			1.2998046875	139	7.4697265625				0	1	no(M2 and SIP pres)	1
55.1979980469	1	male	0	26	552	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	$11-$25k	9	57924	44915.9375	0	25.25	white	110	18.8984375	106	10	38	270	3.6997070313	0.7999267578	1.1999511719	145	7.4697265625					0	adl>=4 (>=5 if sur)	0
74.751953125	1	female	0	19	336	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	10244	11008.71875	0	10	white	69	10.298828125	93	22	35.6953125	295.1875	3.2998046875	1.0998535156	1.2998046875	130	7.4697265625				0	4	no(M2 and SIP pres)	4
72.333984375	0	male	0	6	2006	CHF	COPD/CHF/Cirrhosis	2	12	>$50k	0	2239	2402.23046875	0	6	white	99	7.8994140625	60	20	35.796875	257.125	4.19921875	0.6999511719	1.6999511719	143	7.439453125				0	0	no(M2 and SIP pres)	0
69.8619995117	1	male	1	18	18	Coma	Coma	2	12	$11-$25k	100	63622	46171.65625	0	48.6666564941	white	118	23.8984375	140	46	39.6953125	240	2.2998046875	3.7998046875	2.099609375	130	7.4794921875					0	<2 mo. follow-up	0
50.1079711914	1	male	0	4	5	COPD	COPD/CHF/Cirrhosis	0	8	under $11k	0	2082	1808.2392578125	0	7	white	116		130	40	36.3984375					140					2	0	<2 mo. follow-up	0
77.258972168	1	male	0	21	1699	CHF	COPD/CHF/Cirrhosis	2	8	under $11k	0	16185	14571.4765625	0	13	white	99	6.2998046875	64	32	36.296875	244	3.599609375	0.8999023438	1.6999511719	137	7.3994140625				1	3	no(M2 and SIP pres)	3
75.5649414063	1	female	0	21	1152	ARF/MOSF w/Sepsis	ARF/MOSF	0	9		0	34520	27436.703125	0	16	white	121	8.599609375	52	8	38.3984375	195.90625	2.2998046875	0.6999511719	4.19921875	135	7.3798828125					4	adl>=4 (>=5 if sur)	4
61.1939697266	1	male	0	12	214	CHF	COPD/CHF/Cirrhosis	3	24	>$50k	0	6472	6969.96484375	0	8	white	71	10.3984375	59	24	36	380.9375	3.7998046875	1.6999511719	1.5	127	7.419921875				0	1	no(M2 and SIP pres)	1
63.391998291	1	female	0	5	105	Lung Cancer	Cancer	1	8	$11-$25k	0	2787	2425.013671875	0	7	white	102	7.2998046875	76	20	36.59375		4	0.3999633789	0.8999023438	136					0	1	no(M2 and SIP pres)	1
60.6239929199	0	male	0	6	1973	Lung Cancer	Cancer	1	12	$25-$50k	0	3184	3054.267578125	0	6	white	78		63	16	36.296875				1.3999023438	138					0	0	no(M2 and SIP pres)	0
37.8479919434	1	male	1	60	60	MOSF w/Malig	ARF/MOSF	1	20	$25-$50k	0	153931	108927.4375	21095.609375	47.75	white	107	0.8999023438	112	12	39.3984375	232.5	3.2998046875	4.7998046875	6.5	141	7.4091796875					4		4
71.6059570313	0	female	0	36	1931	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	0	102027	87378.1875	15046.5078125	29.25	white	68	8.8984375	120	28	38.1953125	192.5	2.6997070313	2	0.6999511719	127	7.439453125					1	no(M2 and SIP pres)	1
58.1879882813	1	male	0	21	187	MOSF w/Malig	ARF/MOSF	2	12	$25-$50k	0	23590	16798.296875	17012.75	21.3333282471	white	107	6.3994140625	76	24	35	147.5			0.5999755859	138	7.33984375				6	5	adl>=4 (>=5 if sur)	5
79.5669555664	1	male	0	8	9	Coma	Coma	2	8	under $11k	89	68703	52034	19768	37	white	76	7.599609375	70	6	38.09375	313.3125	3.2998046875	5.5	2	139	7.509765625					1	<2 mo. follow-up	1
77.2319946289	1	female	0	16	19	Lung Cancer	Cancer	1	12		0	10536	9141.625	8242.5234375	6.3333320618	white	65	20.09765625	107	28	35.59375	200	1.5998535156	1.7998046875	0.8999023438	136	7.509765625					5	<2 mo. follow-up	5
72.8349609375	0	male	0	14	1885	COPD	COPD/CHF/Cirrhosis	6			0	10872	8019.34375	6922.66796875	15	white	78	23.09765625	126	44	37.5	247.8125	4.2998046875	0.5	1.1999511719	139	7.439453125							4.150390625
61.4729919434	1	male	0	3	1546	ARF/MOSF w/Sepsis	ARF/MOSF	0	10		0	3448	2522.451171875	2477.509765625	29	white	80	16.796875	67	20	36.296875	126.515625	4.69921875	0.5999755859	1.2998046875	138	7.3193359375					0		0
58.1409912109	1	female	0	16	41	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	22293	17607.46875	16129.4765625	19.6666564941	white	62	6.7998046875	132	40	40	252.375	3.7998046875	1.2998046875	1	140	7.51953125					0	<2 mo. follow-up	0
50.7459716797	0	male	0	4	1832	COPD	COPD/CHF/Cirrhosis	2	8	$11-$25k	0	2421	1880.412109375	1710.1298828125	8	white	77	8.69921875	98	20	36.796875	183.3125			1	142	7.439453125				0		no(M2 and SIP pres)	0.4947998524
71.3759765625	1	male	0	14	285	COPD	COPD/CHF/Cirrhosis	4	12	under $11k	9	16882	12369.4453125	12698.84375	18	white	77	24.5	106	28	36.1953125	288	2.8999023438	0.7999267578	4.69921875	133	7.359375					6	adl>=4 (>=5 if sur)	6
66.9919433594	1	male	0	12	289	Coma	Coma	1			0	7107	5761.171875	5130.546875	10	white	101	12.099609375	71	24	35.59375	261.875	3.6997070313	0.6999511719	0.8999023438	137	7.4794921875							2.3081054688
64.2459716797	1	female	0	10	117	Lung Cancer	Cancer	3	12	under $11k	0	6996	5719.0234375	7208.16796875	11.5	white	70	6.3994140625	130	28	38.59375		3.599609375	0.299987793	0.6999511719	132						1	no(M2 and SIP pres)	1
78.5739746094	1	male	0	10	1524	COPD	COPD/CHF/Cirrhosis	1	8		0	6569	5492.7265625	6386.76953125	15	white	109	7	120	32	36	280.9375	4	0.299987793	2.8999023438	131	7.359375				0	0	no(M2 and SIP pres)	0
58.1929931641	1	male	0	17	49	Colon Cancer	Cancer	1			0	15429	11362.078125	9369.609375	13.6666641235	white	104	6.8994140625	110	24	37.59375		4.69921875	0.5999755859	1.2998046875	131							<2 mo. follow-up	1.8774414063
66.4799804688	0	female	0	21	1762	MOSF w/Malig	ARF/MOSF	1	8		0	39037	26767.109375	23013.859375	19.3333282471	white	103	0.3999633789	118	24	36.6953125		2.5	1.1999511719	0.7999267578	131						0	no(M2 and SIP pres)	0
52.924987793	1	male	0	7	262	Colon Cancer	Cancer	1	12	$11-$25k	0	5568	4115.22265625	3993.5	15	white	73	9.19921875	62	20	36.8984375			1.2998046875	0.7999267578	131							no(M2 and SIP pres)	1.7587890625
58.425994873	1	male	0	9	65	Lung Cancer	Cancer	2			0	2853	2602.09375	2401.669921875	5	white	85	6.2998046875	83	20	36.6953125		4	0.299987793	1.1999511719	137								2.4575195313
56.8729858398	1	female	0	5	339	Lung Cancer	Cancer	1	13	$11-$25k	0	3967	3125.12890625	2416.759765625	6	white	120		70	16	37.3984375				0.8999023438	136					0	1	no(M2 and SIP pres)	1
60.6379699707	1	male	0	40	41	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	41	49563	35439.34375	30543.09375	18	white	106	13	70	26	37.3984375				0.8999023438	157						7	<2 mo. follow-up	7
58.5849914551	1	male	0	17	137	Lung Cancer	Cancer	1	10	under $11k	0	19331	14248.359375	12482.1875	1.6666660309	white	107	5.7998046875	74	20	36.3984375		4.69921875	0.3999633789	0.7999267578	141					0	3	no(M2 and SIP pres)	3
77.7489624023	1	male	0	5	307	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	3096	2368.798828125	2224.23828125	12	white	107	6.69921875	107	36	35.6953125	292.25	4.099609375	0.6999511719	1	136	7.3994140625						adl>=4 (>=5 if sur)	2.427734375
63.8189697266	1	male	0	12	989	Cirrhosis	COPD/CHF/Cirrhosis	3			9	11890	14882.8671875	17460.96875	7	white	114	3.599609375	77	28	36.3984375	395.1875	2.1997070313	5.099609375	1	132	7.439453125							3.095703125
81.3249511719	1	male	0	12	1082	ARF/MOSF w/Sepsis	ARF/MOSF	3			0	17767	12111.5	11936.09375	44	white	153	14.798828125	180	30	37	260		0.5999755859	1.2998046875	137	7.439453125							4.4462890625
65.2349853516	1	male	0	24	26	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	14680	11844.125	10716.4296875	9	white	82	16.59765625	126	26	36.09375	196	4.8994140625	0.5	0.8999023438	134	7.439453125				3	4	<2 mo. follow-up	4
64.9139404297	1	male	0	6	1312	COPD	COPD/CHF/Cirrhosis	4	8	under $11k	0	3954	3177.435546875	3081.94921875	10	white	119	13.3984375	69	30	37.8984375	155.53125	4.099609375	0.299987793	1.5	139	7.3291015625					1		1
70.217956543	1	female	0	8	18	Coma	Coma	2	8	under $11k	44	9225	7920.32421875	8289.5625	13.5	white	115	6.3994140625	60	24	35.59375		3.3999023438	0.299987793	0.8999023438	143						6	<2 mo. follow-up	6
76.2269897461	1	male	1	5	5	COPD	COPD/CHF/Cirrhosis	3	7	under $11k	9	7085	4792.3515625	4949.99609375	26	white	85	13.599609375	138	10	38.09375	170	4.2998046875	0.299987793	1.1999511719	139	7.3994140625					4	<2 mo. follow-up	4
58.5409851074	0	male	0	23	1618	ARF/MOSF w/Sepsis	ARF/MOSF	1			9	43636	37861.71875	31906.53125	17.3333282471	white	103	34.3984375	98	24	37.8984375	219.96875			1.5	145	7.419921875							1.98046875
74.9569702148	1	male	0	4	52	Lung Cancer	Cancer	1	15	$25-$50k	9	3143	2138.390625	1401.779296875	10	white	119	14.599609375	87	20	36.09375		3.7998046875	0.299987793	1.1999511719	138							<2 mo. follow-up	2.0615234375
78.0229492188	0	female	0	7	1604	COPD	COPD/CHF/Cirrhosis	3	8	under $11k	0	5563	4325.4375	3838.919921875	9	white	109	6.19921875	76	28	36.796875	204.75	3	0.1999816895	0.5999755859	140	7.369140625				2	4	no(M2 and SIP pres)	4
63.1209716797	1	male	0	5	89	Lung Cancer	Cancer	2			0	4309	3033.958984375	3010.708984375	11	white	103	5.5	104	22	36.296875		4.19921875	0.6999511719	0.7999267578	134								1.9672851563
82.5789794922	0	female	0	6	1572	CHF	COPD/CHF/Cirrhosis	4	16		0	2881	2437.208984375	1677.169921875	10	white	106	10.599609375	54	24	35.59375	342.8125			1.1999511719	135	7.4599609375				0	0	no(M2 and SIP pres)	0
66.3129882813	0	male	0	7	1566	CHF	COPD/CHF/Cirrhosis	1	12	$11-$25k	0	14233	11140.578125	9157.453125	13	white	62		105	20	38	145			1.1999511719	135	7.4296875				0	3	no(M2 and SIP pres)	3
63.1649780273	1	female	0	6	556	Lung Cancer	Cancer	1	12	$11-$25k	0	2532	2167.48828125	1894.419921875	9	white	73	2	107	16	37.8984375				1	129							no(M2 and SIP pres)	2.0966796875
76.7119750977	1	male	0	16	669	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	9	30223	22569.3125	17698.546875	17.3333282471	white	59	16.796875	72	32	35.8984375	126.515625			11.599609375	145	7.419921875					1	no(M2 and SIP pres)	1
50.2399902344	1	female	0	28	38	ARF/MOSF w/Sepsis	ARF/MOSF	2	12		0	138255	92819.25	102443.9375	38.25	white	119	2	108	34	39.3984375	187.5			1.0998535156	143	7.4892578125					0	<2 mo. follow-up	0
75.2219848633	1	female	0	25	724	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	44402	28899.234375	27155.015625	35.5	white	64	11.099609375	75	10	38	186.65625	3.1997070313	0.5	1	134	7.509765625					0	no(M2 and SIP pres)	0
78.2509765625	1	male	0	11	109	Lung Cancer	Cancer	1	16	$11-$25k	0	11474	7410.67578125	6662.26953125	7.5	white	118	16.796875	85	20	35.8984375		4.099609375	0.5999755859	1.3999023438	138					0	0	no(M2 and SIP pres)	0
76.5389404297	1	male	0	4	824	Colon Cancer	Cancer	2	12	$25-$50k	0	5133	3023.44140625	3598.87890625	7	white	111	11.69921875	53	20	36.6953125		4.19921875	0.5999755859	1.5	142					0	0	no(M2 and SIP pres)	0
69.6949462891	0	male	0	9	1520	COPD	COPD/CHF/Cirrhosis	2			9	7717	5093.11328125	4697.609375	13	white	103	6.2998046875	70	24	37	266.625	4.099609375	0.8999023438	1	144	7.369140625					0		0
59.3289794922	1	male	1	6	6	MOSF w/Malig	ARF/MOSF	2	11	$25-$50k	0	25116	16730.25	15839.359375	41	white	77	0.0999908447	150	30	39.1953125	210.1875	2.3999023438	1.3999023438	2.3999023438	142	7.4794921875					0	<2 mo. follow-up	0
89.0649414063	1	female	0	4	319	CHF	COPD/CHF/Cirrhosis	3	8	under $11k	0	1830	1201.451171875	1016.4399414063	14	white	77	12.599609375	63	28	35.8984375	468			1	140	7.2998046875					2	no(M2 and SIP pres)	2
70.6479492188	1	female	0	14	15	Coma	Coma	0	12	$25-$50k	100	12994	8343.4140625	8123.1171875	20.3333282471	white	121	28.5	138	40	38.1953125	220.40625	4.5	0.6999511719	1.2998046875	138	7.5390625					0	<2 mo. follow-up	0
56.5449829102	1	male	0	3	664	Lung Cancer	Cancer	1			0	2563	1645.44921875	1407.189453125	13	white	104		79	20	36			0.3999633789	1	125								2.1313476563
90.2669677734	1	female	0	16	20	Coma	Coma	4	8	under $11k	44	8338	5678.20703125	4818.9765625	5.6666641235	white	113	27.3984375	107	24	38.59375		3.599609375	0.6999511719	2	134							<2 mo. follow-up	5.3515625
57.100982666	1	female	0	4	1000	Lung Cancer	Cancer	1	11	$11-$25k	0	2784	1590.189453125	914.3999023438	13	white	104	10.599609375	69	24	38.09375			0.1999816895	1.0998535156	132						0	no(M2 and SIP pres)	0
77.4319458008	1	male	0	12	432	Lung Cancer	Cancer	1			0	13719			6.5	white	113	12.599609375	76	20	36.3984375		4.099609375	0.5999755859	1.1999511719	141								2.5205078125
85.9629516602	1	female	0	6	1328	ARF/MOSF w/Sepsis	ARF/MOSF	0	8		0	6391	4357.63671875	4165.546875	20	white	79	23.796875	116	32	38.6953125	186.65625	4.099609375	0.1999816895	0.6999511719	131	7.4892578125					1	no(M2 and SIP pres)	1
77.5819702148	0	female	0	6	1421	COPD	COPD/CHF/Cirrhosis	0			9	8004	5128.5703125	5097.3984375	10	white	115		74	22	36.296875	184				140	7.2890625							2.9409179688
66.0039672852	1	male	0	6	104	Lung Cancer	Cancer	2	8		0	5387	3580.71875	3115.80859375	13	white	79	7.2998046875	130	24	38.5		3.7998046875	0.3999633789	1.0998535156	123					1	0	no(M2 and SIP pres)	0
88.0439453125	1	male	0	5	100	CHF	COPD/CHF/Cirrhosis	4	8	under $11k	9	2461	1665.7099609375	1532.6591796875	6	white	102		83	24	36			0.299987793	2.6997070313	132					6	4	no(M2 and SIP pres)	4
64.2439575195	0	male	0	6	1390	CHF	COPD/CHF/Cirrhosis	2	12		0	4388	2943.193359375	2494.30859375	9	white	72	7.099609375	48	20	35.6953125	323.75			1.6999511719	136	7.4091796875				0	0	no(M2 and SIP pres)	0
57.3609924316	0	female	0	11	1390	COPD	COPD/CHF/Cirrhosis	2	8	$11-$25k	0	16935			13	white	66	11.099609375	114	36	39.59375	192.5625	2.6997070313	1.5	1	135	7.4091796875					3	no(M2 and SIP pres)	3
50.1899719238	1	male	0	6	100	Lung Cancer	Cancer	4	12	>$50k	0	3883	2523.033203125	2455.578125	9	white	77	10.3984375	70	20	35.6953125		3.2998046875	0.1999816895	0.5999755859	132					2	2	no(M2 and SIP pres)	2
70.3709716797	1	female	1	43	43	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	98681	67149.75	74074.8125	43	white	65	22.3984375	72	40	37.6953125	100	1.6999511719	0.299987793	0.6999511719	131	7.44921875					0	<2 mo. follow-up	0
51.8769836426	1	male	0	15	1228	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	12740	8003.8203125	10091.0625	13.6666641235	white	79	10.599609375	98	24	35.59375	361.875	4	1.3999023438	1.6999511719	135	7.4599609375					0		0
65.875	0	male	0	5	1350	Lung Cancer	Cancer	2	11	under $11k	0	5483	3792.6484375	3592.728515625	10	white	71	22.8984375	67	26	35.09375		3.7998046875	0.5	0.8999023438	124							no(M2 and SIP pres)	2.4208984375
73.2699584961	0	female	0	46	1335	COPD	COPD/CHF/Cirrhosis	2			26	65771	44039.9375	44007.46875	27	white	55	7.2998046875	71	8	37.59375	187.5	2.7998046875	0.8999023438	2.5	142	7.669921875							3.068359375
59.8769836426	1	male	0	6	78	Lung Cancer	Cancer	3	12	$11-$25k	9	4064	2535.625	2750.609375	7	white	65	0.8999023438	63	20	36.3984375		2.6997070313	0.5	0.5999755859	135							adl>=4 (>=5 if sur)	2.7900390625
68.0569458008	1	male	0	18	1097	MOSF w/Malig	ARF/MOSF	3			26	25959	18683.546875	18205.53125	27.3333282471	white	57	100	105	12	38.3984375	131.65625	3.099609375	1.6999511719	1.3999023438	146	7.4892578125					0	no(M2 and SIP pres)	0
65.1169433594	1	female	0	7	172	COPD	COPD/CHF/Cirrhosis	2	7		0	6253	4228.27734375	3942.0390625	4	white	70	5.2998046875	71	20	36.796875	257.125	4.19921875	0.299987793	0.8999023438	140	7.51953125	105	7	3400	1		no(M2 and SIP pres)	1.1667480469
63.8379821777	1	female	0	9	281	CHF	COPD/CHF/Cirrhosis	3	9	under $11k	0	5725	3879.41015625	2918.94921875	8	white	105	10.69921875	81	24	36.1953125				1.5998535156	136		218	19	2375	0	1	no(M2 and SIP pres)	1
82.1139526367	1	female	0	16	719	COPD	COPD/CHF/Cirrhosis	1	12		26	20328	13797.953125	13497.3359375	20	hispanic	113	7.69921875	110	10	38.1953125	268.5625	4	0.7999267578	0.5999755859	140	7.3994140625	147	9	2000		0	no(M2 and SIP pres)	0
76.5969848633	1	female	0	5	19	Lung Cancer	Cancer	1	12		0	2698	1880.1591796875	2167.23828125	6	white	61	8.298828125	51	24	39.1953125		3.2998046875	0.299987793	0.6999511719	139		99	20				<2 mo. follow-up	2.23828125
72.4459838867	0	male	0	6	1049	CHF	COPD/CHF/Cirrhosis	6	3	under $11k	0	4549	3150.80078125	2777.62890625	12	white	107	10.5	112	24	36.3984375	428.5625			1.1999511719	138	7.509765625	115	12	2885		0	no(M2 and SIP pres)	0
75.876953125	1	female	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	under $11k	0	86926	56362.84375	54649.09375	26	white	109	10.3984375	126	36	38.296875	192			0.6999511719	139	7.5595703125	256	25	5450		1	<2 mo. follow-up	1
77.1309814453	0	male	0	28	1034	Coma	Coma	1	13	$25-$50k	89	37480	25343.3125	23766.671875	22.75	white	71		65	25	38.09375		3.099609375	0.5999755859	1.2998046875	141		157	14	800		0	adl>=4 (>=5 if sur)	0
64.158996582	0	male	0	84	1030	ARF/MOSF w/Sepsis	ARF/MOSF	2			37	196926	140458.25	134407.625	23.25	white	59	19.19921875	155	30	38.796875	217.5	2.099609375	3	1.6999511719	144	7.51953125	352	67	670			Coma or Intub	2.669921875
71.2059936523	1	male	1	19	19	ARF/MOSF w/Sepsis	ARF/MOSF	1	19	>$50k	41	81716	57042.6875	54791.59375	45.6666564941	white	135	13.599609375	130	24	36.3984375	267.5	2.8999023438	19.296875	3.2998046875	136	7.439453125	104	39	8		0	<2 mo. follow-up	0
44.7909851074	1	male	0	5	423	Lung Cancer	Cancer	1	12	$25-$50k	0	6825	3957.322265625	1819.3291015625	10	white	79		77	24	36.296875					140				2550			no(M2 and SIP pres)	1.9291992188
66.8559570313	0	female	0	17	1019	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	30742	21348.734375	19812.796875	14	hispanic	58	10.5	70	12	38.5	160	2.099609375	0.6999511719	0.5999755859	134	7.4697265625	106	9	2990			no(M2 and SIP pres)	2.1176757813
77.4729614258	0	male	0	6	1001	CHF	COPD/CHF/Cirrhosis	2	8		0	4194	2887.73828125	2590.029296875	11	white	73	7.3994140625	64	20	36.3984375			1.3999023438	1.6999511719	139		200	39	2300		0	no(M2 and SIP pres)	0
70.8469848633	0	female	0	21	992	ARF/MOSF w/Sepsis	ARF/MOSF	3	12		26	53893	35381.03125	40310.5625	18.3333282471	hispanic	68	7.2998046875	81	28	38.59375	277.5	2.5	0.7999267578	1	138	7.419921875	168	18	1138		0		0
67.7479858398	1	male	0	13	22	Lung Cancer	Cancer	1	20		37	8261	5839.03125	5178.41796875	4.5	hispanic	72	8.5	122	32	36.1953125				0.8999023438	138		159	10				<2 mo. follow-up	3.52734375
76.3669433594	1	male	0	11	47	Lung Cancer	Cancer	1	8	$11-$25k	0	13244	9110.2578125	6189.46875	10.5	white	114	10.5	73	28	35.796875		3.2998046875	0.299987793	1.3999023438	142	7.4599609375	181	18			1	<2 mo. follow-up	1
86.633972168	1	male	0	4	335	CHF	COPD/CHF/Cirrhosis	3	8	under $11k	0	2045	1430.6904296875	1166.7392578125	6	white	110	4.8994140625	79	24	36.09375				1.5998535156	141		94	25	575	2	0	no(M2 and SIP pres)	0
55.8249816895	0	female	0	5	970	Lung Cancer	Cancer	1	14	>$50k	0	8226	5446.23828125	5091.078125	6	white	107	16.59765625	53	16	36.796875				0.7999267578	138		117	8	3025				2.0825195313
51.1129760742	1	male	0	4	11	ARF/MOSF w/Sepsis	ARF/MOSF	4	10	under $11k	0	15226	10579.234375	11855.9921875	43	white	68	10.3984375	64	40	36.09375	268	2.5	3.8999023438	0.7999267578	137	7.4091796875	168	25	4550	2		<2 mo. follow-up	1.8388671875
83.9479980469	1	male	0	4	454	Coma	Coma	3	8		41	4574	3325.349609375	3421.068359375	16	white	113	13.798828125	105	32	38.3984375	290		0.5999755859	1	138	7.4091796875	98	20	960		4		4
71.2609863281	1	male	1	3	3	MOSF w/Malig	ARF/MOSF	1	3	$11-$25k	44	70697	48408.125	47537.34375	46	white	135	0.6999511719	112	8	39.3984375	103.328125			5.099609375	134	7.2998046875	90	83	133			<2 mo. follow-up	2.4321289063
75.701965332	1	male	0	12	109	COPD	COPD/CHF/Cirrhosis	3	15	$11-$25k	0	8417	5477.29296875	5899.4765625	10	white	66	8.298828125	56	28	36	221.71875	4.2998046875	1.0998535156	0.8999023438	137	7.3291015625	168	15	1700	3	2	adl>=4 (>=5 if sur)	2
83.9149780273	1	male	0	10	382	CHF	COPD/CHF/Cirrhosis	5			0	6141	4087.0390625	3962.138671875	9	white	70	5.8994140625	54	22	35.8984375	295.1875			2.099609375	143	7.419921875	98	48	1700				5.9384765625
81.8119506836	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	under $11k	0	66049	43404	41449.28125	55	white	53		105	10	38.796875	87.046875	2.8999023438	1.3999023438	2.7998046875	132	7.5	169	68	1898		0	<2 mo. follow-up	0
45.1359863281	0	male	0	8	878	Cirrhosis	COPD/CHF/Cirrhosis	3			0	8785	5756.75390625	5192.65625	8.5	white	80	4.7998046875	81	24	36.5	480.9375	2.099609375	8.19921875	1.6999511719	133	7.4091796875	127	28	1600				2.275390625
76.8099975586	0	male	0	9	868	CHF	COPD/CHF/Cirrhosis	5	14	$11-$25k	0	8619	6012.48046875	5320.12890625	13	white	64	11	102	36	36.59375	204.75		0.8999023438	2	140	7.4091796875	91	32	2595	1	2	no(M2 and SIP pres)	2
73.0379638672	0	male	0	7	860	CHF	COPD/CHF/Cirrhosis	4	8	under $11k	0	8538	5824.74609375	5886.95703125	10	white	57	8.298828125	60	26	36.09375	304.75			1.0998535156	135	7.3994140625	212	16	2485	0			0.4947509766
70.7679443359	1	male	0	8	9	Lung Cancer	Cancer	1	11	under $11k	0	9416	5896.37109375	4755.94921875	15.5	white	117	15.599609375	79	20	36		3.599609375	0.299987793	1.0998535156	134		141	11			1	<2 mo. follow-up	1
66.9789428711	1	female	0	9	220	COPD	COPD/CHF/Cirrhosis	6	13	$11-$25k	0	11621	7526.96484375	8539.84375	16	white	68	16.09765625	107	24	36.3984375	165	4.099609375	0.1999816895	1.1999511719	132	7.33984375	446	42	3150	0	0	no(M2 and SIP pres)	0
59.6079711914	0	male	0	7	827	COPD	COPD/CHF/Cirrhosis	5	11	$11-$25k	0	6488	4236.8203125	4441.9765625	8.5	white	90	13.599609375	69	28	36.1953125	276		0.5999755859	0.7999267578	141	7.369140625	242	20	3300	0	0	no(M2 and SIP pres)	0
58.1849975586	0	female	0	21	820	Coma	Coma	0	12	>$50k	44	28158	20724.09375	20050.796875	21	white	117	16.69921875	76	32	36	188		0.299987793	0.7999267578	139	7.4296875	183	16	1625		0	no(M2 and SIP pres)	0
38.2509765625	0	male	0	33	804	Cirrhosis	COPD/CHF/Cirrhosis	2	12		0	47539	31000.71875	33095.03125	8.25	white	109	8.298828125	114	12	37.796875		1.7998046875	4.69921875	0.5999755859	139		132	7	965			no(M2 and SIP pres)	2.7905273438
63.241973877	0	female	0	8	801	COPD	COPD/CHF/Cirrhosis	7	12		0	6430	4216.78515625	3579.259765625	9.5	white	51	12.3984375	45	24	36.6953125	217.375	3.599609375	0.3999633789	1.2998046875	130	7.3994140625	211	23	1700	0	1	no(M2 and SIP pres)	1
83.2549438477	1	female	0	4	337	CHF	COPD/CHF/Cirrhosis	0	16	$11-$25k	0	2127	1396.1650390625	1228.509765625	11	white	59	5.8994140625	76	30	35.796875		4.099609375	2	2.6997070313	138		98	58	1125	0		no(M2 and SIP pres)	0.4947509766
89.4779663086	1	female	0	9	319	CHF	COPD/CHF/Cirrhosis	6	13		0	5923	3958.7890625	3650.44921875	12.5	white	61	6.099609375	51	32	35.59375	485.6875			1.2998046875	132	7.44921875	96	64	2200		7	adl>=4 (>=5 if sur)	7
88.375	0	female	0	11	763	ARF/MOSF w/Sepsis	ARF/MOSF	0	5	under $11k	0	10371	7066.0859375	7182.9296875	17	white	65	14.5	119	24	36.1953125	209.5	3.3999023438	0.5999755859	0.8999023438	138	7.4296875	115	20	600		1	no(M2 and SIP pres)	1
71.2009887695	1	male	1	16	16	Coma	Coma	2	12		89	23547	16675.140625	17210.046875	29	white	64	21.5	36	32	37.8984375	318	2.7998046875	0.8999023438	2.6997070313	132	7.279296875	268	49	1125		0	<2 mo. follow-up	0
50.9379882813	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	1			0	47782	31594.359375	31824.65625	49	white	56	9.19921875	160	40	38.296875	218.5			1.3999023438	132	7.4697265625	149	13	1300			<2 mo. follow-up	2.0288085938
68.8159790039	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	3	12		0	12606	8449.125	9210.875	24	white	67	15.5	114	28	36.8984375	112.5	4.099609375	0.6999511719	3	132	7.4892578125	123	40	830			<2 mo. follow-up	2.4926757813
33.0949707031	0	male	0	5	717	ARF/MOSF w/Sepsis	ARF/MOSF	2			0	9241	6637.953125	7612.96875	16	white	75	17	105	25	38.09375	285.6875			0.6999511719	138	7.4296875	112	6	3975				2.6635742188
82.6059570313	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	50759	33172.375	35029.34375	47	white	56	8.5	106	10	38.8984375	135	2.2998046875	0.6999511719	5	127	7.3994140625	96	55	472		2	<2 mo. follow-up	2
69.9189453125	0	male	0	6	697	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	4386	2976.162109375	2650.158203125	14	white	78	8.298828125	53	16	35.8984375				1.3999023438	138		124	18	3100	0		no(M2 and SIP pres)	0.4947509766
69.3799438477	1	male	0	8	9	Lung Cancer	Cancer	1	8	under $11k	0	9324	5800.91796875	5449.05859375	13	white	74	13.19921875	98	24	35.59375	290.4375	3.6997070313	0.5	1	130	7.4794921875	126	17	1125		0	<2 mo. follow-up	0
82.9379882813	1	female	1	4	4	COPD	COPD/CHF/Cirrhosis	5	8	under $11k	26	6338	4364.484375	4638.0078125	22	white	57	16.8984375	165	40	38.1953125	280.75			1.2998046875	138	7.369140625	274	32	1250			<2 mo. follow-up	5.9931640625
76.6319580078	0	male	0	18	639	COPD	COPD/CHF/Cirrhosis	3	8	$11-$25k	0	10375	6827.00390625	6236.20703125	7.3333320618	white	69		83	20	36.09375	190.46875			1.6999511719	140	7.349609375	83	26			2	no(M2 and SIP pres)	2
70.5649414063	0	male	0	4	635	COPD	COPD/CHF/Cirrhosis	1	13	$25-$50k	0	2365	1585.7607421875	1604.69921875	5	white	71	9.19921875	60	28	35.796875	268		0.5	1.0998535156	140	7.3193359375	118	10		0	0	no(M2 and SIP pres)	0
65.4869995117	1	male	0	7	28	CHF	COPD/CHF/Cirrhosis	2	7	under $11k	37	5066	3334.22265625	3096.908203125	5	white	103	10.8984375	57	24	36.296875			0.5	1.5	138		114	24	1615	0	0	<2 mo. follow-up	0
62.9239807129	1	female	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	100	58428	38707.15625	39558.03125	47	white	33		76	20	38.59375	102.34375			4.19921875	144	7.19921875	235	70	330		1	<2 mo. follow-up	1
75.2219848633	0	male	0	15	633	ARF/MOSF w/Sepsis	ARF/MOSF	1	7		0	46467	31250.390625	32330.640625	27.3333282471	white	65	12	109	40	38.1953125	177.5	2.5	1.1999511719	1.3999023438	134	7.4892578125	147	43	3400		0	no(M2 and SIP pres)	0
70.751953125	1	male	0	5	240	COPD	COPD/CHF/Cirrhosis	5	8		0	3427	2172.2734375	1754.349609375	9	white	53	15.298828125	60	28	35.6953125		3	0.5	1.6999511719	134		202	24		1	0		0
78.7569580078	1	male	0	9	536	MOSF w/Malig	ARF/MOSF	0	8		0	27466	18589.9375	18974.40625	27.5	white	73	19.296875	50	13	38.1953125	177.125			1.5998535156	131	7.4599609375	117	28	1690		0	no(M2 and SIP pres)	0
87.5669555664	0	female	0	14	617	CHF	COPD/CHF/Cirrhosis	3	8		0	9171	6001.64453125	5309.58984375	7.3333320618	white	109	9.8984375	83	38	37.8984375	212		1.1999511719	1.3999023438	137	7.51953125	69	19	5950		2	no(M2 and SIP pres)	2
69.592956543	1	male	0	5	103	Colon Cancer	Cancer	1	8	under $11k	0	2545	1613.30859375	1731.619140625	13	white	69	11.099609375	69	20	35.796875		3.599609375	1.7998046875	0.7999267578	132		153	16		0		no(M2 and SIP pres)	0.4947509766
75.9669799805	0	female	0	12	593	COPD	COPD/CHF/Cirrhosis	3	8	under $11k	44	17883	12190.140625	12751.859375	17	white	115	12	76	29	36.296875	223.3125			0.8999023438	135	7.349609375	177	17	2025		2	no(M2 and SIP pres)	2
61.4649963379	1	male	0	43	376	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	$11-$25k	44	137058	91445.5	97328.6875	42.25	white	63	10	127	8	40.8984375	155	2.5	1.5	3.6997070313	144	7.4697265625	108	72	1510		0	adl>=4 (>=5 if sur)	0
76.7199707031	0	male	0	6	562	COPD	COPD/CHF/Cirrhosis	2	16		0	5013	3363.3359375	3150.138671875	16	white	117	6.599609375	67	24	36.3984375	308.6875	4.099609375	1	1.8999023438	138	7.4697265625	216	31	1550	0	1	no(M2 and SIP pres)	1
68.7969970703	0	female	0	8	558	COPD	COPD/CHF/Cirrhosis	0	12		0	5659	3657.369140625	4326.84765625	6	white	67	23.3984375	98	24	35.796875	195.21875	2.6997070313	0.299987793	0.5999755859	131	7.419921875	141	14		1	0	no(M2 and SIP pres)	0
62.4699707031	1	male	0	11	265	Colon Cancer	Cancer	4	14		0	8591	5707.18359375	4523.44921875	15	white	71	13.099609375	54	20	36.8984375		4.69921875	0.5	1.1999511719	134		194	16	2875	0	1	no(M2 and SIP pres)	1
71.3159790039	0	male	0	21	527	ARF/MOSF w/Sepsis	ARF/MOSF	1	12		41	98932	67951.6875	65919.25	26	white	69	16.796875	117	26	36.8984375	400			5.099609375	134	7.4599609375	135	80	220		0	no(M2 and SIP pres)	0
58.7789916992	1	male	1	4	4	Coma	Coma	0	12	under $11k	100	5555	3875.2421875	4022.19921875	36	white	158	27.296875	118	29	36.3984375	220			1	142	7.58984375	171	16	1800			<2 mo. follow-up	2.2841796875
62.8639831543	1	female	0	14	258	COPD	COPD/CHF/Cirrhosis	2	14		26	18628	12560	13344.46875	17	white	101	17.3984375	77	12	36.3984375	177.125			0.7999267578	139	7.369140625	132	15	1975		0	no(M2 and SIP pres)	0
70.0919799805	1	female	0	13	77	ARF/MOSF w/Sepsis	ARF/MOSF	5	9	under $11k	0	14271	9694.84375	12627.375	20.5	white	65	38.3984375	104	30	36	152.5		1	1.2998046875	132	7.419921875	243	25	1225	6	3	SIP>=30	3
81.7219848633	1	male	0	4	437	COPD	COPD/CHF/Cirrhosis	3	8	under $11k	0	3043	2024.9912109375	2515.109375	16	white	71	4.599609375	67	24	36.296875	252.375		0.3999633789	1.2998046875	141	7.3798828125	113	32				no(M2 and SIP pres)	2.884765625
74.5219726563	1	female	0	3	309	CHF	COPD/CHF/Cirrhosis	5	8	$11-$25k	0	2172	1436.1357421875	1715.029296875	4	white	99	7.599609375	110	24	36.3984375	428.5625	1.1999511719	0.3999633789	3.5	135	7.4697265625	246	55				no(M2 and SIP pres)	2.8486328125
88.4649658203	0	female	0	8	453	MOSF w/Malig	ARF/MOSF	0	8		9	19050	12381.96875	11637.859375	10	white	78	16.09765625	85	28	38.1953125	217.5			0.7999267578	133	7.4296875	115	10	1925	5	6	no(M2 and SIP pres)	6
75.1699829102	0	female	0	13	451	COPD	COPD/CHF/Cirrhosis	3	8		26	13763	9029.9921875	8189.796875	15	white	77	16.3984375	118	28	36.1953125	233.3125		0.6999511719	1.0998535156	133	7.4697265625	269	15	1075		0	no(M2 and SIP pres)	0
36.8099975586	1	female	1	25	25	MOSF w/Malig	ARF/MOSF	1	14		0	127198	82520.25	87494.75	36	white	106	0.0999908447	128	30	38.8984375	160	3.1997070313	6.599609375	4.7998046875	136	7.369140625	113	99	2075		0	<2 mo. follow-up	0
49.116973877	0	male	0	6	394	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	5799	3943.54296875	3946.158203125	12	white	108	8.8984375	87	28	36.796875	269.5625			1.0998535156	136	7.33984375	146	26	4750				2.9858398438
76.7279663086	1	male	0	4	242	Lung Cancer	Cancer	1	12		0	10134	6054.04296875	5996.0390625	10	white	119	6	77	20	36.59375		4.2998046875	0.5999755859	1.5998535156	140		122	17	3550			no(M2 and SIP pres)	1.775390625
18.4149932861	0	male	0	9	380	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	>$50k	0	22047	13396.90625	14879.546875	23	white	67	12.099609375	66	15	36.3984375		3.599609375	0.5999755859	0.7999267578	131		348	10	3300		0		0
74.6199951172	0	male	0	9	361	CHF	COPD/CHF/Cirrhosis	5	12		0	6963	4772.4609375	5048.37890625	10	white	64	6.7998046875	114	24	36.1953125	400	3.1997070313	0.8999023438	1.0998535156	138	7.509765625	158	21	2150	0	0		0
75.9479980469	0	male	0	13	359	ARF/MOSF w/Sepsis	ARF/MOSF	2	8		26	25038	17292.65625	15560.1796875	14.5	white	75	8.099609375	145	24	37.796875	230			1.1999511719	128	7.51953125	166	20	1570		2	no(M2 and SIP pres)	2
18.0419921875	0	female	0	12	358	MOSF w/Malig	ARF/MOSF	0			0	32141			18	white	70	0.8999023438	73	28	35.6953125		2.6997070313	1.2998046875	1.7998046875	135		239	42	5980				2.1474609375
